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ABSTRACT 
 
AN ETHICAL JUSTIFICATION OF WEIGHT LOSS SURGERY 
 
 
 
 
By 
Amy M. VanDyke 
May 2013 
 
Dissertation Supervised by Gerard Magill, PhD 
This dissertation provides an ethical justification of surgical weight loss 
interventions for the treatment of obesity. Situating obesity as not merely a public health 
concern but also fundamentally a problem of clinical medicine confronting individual 
patients and physicians, the dissertation argues that the time frame of public health 
interventions is too long for individuals presently facing obesity and its deleterious 
physical and social co-morbidities. It argues that failure to address weight loss on an 
individual level, and specifically to consider the clinical appropriateness of weight loss 
surgery (WLS), raises serious questions about failure to respect autonomy and promote 
patient welfare. Moreover, social skepticism or rejection of WLS as a treatment option 
raises concerns about fairness, as this failure indicates that obesity is not regarded in 
relevantly similar ways to other life-threatening and health-impairing conditions.  
 v 
 
The dissertation examines various reasons that obesity and its myriad 
interventions, including WLS, are inadequately addressed in the clinical setting. It argues 
that considerations with cultural and ethical valence play a critical role in obesity‘s 
different and unfair treatment within clinical medicine. Gendered and theologically 
informed attributions of blame, self-blame, shame, and self-stigma influence the attitudes 
and actions of both patients and clinicians with regard to addressing obesity. 
Inappropriate and conceptually confused ascriptions of responsibility impede social 
acceptance of, and access to, WLS. The dissertation‘s criticism and subsequent 
reconceptualization of these ascriptions of responsibility from a perspective informed by 
feminist epistemology and ethics provide the foundation upon which to consider reform 
of current clinical practices surrounding treatment of obesity.  This dissertation concludes 
that WLS is both ethically and clinically justified. 
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Chapter One: Statistics, Trends, and Factors Contributing to Obesity 
 Although it may seem that the problem of obesity is obvious—after all, people 
wear the problem not just on their sleeves but on their entire bodies—the obesity problem 
nevertheless is both complex and sometimes obscure. This chapter demonstrates that 
obesity is not only scientifically and medically complex, but also conceptually and 
socially complicated in ways that are sometimes obscured by its status as an alleged 
medico-scientific fact. Indeed, the scientific ―facts‖ and social norms surrounding the 
definition, measurement, and etiology of obesity constitute a contested terrain within 
which interventions to address obesity are developed, debated, accepted, or rejected.  
 This chapter provides relevant background information on the problem of obesity. 
Specifically, Section A focuses on the scope of the current problem by examining the 
increase in obesity‘s prevalence and severity, both in the United States and in other parts 
of the world. Section A also addresses the controversial definition and measurement of 
obesity. Section B discusses the myriad effects of obesity on physical health and quality 
of life..The far-reaching deleterious physical co-morbidities and reduction in quality of 
life indicators associated with obesity are explicated.. These first two sections establish 
that there is substantial, though not perfect, consensus that obesity is a growing and 
complex health problem. Subsequent sections take up the contentious issues of how the 
problem should be framed and addressed. Specifically, section C of this chapter discusses 
various highly contested terrains surrounding the diagnosis of obesity, the acceptance of 
obesity as a disease, the understanding of obesity as modern-day epidemic, and the 
approval or rejection of various interventions applied to this problem. This section 
examines numerous problems of communication about obesity which exist in society in 
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general and in the healthcare system specifically. Section three argues that 
communication problems, combined with varying degrees of understanding or acceptance 
of the myriad causes of obesity, impede the application of typical ethical standards 
applied in health care such as those found in informed medical decision making, as well 
as considerations of justice, and argues that ultimately patient welfare is sacrificed. 
Analysis of ethical standards and considerations initiated in this chapter will be examined 
in depth throughout the dissertation. Finally, this chapter claims that inappropriate 
ascriptions of blame, often based in communication errors, have implications for the 
social acceptance of various treatments including weight loss surgery (WLS). The first 
section of the chapter reflects the interplay of measurable facts and social context as it 
reveals the points of consensus and controversy involved in defining obesity by 
examining the scope of the obesity problem and its trends.  
A. Scope of the Problem 
 The first section of this chapter illuminates what is generally perceived to be the 
increasing problem of obesity both in the United States and across the globe. A review of 
the trends and disparate impact of obesity is necessary to understand both the present 
scope of the problem of obesity and its potential for the future. It is also relevant to 
examine those foundational issues where consensus is lacking. The first subsection will 
focus on the definition of obesity and on the various means of measuring it. The lack of 
consensus around these foundational concepts will be shown to complicate both 
appropriate identification and the treatment of obesity. The second subsection will 
provide national and international statistics on trends in the prevalence and incidence of 
overweight and obesity. These statistics will reveal particular populations in which 
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obesity has been shown to have become more deeply embedded than others. The 
following subsection begins by identifying the definitions of overweight and obesity and 
the contested nature of how it is measured.  
A.i Obesity: Its Definition and Measurement 
In order to understand the scope of the obesity problem, it is important to have 
knowledge of the manner by which it is most commonly diagnosed, along with proposed 
alternative methods of diagnosis, and controversies which surround its measurement. 
Historically, the definition of obesity and the means of diagnosing it have been fraught 
with controversy.
1
 However, measuring the body mass index (BMI) of an individual has 
emerged as the most common diagnostic tool for overweight and obesity. The use of BMI 
has been accepted as the measurement of adiposity by the Centers for Disease Control 
and the World Health Organization.
2
 The measurement of BMI provides an estimate of 
the percentage of body fat based on an individual‘s height and weight. BMI is calculated 
by dividing a person‘s weight (in kilograms) by the square of their height (in meters): 
BMI = kg/m
2
.
3
 A person with a BMI of below 18.5 kg/m
2 
is considered to be 
underweight, and a BMI between 18.5 and 24.9 kg/m
2 
is considered average or normal. A 
person with a BMI equal to or greater than 25 kg/m
2 
is considered to be overweight; a 
BMI of 30 kg/m
2 
is considered obese, and a BMI of 40 kg/m
2
 is considered to be 
morbidly, severely, or extremely obese.
4
  
The widespread usage of BMI is generally attributed to a contingent social fact—
namely, the ease with which height and weight can be obtained in a clinical setting.
5
 
Primary care physicians and office staff can take these measurements rapidly without 
expensive equipment or time-intensive activities.
6
 The use of BMI to define and measure 
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obesity is thus attractive in clinical practice. Additionally, this rough formula, which 
estimates the lean tissue ratio relative to adipose tissue, has achieved widespread usage in 
social science research. Replacing BMI with a different system of measurement may 
impair the usefulness of data captured under BMI in comparison with data captured with 
newer, perhaps better, diagnostic tools.
7
  
 Nonetheless, the use of BMI as the index by which to define and measure obesity 
has been widely criticized.
8
 These criticisms may best be understood in light of the 
development and evolution of BMI as a practical tool. Lambert Adolphe Quetelet, a 
Belgian mathematician, developed the Quetelet Index in 1832 as a part of a larger project 
to define the typical human of the time.
9
 This tool was later renamed the Body Mass 
Index in 1972 by Ancel Keys.
10
 Quetelet‘s quest was to identify the ―normal man‖—i.e., 
to identify and document the standard proportions of the human (male) build of the time. 
He set out to measure various characteristics, including arm length and the age at which 
men married. Quetelet collected measurements from several hundred people in his native 
country of Belgium, in the area of Brabant. What Quetelet found was that the weight 
among those he studied varied in proportion to the square of height. Quetelet‘s research 
on the proportional relationship between height and weight was used to refine of the 
earlier work of French military doctor Paul Broca, who proposed that weight varied in 
direct proportion to height. Quetelet‘s findings on weight and other standard proportions 
of Belgian people in the nineteenth century was published in the book A Treatise on Man 
and the Development of His Faculties.
11
 During Quetelet‘s lifetime, his heuristic device 
had little influence in the medical community. Its purpose was descriptive, not diagnostic, 
and was of little practical value at that time. It was not until the following century that the 
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use of the BMI became a standard by which weight anomalies, including overweight and 
obesity, were defined. Subsequently, critics have questioned the wisdom of generalizing 
results obtained from a relatively small sampling of a specific population group 
(primarily male citizens from the Brabant region of Belgium in the 1800s) and 
developing a standard measurement tool based on those results.
12
 
 The most common and perhaps the most serious criticism of using BMI to define 
and measure obesity is that the BMI is only an indirect measurement of adiposity and that 
it does not account for lean body mass (bone, muscle) relative to other body mass 
(adipose tissue).
13
 This important distinction between types of body mass, for which BMI 
cannot account, may well be crucial in determining the relative health risks associated 
with weight of those individuals on either end of the weight continuum. Instead of using 
BMI as a screening tool, the current practice is to use the BMI as a diagnostic tool which 
is considered informative with regard to health risk. What this means is that merely by 
being categorized as overweight or obese, an individual is assumed to carry significantly 
more risk based on weight as related to health than are those of normal weight (again, as 
measured and defined by BMI). Such categorization and attribution of risk is thought to 
be problematic on many levels—conceptual, medical, social, and ethical—as this 
categorization is seen by many to be but a small part of the overall risk assessment for an 
individual screened for being beyond the norms of weight.
14
  
Other criticisms of using BMI to define obesity include that it does not account 
for the location of the adipose tissue and thus fails to enable distinction between the 
relative risks of carrying excess visceral or subcutaneous adipose tissue. More recent 
research has shown that there are significant risk differences in the nature and magnitude 
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of health risks based upon where one carries excess weight.
15
 Another criticism is that 
BMI measurement does not take into account what might be considered normal bodily 
changes with aging. These normal weight changes associated with aging may or may not 
be associated with greater health risks.
16
 By ignoring the relevance of age and adipose 
location to weight-related health risk, the use of BMI as a weight measurement risks 
being both insufficiently sensitive and insufficiently specific. Use of BMI may result in 
false negatives and false positives when used to diagnose obesity and associated risk 
factors.
17
  
 Finally, BMI and the weight categories it is used to create are criticized for being 
treated as absolute and rigorously evidence-based, when in reality the thresholds assigned 
to various BMI levels and weight categories are grounded in perceptions of clinical 
exigency.
18
 In fact, the category thresholds have changed over the years. In 1998 the 
National Institutes of Health (NIH) altered its category designations to accept those used 
by the World Health Organization. The NIH at that time lowered the normal weight and 
overweight cut-off points from a BMI of 27.8 to a BMI of 25. This had the effect of 
immediately assigning the designation of overweight to approximately twenty-five 
million Americans who had previously been categorized as being of normal weight.
19
 
While the BMI categories used by the United States and the WHO are now the same, 
other countries—including Japan and Singapore—have set cut-off points for categories at 
lower levels than those used by the United States and the WHO.
20
 Those lower thresholds 
are thought to reflect the smaller physical stature of the individuals from those 
countries.
21
 Some in the United States have even suggested that BMI insufficiently 
accounts for physical variability present between African Americans and Caucasians.
22
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Other measurements of overweight and obesity such as hip-to-waist ratio, skin-
fold thickness, and the measurement of waist circumference have been proposed as 
replacements for BMI. These proposed replacements are thought to have greater 
diagnostic usefulness for predicting health risk relative to adiposity.
23
 However, these 
methods have not yet been widely adopted in clinical settings. Thus, despite what some 
would term serious flaws that may endanger health, BMI continues to be the most widely 
used clinical measurement of normal and anomalous weights, including the designation 
of overweight and obesity.
24
 The following section will discuss the trends being observed 
in obesity in the United States and other parts of the world. Even with the controversies 
surrounding which is the most appropriate tool for diagnosis, obesity appears to be 
increasing both in prevalence and in severity.  
A.ii Trends in Obesity 
 There is widespread agreement, based on national and international data, that the 
problem of overweight and obesity in the United States and in other developed nations is 
increasing.
25
 Indeed, the prevalence and incidence of overweight and obesity has been on 
the rise for several decades.
26
 Prior to the 1950s, there were no reliable estimates of the 
incidence and prevalence of overweight and obesity.
27
 Some have stated that there was 
little need to capture these statistics because the problem of obesity was rare and in itself 
unremarkable.
28
 
It was not until the 1960s that statistics relative to weight began to be captured. 
Statistics on the health and nutritional status of adults and children in America, including 
data on obesity trends, have been collected by the US Department of Health and Human 
Services through the National Center for Health Statistics (part of the Centers for Disease 
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Control and Prevention) since the early 1960s. The National Health Survey Act of 1956 
provided legislative authorization for gathering health and nutritional statistics, as well as 
data on the effects of illness and disability in the United States.
29
 Surveys were 
implemented to collect data from three main sources: direct interviews, clinical tests and 
physical examinations of individuals, and information recorded in doctor‘s offices, 
hospitals, and other settings through which people access medical treatment. Among the 
information collected were data on various ―risk factors, aspects of a person‘s life-style, 
constitution, heredity or environment that may increase the chances of developing a 
certain disease or condition.‖30 Included were factors such as drug use, alcohol 
consumption, sexual practices, and weight. The same mandate included obesity among 
―diseases, medical conditions and health indicators to be studied.‖31  
The first in the series of National Health Examination Surveys (NHES), later 
renamed the National Health and Nutrition Examination Survey (NHANES), was 
conducted from 1960 to 1962. Since the first of these, at least eight such surveys have 
been conducted. Over the years the survey‘s focus has changed to reflect the most 
prominent health concerns of the time, such as children‘s health issues, chronic diseases, 
and obesity.
32
 In response to medical research in the 1970s which reported a relationship 
between nutritional status and health indicators, the survey began to focus additional 
attention on the relationship between diet or nutrition and health status, such as the 
relationship between what one eats and the development of obesity and its co-morbidities 
(e.g. diabetes or cardiovascular disease).
33
  
 The outcome of the first survey (1960–1962), with 6000 participants, found that 31.5 percent of 
Americans were overweight, with 13.4 percent being obese and 0.9 percent being extremely obese.34 These 
preliminary results serve as the baseline from which subsequent survey results have been 
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compared. There were two NHANES conducted in the 1970s. The NHANES I was 
conducted between 1971 and 1974 and included almost 13,000 individuals, while the 
next survey conducted between 1976 and 1980 and included fewer than 12,000 
participants.
35
 Statistics from these two surveys began to show an increase in the 
prevalence of overweight and obesity across categories. Survey results from 1970 
through 1974 showed those who were overweight at 32.3 percent, obese at 14.5 percent, 
and those with extreme obesity were 1.3 percent of the population. Late in that same 
decade the number of overweight individuals stood at 32.1 percent, those with obesity 
were at 15.0 percent, and those having extreme obesity had increased to 1.4 percent.
36
 
 The 1988–1994 NHANES survey of 14,000 found that while there was only a 
small increase in the number of people who met criteria for overweight, those who met 
criteria for being obese or extremely obese had seen greater increases.
37
 The percentage 
of those who were overweight was 32.7 percent. Obesity and extreme obesity were at 
23.2 percent and 3.0 percent respectively. These figures translate to an eight-point 
increase in obesity and slightly more than double the number of people with extreme 
obesity (up from 1.4 percent) in just eight years. The number of those surveyed between 
1988 and1994 was over 14,000 people.
38
 In 1997 in the United States, the number of 
adults with a BMI falling into the category indicating obesity was approximately 27 
percent, with some sources citing as much as 33 percent.
39
 These figures represent almost 
double the prevalence of obesity just twenty years earlier.    
In the nutrition and health surveys conducted between 1999 and 2000 and again 
between 2001and 2002, the numbers of those being surveyed was noticeably smaller 
(between 3,600 and 3,900 participants). However, the participants themselves had 
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continued to increase in size. As discussed earlier in this chapter, the threshold for 
designating an individual as overweight or obese was lowered in 1998 to be in line with 
the categories accepted by the WHO.
40
 Survey participants who would previously have 
been considered to be of normal weight were recategorized as overweight based on this 
threshold realignment. The increasing rates of overweight, obesity, and extreme obesity 
continued to show increases during these time frames as well. The increased rates for the 
two survey periods were as follows: overweight individuals at 33.6 percent and 34.4 
percent, obese individuals made up 30.9 percent and 31.3 percent, and those with extreme 
obesity were at rates at 5.0 percent and 5.4 percent.
41
 
 In the two most recent surveys this unfortunate trend has continued across almost 
all categories. NHANES (2003–2004), with a survey group of just over 3,700 
participants, showed the rate of overweight at 33.4 percent, obesity at 32.9 percent, and 
extreme obesity at 5.1 percent of the population. NHANES (2005–2006), with just under 
4,000 participants, found overweight came in at 32.2 percent, obese at 35.1 percent, and 
extremely obese individuals at 6.2 percent of the American population.
42
 Based upon the 
most recent statistics available, during the years 2005–2006, the prevalence of obesity 
(including all those with a BMI greater than 30) and extreme obesity (including all those 
with a BMI greater than 40) in the United States stood at approximately 41.3 percent.
43
 
The US population is currently estimated at approximately 310,718,864 people.
44
 
Therefore, at present there are approximately 128 million Americans who are overweight 
or obese.  
 Data collected from the first survey to the present survey have shown an 
interesting sex-based disparity in the trends found in overweight and obesity. Across the 
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surveys men have comprised a greater percentage of those occupying the category of 
overweight, while the greatest percentage of those categorized as obese has been 
occupied by women.
45
 
 In addition to agreement that obesity is increasing in the United States (and much 
of the world), there is also growing consensus that obesity is associated with a variety of 
demographic factors.
46
 In the US, those most vulnerable to weight concerns are minority 
groups (primarily African Americans and Hispanics), low-income or low socioeconomic 
groups, men and women over 60, as well as women ages 20–34 who are 
disproportionately represented among those diagnosed with obesity.
47
 While the 
increasing prevalence of obesity can generally be seen across the nation, there are 
particular states in which the problem is exacerbated. These states include Alabama, 
Mississippi, Oklahoma, South Carolina, Tennessee, and West Virginia. These states also 
report having a high concentration of minorities and lower per capita incomes.
48
  
 The increasing prevalence of obesity in the United States is not limited to adults. 
Current studies indicate that approximately 15.5 percent of children and adolescents meet 
the clinical criteria for obesity and approximately 16 percent are diagnosed as 
overweight.
49
 An additional 34 percent of children and adolescents are at risk for 
overweight.
50
 Since the 1970s, the obesity rate has more than doubled for children ages 
2–5 and adolescents between the ages of 12 and 19. In the age range of 6–11 the rate of 
obesity has more than tripled.
51
 The myriad health problems associated with obesity in 
adults may well be surpassed by those found among obese children in this generation, 
resulting in a lower life expectancy for this generation of children than for their parents.
52
 
 12 
 
These trends in obesity are being observed throughout other parts of the world in 
both developed and developing countries. Specifically, countries such as Australia, 
Russia, Brazil, Malaysia, and even China are showing obesity as an increasing problem 
among their populations.
53
 It is estimated by some that in the future obesity will overtake 
tobacco-related diseases as the number one public health problem leading to patient 
mortality.
54
 
The following section discusses two areas which are affected by overweight and 
obesity. This section discusses impairments in physical health and quality of life 
indicators for those who are obese.  
B. Obesity‘s Effects on Physical Health and Quality of Life 
The following section explores the effects of obesity on various aspects of 
physical health and longevity as well as on associated non-health quality-of-life 
indicators. A point of widespread agreement regarding obesity is that, in general terms, it 
has negative effects on physical health and quality of life. From a health perspective, 
progression along the spectrum from merely being diagnosed as overweight to being 
diagnosed with more serious obesity is generally associated with progressively elevated 
risks of life-threatening and debilitating physical co-morbidities which ultimately have 
the effect of decreasing longevity and quality of life.
55
 It has been said that ―the medical 
problems caused by obesity begin with the head and end with the toes and involve almost 
every organ in between.‖56 This section is divided into two parts. The first subsection will 
address the effects of obesity on physical health while the second subsection addresses 
the effects of obesity on other quality of life indicators. 
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B.i Physical Health 
Being either overweight or obese is linked to numerous medical sequelae 
including: type II diabetes, coronary artery disease, hypertension, sleep disturbances, acid 
reflux disease, fatty liver disease, joint disease, depression, infertility, fetal abnormalities, 
various malignancies, asthma, incontinence, lower back pain, various skin disorders, and 
kidney disease.
57
 
Approximately 300,000 Americans die each year from obesity-related diseases.
58
 
This number is approaching the estimated 400,000 deaths that are annually attributed to 
smoking and tobacco-related diseases.
59
 Additionally, in children who are overweight or 
obese, the latency period between developing obesity and developing secondary diseases 
may be diminished. This means that diseases such as hypertension or diabetes develop 
more rapidly in obese children and adolescents than would occur in obese adults.
60
 
Research has frequently focused on single co-morbidities such as diabetes or the 
presence of heart disease.
61
 A limitation of such studies is that they are not able to shed 
light on the relative risk of multiple co-morbidities present in those who are overweight 
or obese. With this limitation in mind, one particular study undertook a meta-analysis of 
the twenty chronic diseases thought to be associated with overweight and obesity. Co-
morbidity specific studies which included these twenty associated chronic diseases were 
reviewed. In this meta-analysis, the authors sought, in part, to provide a more 
comprehensive picture of the relative disease risk across chronic diseases related to being 
overweight or obese for men and women. The authors confirmed that indeed there are 
elevated health risks associated with being diagnosed as overweight or obese and that 
relative risk increases based on the severity of an individual‘s overweight.62 Hence, the 
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more overweight a person is, the greater the relative risk for developing debilitating 
chronic, co-morbid disease. Additionally, the greatest health threat appears to be from 
developing type II diabetes. However, elevated relative risk for certain cancers (breast, 
colorectal, endometrial, esophageal, kidney, ovarian, pancreatic, and prostate), various 
forms of cardiovascular diseases (hypertension, coronary artery disease, congestive heart 
failure, pulmonary embolism, and stroke), as well as asthma, gallbladder disease, 
osteoarthritis, and chronic back pain, is associated with overweight and obesity.
63
 The 
authors conclude that ―findings confirm that overweight and obesity carry a profound 
health burden and will have a significant impact on health expenditures.‖64 Each of these 
additional chronic diseases is associated with it its own trajectory of potential medical 
complications so that an overweight or obese person diagnosed with type II diabetes 
incurs additional risks for medical complications such as kidney disease. In effect, 
overweight and obesity can increase the threat to health and longevity exponentially, as 
the individual is now susceptible to developing further tertiary disease which carries with 
it its own set of potential serious life-limiting or mortality-producing medical 
complications. 
Another important and highly stigmatizing, though perhaps not strictly 
physiological, co-morbidity related to being overweight or obese is an increased risk for 
developing various mental health disorders.
65
 Individuals diagnosed with obesity also 
tend to have an increased incidence of clinical depression, which in turn has been 
positively correlated to adverse childhood experiences including self reports of physical, 
sexual, and verbal abuse as well as neglect.
66
 Specifically, those individuals who report 
exposure to all four types of abuse have the greatest level of severity of both obesity and 
 15 
 
depression. The reported long-term repercussions of abuse on the development of both 
depression and obesity may reflect issues of ―powerlessness, loss, and humiliation,‖ 
according to Stunkard et al.
67
 A related analysis suggests that the development of obesity 
might reflect an attempt at a protective adaptive function for people who have been 
sexually abused, with the excess weight effectively producing an emotional and physical 
barrier that may adaptively assist the obese individual in controlling further unwanted 
attention or thwarting future abuse.
68
  
Obesity was found to be associated with significant increases over the general 
population risk not only of major depression, but also bipolar disorder, panic disorder, 
and agoraphobia during the subject‘s lifetime.69 Other studies have shown a more robust 
association between anxiety disorders and obesity than between mood disorders and 
obesity, as well as a strong association between obesity and post-traumatic stress 
disorder.
70
 Whether developing a mental health disorder is a result of the societal 
stigmatization of those who are overweight and obese, or whether a predisposition to 
mental health disorders precedes their diagnosis and overweight and obesity are 
secondary, appears to remain an unresolved question. 
The presence of overweight or obesity has been shown to diminish quality in 
various non-health related areas. The following subsection explores these areas of 
diminished quality of life. 
B.ii Quality of Life 
Similar to physical co-morbidities, the presence of psychiatric co-morbidities can 
have the effect of reducing quality of life and longevity.
71
 Each additional co-morbidity, 
whether physical or psychological, has the consequence of adding to the aggregate health 
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and well-being burden for the individual diagnosed with obesity. Moreover, health is only 
one dimension of well-being or quality of life. Factors comprising quality of life are those 
factors which make living pleasant.
72
 Those items which are considered to be 
contributing factors to an individual‘s quality of life assessment are quite diverse and 
highly subjective. Assessment of quality of life is highly individualized as it is based on 
the unique combination of factors found in particularly appealing ratios for each person. 
Hence, there is wide disparity among which or how much of each particular factor makes 
a life one of quality.
73
 
Evidence suggests that in general, individuals who are overweight or obese report 
lower levels of satisfaction or quality of life based on several commonly accepted 
attributes of a quality of life.
74
 Indicators of quality of life commonly employed in 
research include a person‘s educational attainment, employment status, earning potential 
(both present and future), opportunities for career advancement, the presence of 
significant intimate relationships (such as marriage or a similarly committed 
relationship), having children, the ability to get around, and where one resides.
75
 
Commonly accepted quality of life indicators have all been reported to be inversely 
related to the presence of overweight or obesity
76—the more overweight a person is, the 
less likely he or she is to have attained a high level of education, high income, and 
significant personal relationships. Numerous reports in the popular press in recent years 
have pointed out that current and future projected earnings and opportunities for career 
advancement are inversely related to above normal weight.
77
 Research further indicates 
that parents of overweight and obese children provide less college support for their 
overweight children than for their thinner offspring.
78
  This was found to be true even 
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when controlling for factors such as parental income and student grades.
79
 
 Puhl and Brownell, in an article on bias and discrimination against those who are 
obese, reviewed available research in three primary areas of potential discrimination and 
bias against those with obesity. Those areas included employment, education, and health 
care.
 80
 Their analysis of various research studies on the topic concluded that there is 
―clear and consistent scientific literature showing pervasive bias against overweight 
people‖ across these domains.81 
 The third section begins to address communication problems surrounding how 
obesity is talked about and how this can lead to subsequent problems with commonly 
applied ethical standards such as those seen in informed consent, considerations of 
justice, and possible violations of patient welfare. Additionally, the following section will 
begin to address the effect of inappropriate ascriptions of blame and the implications for 
acceptance or rejection of various weight-loss interventions. 
C. Framing the Ethical Problem 
The final section of this chapter discusses the contentious nature of properly 
framing issues around obesity and the resultant problems of communication which arise 
in accepting particular frameworks. This section will argue that accepting particular 
frameworks results in associated problems of communication both in society in general 
and within the clinical healthcare system charged with providing assistance in solving an 
individual patient‘s obesity. This section will introduce the argument that problems of 
communication arising from errors in framing lead to breaches in commonly accepted 
and applied ethical standards in health care, which ultimately serve to violate obligations 
to patients who are obese. The first subsection addresses various problems in accurately 
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and adequately communicating about obesity and elucidates problems in the healthcare 
system which arise from failures in communication. The second subsection focuses on 
the way in which obesity is conceptualized and the associated ethical issues which arise 
from these conceptions. The final subsection discusses how blame is assigned in obesity 
and the way in which blame can impair or reinforce acceptance of various weight loss 
interventions. The discussion begins with problems in communicating about obesity. 
C.i Problems of Communication and Failure of the Healthcare System 
  Despite general consensus about increased rates of obesity and demographic 
trends, as well as substantial consensus about the association of obesity with various life-
limiting, life-threatening, and quality-of-life-diminishing co-morbidities, multiple points 
of controversy remain. Among these are contested views about the etiology of obesity, its 
social characterization or construction, and the most appropriate way to frame the 
problem of obesity and the range of appropriate solutions to the problem.
82
 In essence 
these are problems in communicating about obesity which have potentially far reaching 
consequences. Moreover, in reality, it remains likely that these three dimensions of the 
obesity problem will remain contested. For each of the three, the reality is more complex 
than any one of the proffered explanations, characterizations, and conceptualizations. In 
this regard, obesity will remain problematic. The etiology of obesity has been and 
continues to be widely debated. Most believe that obesity is caused by some combination 
of factors which include but are not limited to genetics or biological factors, the 
environment, and social policies such as farm subsidies which have altered the way in 
which Americans access and consume food.
83
 Several factors considered contributory to 
the development and maintenance of obesity are discussed below.  
 19 
 
C.i.a Genetics 
 Though some progress has been made, the role of genetics in the development of 
the obesity problem is not entirely clear. First-generation investigation into the role of 
genes in the development of obesity included heritability studies done with identical and 
nonidentical twins. These studies found that the heritability rate for obesity based on 
genetic factors falls in the range of 70–80 percent. The only other characteristic which 
rates consistently higher for heritability is an individual‘s height.84 
Some genetic disorders clearly have an obesity component as a primary 
manifestation, such as Praeder-Willi syndrome or Bardet-Biedl syndrome.
85
  These 
syndromes typically have a developmental anomaly associated with them as well. 
Additionally, monogenetic obesity syndromes exist which do not carry with them 
developmental disabilities or other aspects of mental retardation.
86
 These syndromes 
include among them congenital leptin deficiency in which obesity can be corrected with 
therapeutic doses of leptin.
87
 Newer research techniques which include genetic mapping 
have permitted these particular genetic anomalies to be identified; however, this has been 
possible in only a small number of obesity-related disorders.  
Through genome-wide association studies, several other gene mutations have 
been implicated in the obesity problem, but their full role remains unclear. Moreover, the 
genes implicated in the development of less specific obesity patterns are thought to be 
part of the biological system that regulates energy balance.
88
 The mutations are thought to 
cause disregulation in these systems with obesity as the result. It remains ―unclear 
whether such genes contribute to obesity through many different single-gene mutations or 
through potentially complex interactions involving several genes each having small 
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effects of their own (or a combination of both).‖89 The relationship between social policy 
and the social environment in relationship to obesity is discussed below. 
C.i.b Social policy and social environment 
 Recently and historically, American social policies have been implicated in the 
onset of obesity as population-wide problem in the United States.
90
 The rise of obesity 
may have its historical roots in World War II (1941–45) when mandatory food rationing 
was enacted. The United States sought to overcome the scarcity of food by reformulating 
the appeal of certain foods, including a campaign to increase consumption of organ 
meats, which was ultimately unsuccessful.
91
 Despite this and other efforts, the net result 
was that the typical population food patterns were substantially disrupted during this war 
era. A relationship between increased body fat and episodic food shortages was first 
proposed in 1994 by Deitz.
92
 In a case study, he proposed that there might be a 
relationship between ―food choices or physiologic adaptations in response to episodic 
food insufficiency‖93 which could cause increased body fat.  
The phenomenon he was tentatively describing is what is now called food 
insecurity. Food insecurity is defined as limited or uncertain availability of nutritionally 
adequate and safe foods, or limited or uncertain ability to acquire acceptable foods in 
socially acceptable ways.
94
 A related concept is that of food restriction, which is the 
externally imposed restriction of intake due to lack of access to food or foods one would 
otherwise choose.
95
 This term can also be applied to a self-imposed restriction—for 
example, by dieting. Recent research has shown a relationship between food insecurity 
and the presence of both disordered eating patterns (binge eating) and obesity.
96 
Episodes 
of mild food insecurity or food restriction, such as those found in America during World 
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War II, may have mimicked the conditions of food insecurity, based on imposed food 
restrictions, as we now understand this phenomenon. On the heels of World War II, with 
unprecedented growth and prosperity in the United States, food was abundant.
97
 The 
implications of food rationing, and the mandated changes in food consumption 
immediately prior to this time, may have had unforeseen effects on the obesity problem 
which arose in the decades of abundance that followed. 
More recently, agricultural policy has also been cited as a contributing factor in 
the development and maintenance of the obesity problem in the US. ―From 1985 to 2000, 
the real price of fresh fruits and vegetables went up almost 40 percent in the United 
States, while the real price of fats and sugars declined.‖98 This trend, driven by fifty years 
of farm policy, has directed farmers toward overproduction of particular crops such as 
corn and soybeans, resulting in low-cost oils and the availability of high-fructose corn 
syrup (which has been added as a less expensive replacement for other sugar sources).
99
 
In the last thirty years, farm policies which support corn and soybean crops have resulted 
in an increase in the consumption of high-fructose corn syrup of over 1,000 percent.
100
 
The US consumption of added fats increased more than 35 percent during that same 
time.
101
 It has been stated that ―the problem with the extensive use of these cheap 
commodities in food products is that they fall into the very dietary categories that have 
been linked to obesity: added sugars and fats.‖102 
These less expensive commodities have replaced more expensive counterparts 
and have served to drive down the cost of unhealthy foods while simultaneously limiting 
the availability of locally grown, less expensive, and healthier choices in the American 
diet. For economically constrained individuals, who are disproportionately represented 
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among the obese, the opportunity to purchase lower cost food may be viewed as a 
desirable consumer option, even though such food is less healthy than more expensive 
alternatives.
103
 Indeed, purchasing low-cost unhealthy foods may seem the only viable 
option. Another area for consideration which is addressed below is the way in which 
housing, roads, and green space are currently being utilized which may facilitate 
sedentary lifestyles, overweight and obesity. 
C.i.c Built environment 
 Characteristics of the modern built environment have also been charged with 
producing the conditions necessary for obesity to flourish.
104
 The built environment 
includes how land is used in designing and developing housing plans, neighborhoods, and 
cities.
105
 Characteristics such as vehicular and pedestrian traffic patterns, green space set 
asides for recreational activities, the availability of sidewalks for pedestrian traffic, 
bicycle lanes, and the proximity of grocery and other stores are features of the built 
environment that affect the ability of those living in the area to be physically active and 
have access to affordable healthy food without depending on motorized transport.
106
 A 
meta-analysis of research conducted between 1966 and 2007 on the association between 
the built environment and obesity found that ―eighty-four percent[of studies] reported a 
statistically significant positive association between some aspect of the built environment 
and obesity‖107 The authors conclude that ―understanding the mechanisms through which 
environmental factors may influence obesity will aid in developing future community-
level intervention strategies.‖108 There have been many other factors posited as being 
contributory to the development of obesity. Several of these additionally proposed areas 
are discussed below. 
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C.i.d Additionally proposed etiology 
 There have been several other associations proposed as possible contributing 
factors in developing obesity. A few of these correlative relationships include the length 
of time mothers breast-feed their children and the social network theory. In a study of the 
Helsinki Birth Cohort, it was found that those who had been breast-fed for less than two 
months or greater than eight months had the highest adult rates of BMI and percentage 
body fat.
109
 Of those who were breast-fed the shortest duration, the authors suggest that 
the higher rate of obesity might be explained by the fact that growth factors or hormones 
available in breast milk might program the baby in ways that protect against developing 
adipose tissue in later life. On the upper end of breast-feeding duration, it is thought that 
prolonged exposure to breast milk may predispose the body to seek high-lipid foods later 
on, which could contribute to weight gain and a high BMI.
110
 
In a study which spanned thirty-two years, the relationship between one‘s social 
network members and the potential of developing obesity was examined. It was found 
that a person‘s chances of becoming obese increased by 57 percent in a given time 
interval if he or she had a friend who had also become obese. This was true regardless of 
the proximity of the person in the social network. In other words, even if the friend did 
not live in the same locale, the study discerned an interesting association among social 
network members and weight gain regardless of physical proximity.
111
 
 The theories and associations provided above are but a few of those proposed to 
shed light on the etiology of overweight and obesity. While these theories and 
associations shed light on the complexity of the problem, they do not definitively provide 
closure on the etiology of overweight and obesity. Indeed, it is most probable that 
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overweight and obesity are attributable in some part to each of the above areas and 
several others which have not been addressed here. The following section moves the 
discussion from the disputed areas contributing to obesity to how obesity is 
conceptualized. 
C.ii Conceptualizing Obesity and Associated Ethical Issues  
 Distinct from the question of obesity‘s cause, yet related to it, is the question of 
how obesity is conceptualized. Obesity can be conceived of as a health problem, personal 
problem, or a social problem. Describing someone as obese can be merely a description, 
an aesthetic judgment, or a medical diagnosis. Obesity can be conceptualized as a 
disease, epidemic, condition, trait, or simply as a risk factor. Moreover, obesity can be 
seen as the physical manifestation of gluttony, or as a social marker of personal wealth or 
societal economic development.
112
 In labeling someone obese we can either identify a 
fact or make a judgment, or both. In making the claim ―Herbert is obese,‖ several kinds 
of a judgments or indeed presumptions of fact can be asserted based on one‘s point of 
reference. How obesity is conceptualized by society in general and healthcare 
practitioners specifically will likely have implications for what alternatives are offered to 
patients with obesity who are seeking treatment. The following section discusses various 
conceptualizations and briefly introduces how various commonly accepted ethical 
constructs can either be supported or violated based upon the practitioners conception of 
the problem and hence the appropriate solution for a patient‘s obesity. 
C.ii.a Realist and nominalist conceptions of obesity 
 Jon Reif argues that from a realist perspective obesity is ―a fundamentally real 
body category.‖113 That someone is obese is a scientific fact, an empirical matter to be 
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discovered. In contrast, from a nominalist perspective, ―obesity is a culturally and 
historically constructed notion.‖114 No one is obese but for our describing him or her that 
way according to some socially determined, culturally bound criteria. Once those criteria 
emerge or gain acceptance within a society, however, then whether or not Herbert is 
obese is a matter of fact—a matter of either scientific or social fact, and no wishing or 
thinking it otherwise can alter Herbert‘s obesity. Only an intervention resulting in his 
weight loss can change his status (or diagnosis) as obese.  
In support of adopting a nominalist conception of obesity is the fact that social 
attitudes toward body mass and weight vary across time and across different populations, 
social classes, ethnicities, and cultures. Indeed, they vary so much that different attitudes 
toward obesity do not always seem to be differing attitudes toward the same thing, but 
actually seem to construct obesity as something different altogether in different cultural 
contexts. Within the United States, for example, various ethnic groups perceive weight in 
vastly different ways.
115
 Currently, among African Americans, Hispanics, and Hawaiians, 
larger people are seen as being more acceptable and perhaps more sexually appealing and 
desirable than more svelte counterparts.
116
 The same is not true among typical, modern 
Caucasian Americans, for whom additional weight is considered unappealing and 
sexually undesirable.
117
 However, these modern conceptualizations of size and weight 
have not been stable concepts across time. In fact, throughout history, the way in which 
weight has been perceived has dramatically changed.
118
 In medieval times, people who 
were overweight were often portrayed negatively and as lacking in morals and self-
control.
119
 Similarly, ancient Asian pictures depicted the dreaded tax collector as an 
overweight person and described this person as greedy and lacking a righteous 
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character.
120
 In contrast, the ideal of American beauty in the late 1800s was epitomized 
by Lillian Russell, who reportedly weighed over two hundred pounds.
121
 In the early 
twentieth century, a time which saw rampant tuberculosis, the person who was physically 
large was perceived positively. In fact, girth was seen as a sign of health and an indicator 
that the person was not infected with tuberculosis, commonly referred to as consumption, 
of which a primary symptom was emaciation; tuberculosis ―consumed‖ people.122 There 
was social value in being a person of substantial weight as it signaled that the person was 
free from potentially deadly infection and a safe person with which to associate. 
 During the 1930s, a period of time with both low prevalence and incidence of 
overweight and obesity, a debate emerged regarding whether obesity should be 
considered a medical problem or merely a cosmetic concern.
123
 During World War II, 
however, when many women were going into the workforce, the image of the ideal 
woman began to change to project a slimmer and more capable, perhaps even more 
masculine ideal.
124
 Following World War II, for a time in America, the contours of the 
ideal woman once again rounded out so that curvaceous women such as Marilyn Monroe 
epitomized beauty. Coincidentally, this was at a time when men were returning from war 
and seeking to regain jobs and return women to a more traditional domestic role. In 
addition, it is thought that this shift toward a more voluptuous image of beauty and health 
occurred at this time partly due to the immigrants who came to America after having 
survived the Nazi death camps. Ample weight was a luxury and once again a sign of 
prosperity and health.
125
 In recent years, as the association between ill health and excess 
weight has become more evident through research, the tides have again changed so that 
excessively curvaceous, overweight, or obese bodies are the source of societal disdain. 
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Moreover, other social attitudes or ascriptions, beyond those of healthy or 
unhealthy, are attached to norms of beauty and body size. Present-day women who 
exhibit the body contours of the ideal nineteenth-century woman are considered fat and 
have a long string of negative attributes attached to them based on their weight.
126
 
Modern women who meet the previous ideal are considered lazy, undisciplined, sexually 
undesirable, unintelligent, and hedonistic.
127
 Even as they are considered sexually 
undesirable, they are also considered sexually voracious, out-of-control, and threatening 
for the sheer space they take up, the amount of resources (food, space) they consume, and 
the insatiable desires they represent.  
With respect to the stigma of being overweight and obese, men fare marginally 
better than women. So long as they and their size are not ―gross,‖ overweight or obese 
men are more often given socially appealing attributions related to their size than are 
women.
128
 They are seen as being powerful, masculine, and, if it not too fleshy, athletic. 
While for men social attributions appear to be somewhat better and the range of 
acceptable individual variability from the ideal is arguably broader, men certainly face 
issues of prejudice in employment and discrimination in social settings based on weight. 
The experience of bias for men however, allows for greater deviation from the ideal 
before negative social attributes are employed as descriptors of the individual.
129
 In other 
words, a woman who is overweight to the same degree as a man would likely face 
prejudice, discrimination, and stigma more frequently and more severely than the man. 
This is in part because men in general are expected to have insatiable appetites, take up 
more space, and assert themselves physically and sexually in a way not acceptable for 
women.
130
 Despite temporal, geographic, and cultural differences, one thing remains 
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constant: societies are seldom neutral about extremes of weight. Despite the social norms 
that ground a judgment that someone is obese, and despite the additional social 
judgments—even moral judgments—that frequently accompany the initial judgment or 
observation of someone‘s obesity within a particular society or social frame, that 
someone is obese is treated as a matter of fact. 
Thus, obesity is not a context in which a debate between nominalist and realist 
positions can be resolved. Instead, persistent tension between the two approaches can best 
be addressed by recognizing that obesity is treated as a matter of fact or medico-scientific 
judgment. Two terms that have entered popular discourse reflect the dual realist and 
nominalist perspectives, the emphasis on scientific discovery, or on social judgment. 
―Obesogenic‖ refers to a combination of factors including environments that promote 
over eating which, when combined with limited physical activity, subsequently lead to 
obesity.
131
 This term seems to imply toxicity in the physical and food environments of 
most Americans. The combination produces damaging results.
132
 In contrast, the 
colloquially used term ―obeast‖ reflects a nominalist conception—even a moralized 
conception—of obesity, and graphically describes a social perception of obese 
individuals as in some sense beasts—something both less than fully human and also 
threatening. Used somewhat differently, the term also highlights the vigilance required by 
those pursued by weight who are in continual peril of being caught and suffering harms—
the harms of the (o)beast.  
The presence, prevalence, and persistence of such terms reflect not only the 
competing realist and nominalist conceptualizations of obesity, but also competing social 
characterizations of the growing obesity problem. On one side there are legitimate social 
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concerns which include its potential public health ramifications and associated costs, and 
these support application of potential public health interventions.
133
 On the other side are 
the social attitudes toward obesity that prove detrimental to those with obesity and 
ultimately to society itself.
134
 Social ascriptions to the obese of both causal and moral 
responsibility for their condition result in the stigmatization of obesity, discrimination 
against those with obesity, and obesity-associated diminished opportunities.
135
 The 
medical decision making of obese patients, with the assistance physicians whose personal 
conception of obesity is realist, nominalist, or somewhere between, holds potentially 
serious implications for those who are obese and seeking treatment. Indeed, some 
research has shown significant reluctance on the part of family practitioners and primary 
care physicians to address the issue of overweight and obesity with patients.
136
 While 
several reasons may explain this reluctance, including physicians‘ lack of training, 
personal negative biases about overweight and obesity, or skepticism about the efficacy 
of available treatment options, the result is that a lack of information about each of the 
alternatives for treatment impedes informed medical decision making, constrains justice, 
and potentially impairs patient welfare overall.  
In addressing the issue of weight loss with their obese patients, it has been found 
that physicians employ some measure of bias against overweight and obese individuals 
they see in their own practice.
137
 In fact, many physicians fail to address the options for 
obesity treatment with patients at all.
138
 Whether this is because physicians feel they lack 
adequate time to address the issue, believe that interventions provide only marginal 
success, or perceive the issue of overweight and obesity to be one of discipline and 
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willpower, the outcome is that many patients never receive adequate information 
regarding obesity interventions.
139
 
   Without the proper medical information, patients with obesity cannot make a 
decision to pursue the option of surgery for weight loss. Some authors suggest that the 
failure of physicians to fully address a health issue along with its possible interventions 
constitutes abandonment of the patient.
140
 Abandonment of the patient is ethically unjust 
and prima facie contrary to patient welfare. Failure to provide the patient with necessary 
information regarding repercussions of overweight and obesity along with the full scope 
of available treatment options should similarly be construed as abandonment. These 
topics will be more fully addressed throughout the dissertation. At present, it is sufficient 
to introduce the notion that societal conceptualizations imbedded in the framing of 
obesity by physicians and other healthcare providers has deleterious effects on patients 
seeking treatment for obesity by conscious or inadvertent violation of ethical principles 
and standards in practice. The following section will build on the manner in which 
inappropriate ascriptions of blame can also impede social acceptance of various 
interventions for weight loss. 
C.iii Inappropriate Ascriptions of Blame and Implications for the Social Acceptance 
of Interventions 
 Complicating conceptualization of obesity, attributions of responsibility for its 
onset, and identification of potential solutions or interventions are the competing 
etiological explanations for individuals‘ obesity and for the growing social problem of 
obesity. Not surprisingly, perceptions of cause shape endorsement of one or another set 
of interventions to address the problem.
141
 Those who emphasize built environments and 
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social policies as primary causal factors in obesity are more likely to embrace policy-
level public health interventions to address it.
142
 Emphasis on one or another set of causal 
factors is also likely to affect attitudes toward the obese individual and her role in—or 
responsibility for—her obesity. Yet there are multiple ways of interpreting etiology. 
While discovery of obesity-associated genes might be thought to mitigate or alleviate 
entirely attributions of moral responsibility—and even attributions of personal control 
and causal responsibility—to individuals with obesity, identification of obesity-related 
genetic factors may simply lead to greater specificity in responsibility attribution. As with 
the supposed identification of genetic risk factors for alcoholism, other substance abuse, 
or sexual orientation, the identification of genes associated with obesity may simply 
prompt calls for those at genetic risk to use this information to motivate increased 
behavioral interventions to avoid manifesting the condition. For others, the identification 
of genetic or environmental factors that increase the risk of developing obesity does serve 
to alleviate or at least mitigate personal and especially moral responsibility, and to 
suggest that clinical, medical, public health, or social policy interventions are warranted 
at the very least to support individual efforts to maintain a healthy weight. 
The complex relationship between social attitudes toward obesity and etiological 
explanations is evident in the terms with which the obesity problem is popularly depicted. 
Obesity has been referred to in the scientific literature, the popular press, and other forms 
of mass media as being an ―epidemic,‖ ―being of epidemic proportions,‖ and a ―post-
modern epidemic.‖143 Despite the common thread of the term ―epidemic,‖ rather different 
perspectives on obesity are revealed by these descriptions.
144
 An epidemic is generally 
described as ―the occurrence in a community or region of cases of an illness…or other 
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related heath events clearly in excess of normal expectancy,‖145 or as ―an outbreak or 
unusually high occurrence of a disease or illness in a population or area.‖146 When used 
as an adjective, ―epidemic‖‘ is defined as ―spreading rapidly and extensively by infection 
and affecting many individuals in an area or population at the same time, as of a disease 
or illness.‖147 The presence of such a population-based problem is frequently considered 
to prompt population-based interventions, such as public health measures, to combat 
contagion (e.g., vaccination) or to address a common threat (e.g., sanitation measures). 
In contrast to and yet building upon more traditional definitions, post-modern 
epidemics have been described as ―epidemics in which unevenly medicalized phenomena 
lacking a clear pathological basis get cast in the language and moral panic of ‗traditional 
epidemics.‘‖148 In this characterization of the obesity problem as a post-modern 
epidemic, causal and moral responsibility—for both its creation and its elimination—
become blurred. Obesity occasions not just panic, but moral panic, typically with 
associated blaming, stigmatizing, and disenfranchising behaviors and attitudes—the 
widespread, ostensibly morally justified fear that arises whenever a population believes 
that the social or moral order is threatened. 
These complex relationships among etiological explanations, social attitudes, and 
moralizing attitudes about obesity influence the acceptability and adoption of different 
ways of framing obesity and its potential solutions. Even though contemporary society 
has largely rejected the framing of obesity as being the manifestations of sin or gluttony 
for which appropriate solutions are atonement, behavioral change, and absolution, 
competing frames persist within a generally medico-scientific understanding of obesity. 
Obesity may be viewed as a problem at the individual level to be addressed by behavioral 
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and clinical medical approaches, or as a population-level problem susceptible to public 
health and public policy interventions, or some combination of these.
149
 The argument of 
this project embraces the importance of adopting a combined approach, but focuses its 
attention on the individual level of clinical medical intervention. The social dimensions 
of obesity, including moralized attitudes toward it, are nevertheless important to the 
argument, because the social acceptability of interventions at the individual level depends 
in part on the social attitudes toward obesity and those who are obese, as well as on 
socially reinforced etiological explanations of obesity. 
D. Conclusion 
This chapter provided relevant background information on the problem of obesity. 
The chapter began by examining controversies surrounding the most widely used tool for 
the diagnosis of obesity, the measurement of BMI, along with several proposed 
alternatives which might provide a more accurate clinical picture of the problem. Obesity 
trends seen over the past fifty years through the NHANES system were reviewed. 
Generally, these surveys have shown that obesity is becoming both more prevalent and 
more serious in the United States. International indicators have shown that obesity is 
increasing in other part of the world as well. Increased obesity has subsequently led to 
increased physical and social co-morbidities such as diabetes, hypertension, reduced 
longevity, increased mortality, and in general a lesser quality of life based on social 
indicators. Contested theories on the etiology of obesity and thus various ascriptions of 
blame were discussed. The implications of the contested terrain surrounding obesity were 
addressed. This chapter introduced the notion that various conceptualizations of obesity, 
including the appropriateness of its diagnostic tool, the acceptance of obesity as a disease, 
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the understanding of obesity as a modern-day epidemic, and the subsequent approval or 
rejection of various interventions as applied to this problem, may serve to violate 
commonly accepted ethical frameworks such as those found in medical decision making, 
considerations of justice, and patient welfare. Subsequent chapters will address the 
ethical implications of various conceptualizations and the contested terrain of obesity in 
greater detail. Ascription of blame has implications both for societal acceptance of 
various interventions and for physician acceptance of particular interventions such as 
WLS. Chapter two will take up the history of nonsurgical and surgical weight-loss 
interventions, focusing on the benefits and burdens of each type of intervention along 
with their perceived acceptability based on conceptualizations of personal responsibility 
for obesity. 
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Chapter Two: Obesity Treatment Options, Their Underlying Rationales, and the 
History of Surgical Weight Loss Interventions 
To appreciate the different responses weight loss interventions have received—
from clinicians, overweight individuals, and society in general—it is important to 
understand the developmental trajectories of three categories of intervention for weight 
loss: behavioral or lifestyle-focused interventions, pharmacological interventions, and 
surgical interventions. This chapter‘s section A examines the history of several types of 
behavior or lifestyle-mediated technologies for weight loss. The following lifestyle 
interventions will be considered: self-help groups, commercial weight loss programs, and 
physician-supervised weight loss. This chapter‘s section B concludes by surveying the 
over fifty-year history of weight loss surgery (WLS), along with an exploration of 
exceptionalism as applied to surgical technologies for weight loss. 
Development, support for, and acceptance of different technological 
innovations—and the term ―technology‖ is used in the sense Nikolas Rose employs—are 
obviously influenced by culturally normative factors. Nikolas Rose, sociologist, defines 
technology broadly as an assemblage of social and human relations within which 
equipment and techniques are only one element. ―Technology, here, refers to any 
assembly structured by practical rationality governed by a more or less conscious 
goal…hybrid assemblages of knowledge‘s instruments, persons, systems of government, 
building spaces, underpinned at the programmatic level by certain presuppositions and 
assumptions about human beings.‖1  
In this sense, even behavioral interventions, from talk therapy to support groups 
which encourage weight loss, may be understood and analyzed as weight loss 
 44 
 
technologies. A discussion of various weight loss interventions supported by Rose‘s 
conception of technology permits an analysis of the ethical frameworks which provide 
the scaffolding for each type of technology. Specifically, the role of cultural norms, 
power relationships, various perspectives on the technology itself, as well as the products 
of these weight loss technologies, can be engaged.
2
 This conceptualization of 
―technology‖ emphasizes the normative basis and hierarchical structuring of 
technological intervention. To understand and criticize these culturally influenced weight 
loss technologies, it is important to have knowledge of the basic methods of weight loss 
intervention, the history of their development, and the particular normative frameworks 
grounding each of these treatment options. 
Currently in the United States, the most commonly employed advice for those 
seeking to lose weight has been to reduce caloric intake and increase physical activity.
3
 
Weight loss, simply put, is achieved either when fewer calories are consumed than are 
expended, or when more calories are burned than are consumed.
4
 It appears to be a 
simple issue of mathematics: ―more out, less in‖ will indeed lead to weight loss. 
Specifically, in order to lose one pound, it is necessary for an individual to either expend 
or reduce the number of calories consumed by approximately 3,500.
5
  
As discussed in chapter one, in post–World War II America, the problem of 
obesity began to surface.
6
 This burgeoning problem led to several nonsurgical methods to 
support this seemingly simple equation for weight loss. When diet and exercise changes 
alone were unable to ameliorate obesity, pharmacological and surgical possibilities began 
to be developed and utilized with varying degrees of success and risk. The history of 
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various interventions, along with their normative underpinnings, is explored below. The 
following section examines various nonsurgical weight loss interventions.  
A. History of Nonsurgical Weight Loss Interventions 
 The following section addresses the history of various types of nonsurgical weight 
loss technologies. Each of these technologies has been applied to the problem of obesity 
with generally low levels of sustained success. These technologies fall into four broad 
categories: self-help initiatives, commercial weight loss programs, weight loss drugs, and 
physician supervised weight loss by individuals. The four subsections below take up each 
of these technologies, beginning with a review of self-help initiatives.  
A.i Self-Help Initiatives 
 Several self-help initiatives have evolved in an effort to help overweight or obese 
individuals lose weight. One such self-help group, TOPS Club, Inc., was founded in 1948 
by Ester Manz and is still in existence. The approach of TOPS, which stands for Take Off 
Pounds Sensibly, is to encourage healthy lifestyles through weight management and peer 
support of ―good‖ behaviors.7 The norm-governed assumptions informing the TOPS 
program are that weight control is fundamentally an individual responsibility and that 
weight is controllable by the individual with the proper application of personal willpower 
and group support. Participants are taught that individual motivation, willpower, personal 
actions, and the development of patterns of appropriate behaviors are responsible for their 
success or failure at weight loss.
8
 Overweight is thus the result of previous and present 
failures of willpower and motivation. Participants must accept, at least to some degree, 
this assignment of backward-looking responsibility in order to access the program‘s 
support of forward-looking, responsible behaviors. Upon such acceptance, appropriate 
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behaviors and individual changes in motivation and action are socially reinforced by 
other members within the organization. Weight loss, according to this organization, can 
best be supported through a group mentoring process.  
 The TOPS organization is comprised of individual chapters, each with voluntary 
leadership, through which members receive positive reinforcement and encouragement.
9
 
This structure of motivation is designed to assist members in sticking to healthy food 
choices and exercise plans. There are modest costs associated with membership in TOPS, 
Inc., including annual dues for membership (approximately $26.00) along with an 
additional monthly fee paid to the local chapter in which members participate 
(approximately $5.00). The annual membership fee provides a variety of goods, services, 
and events that are designed to reinforce members‘ commitment to weight loss. Some of 
the available options include a system of competitions, awards, and recognition for 
success in meeting weight loss goals; a variety of helpful tools, including The Choice Is 
Mine, a healthy lifestyle guide; retreats, rallies, and recognition events; and TOPS News, 
a membership magazine.
10
 Local chapters offer weekly meetings to their membership. 
TOPS advertises that it is comprised of men, women, and children age seven and older. 
They report a membership of approximately 170,000 members in nearly 10,000 chapters 
throughout the United States and Canada.
11
  
As is typical of self-help group formats, ongoing medical monitoring is not a 
requirement for members participating in this program. However, when members join, 
they are asked to consult with healthcare professionals to learn what is considered a 
healthy weight goal for them. Members are asked to share this information with an 
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official volunteer within the chapter who records this information, presumably to 
encourage member accountability and assist in the monitoring of progress.
12
  
   TOPS, Inc. has conducted research into obesity since 1966. Its website reports 
that TOPS has spent over $6.5 million on developing and contributing to research on 
obesity and metabolism at the Medical College in Milwaukee.
13
 However, the website 
reveals nothing about the complex associations among biologic, environmental, and 
lifestyle factors currently thought to be associated with the development and maintenance 
of overweight and obesity. This empirically informed and complex relationship has been 
borne out in much of the research on obesity.
14
 Indeed, while biologic and environmental 
factors beyond individual control have been shown to contribute to the development and 
maintenance of obesity, the underlying philosophy of TOPS is that it is incumbent upon 
overweight or obese individuals to address the problem from within an individualistic 
framework of behavior modification. 
 Overeaters Anonymous (OA) is another popular self-help group option for weight 
loss. OA was founded on the twelve-step intervention platform of Alcoholics Anonymous 
(AA).
15
 Both self-help groups (in addition to Narcotics Anonymous and Gamblers 
Anonymous) employ a progressive disease model. The OA program philosophy, which 
accepts obesity as a disease, seems to further a normative conception which allows that 
there are things affecting weight and weight loss beyond the immediate control of the 
individual.
16
 OA explains obesity as the result of a compulsion and thereby focuses on 
the mental or psychological aspects within a bio-psycho-social model of disease. Similar 
to the TOPS program, OA effectively ignores the relevance of specific genetic or other 
biological factors associated with obesity. Departing from typical reliance on a disease 
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model, this program contends that the factors leading to overweight and obesity are a 
product of compulsion which can only be overcome by depending on the strength of the 
higher power.
17
 In other words, this program seems to accept that the compulsive eating 
which can lead to overweight and obesity is part of a disease process (similarly, OA 
would describe anorexia and bulimia as the manifestation of compulsive eating amenable 
to its interventions) but utilizes dependence on a supernatural intervention or divine 
presence to facilitate resolution of the compulsions. This view blurs backward-focused 
causal and quasi-moral responsibility for obesity. Participants must accept that a failing 
or weakness in themselves resulted in their obesity and that only reliance on a higher 
power can overcome that failing. 
OA utilizes the twelve steps and eight tools upon which AA is based.
18
 These 
steps and tools are common among the Alcoholics Anonymous, Narcotics Anonymous, 
Gamblers Anonymous, and Overeaters Anonymous programs. These steps and tools, 
when properly used in the OA program, are designed to interrupt the disease process and 
provide an alternative way of coping with the compulsive desire to overeat, a desire 
which leads to overweight and obesity. The goal is to restore normal eating patterns by 
relying on the assistance of a ―higher power‖ and on other group members‘ experience 
and support on a shared journey to change thought and behavior patterns, which will 
ultimately lead to changes in weight, restore health, and defeat obesity.  
OA was founded by Roxanne S. several years after she attended a GA meeting 
with a friend in 1958. In 1960, determined to overcome her weight problem she, along 
with a neighbor and a fellow compulsive overeater, held the first meeting of the fledgling 
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OA. Currently it is reported that 6,500 groups meet across the world in any given week. 
OA reports 54,000 members worldwide working towards recovery.
19
  
 One of the primary traditions on which OA is established is that of anonymity at a 
public level.
20
 Therefore it is difficult to obtain adequate demographic information 
regarding group membership. However, in 2010 OA undertook a membership survey as 
part of the organization‘s strategic plan. The survey was distributed to a small sample of 
members (n=2,400) in various parts of the world. This particular sample was chosen to 
receive the survey as it was thought to be representative of the larger membership. The 
survey asked questions related to the age at which food became a problem, the nature of 
the problem (compulsive overeating, anorexia, or bulimia), and various demographic 
questions. Survey responses revealed membership to be predominantly female, age fifty-
six to sixty-five, married, white, and college-educated.
21
 The average return rate was 36 
percent with 836 of the 2,400 surveys returned.
22
  
 Although the social structure of individual OA groups and member participation 
are assumed to play a role in supporting weight loss efforts, as previously stated, 
overweight and obesity are themselves viewed as the results of an individual-level 
compulsive desire.
23
 Unlike TOPS, which emphasizes personal responsibility for both the 
behaviors that result in becoming overweight and those that remedy the problem, OA 
urges members to accept the presence of a higher power that must be invoked to support 
individual efforts to overcome the compulsion to overeat.
24
 OA states that it has ―among 
its membership people of many religious faiths as well as atheists and agnostics,‖ but OA 
is a spiritual program based on each members‘ personal interpretation of a ―higher 
power.‖25 Most members acknowledge that participation, and therefore the opportunity 
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for success in this program could be curtailed by an inability to accept some form of 
higher power. This would effectively limit the utility of the OA program for those who 
are religious nonbelievers.  
 OA interventions are based, first and foremost, on accepting powerlessness over 
food and acknowledging the strength of the higher power to overcome the 
powerlessness.
26
 Acceptance of these factors, bolstered by the value of a shared journey 
with other compulsive eaters, allegedly enables members to overcome the compulsion 
with food. Only once the participant recognizes this utter powerlessness over food, and 
acknowledges dependence on a higher power, can the obese individual go on to learn 
new behaviors which support weight loss (e.g., portion control, making good dietary 
choices, getting enough exercise). Failure to utilize and draw adequate strength from 
one‘s higher power, however conceived by the individual, is conceptualized as a personal 
failure that is evidenced by ongoing weight issues. If obese individuals were truly to 
understand and utilize the strength of the higher power and accept their powerlessness 
over food, OA maintains, they would be successful and the weight problem would 
resolve.
27
 
While there is anecdotal evidence regarding the efficacy of self-help groups for 
weight loss,
28
 the private nature of such groups‘ activities does not permit the rigorous 
scientific evaluation needed to determine long-term effectiveness. Therefore, it is difficult 
to determine adequately the number of participants who have been able to achieve long-
term, significant weight loss, to decrease or ameliorate health co-morbidities, and to 
improve other quality-of-life indicators. The efficacy of these self-help weight loss efforts 
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therefore remains largely unknown.
29
 The following subsection discussed another often 
used technology for weight loss—commercial weight loss programs. 
A.ii Commercial Weight Loss Programs 
 Numerous commercial weight loss programs such as Weight Watchers, Jenny 
Craig, OPTIFAST, and Medifast combine both calorically restrictive food plans with 
various support mechanisms for individuals seeking to reduce their weight.
30
 Generally, 
moralized norms of backward-looking responsibility, blame, and shame do not inform 
these programs. Instead the programs are informed by autonomy-oriented, take-charge-
of-your-life values. A new and improved ―you‖ is the product being sold. Assigning 
personal blame for overweight would be contrary to the positive, self-actualizing 
orientation of these commercial enterprises. Commercial weight-loss programs generally 
do not characterize obesity as resulting from personal failings or character flaws, but 
instead focus on cognitive-behavioral changes and the development of new habits.
31
 
These programs‘ individual-level intervention is almost entirely forward-looking, with 
little if any attention to the cause of obesity beyond the assumption that too many calories 
have been consumed and too few have been expended. These programs tend to 
acknowledge, albeit very simplistically, the biological factors associated with developing 
obesity. They seem to reflect little understanding, however, that not all obese people are 
created equal, and that even a program applied with equal diligence among participants 
can produce vastly differing results depending on a variety of factors, including genetic 
variation.  
 Unlike most self-help programs, there is some governmental oversight of 
proprietary programs. Commercial weight loss programs are regulated by the Federal 
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Trade Commission (FTC), not by the Food and Drug Administration (FDA) as might be 
expected given their health-related focus.
32
 While the FDA oversees food safety and 
regulates drugs and medical devices, commercial weight loss programs fall under FTC 
jurisdiction because they advertise and therefore the veracity of their advertising claims 
may be evaluated by the FTC. The authority of the FTC is empowered to intervene when 
it believes that a program is making misleading or false claims. However, programs are 
not required to disclose individual or aggregate outcome measures of success or failure. 
FTC guidelines require only that commercial weight loss programs provide information 
in the following four categories: key programmatic components, qualifications of the 
staff, program costs, and any risks of treatment. In other words, it is difficult to 
adequately ascertain how effective a particular program or intervention is in assisting 
participants in losing excess weight.
33
  
The three largest commercial weight loss programs in the United States are 
Weight Watchers, Jenny Craig, and LA Weight Loss.
34
 Each offers moderately restricted 
diets in addition to behavioral counseling and motivational interventions to increase 
physical activity/exercise. These programs do not require or provide physician 
supervision; therefore they advocate that members with weight-related medical concerns 
should be monitored by their own physicians. Weight Watchers provides its services 
using group sessions, whereas the other two programs provide services to members 
through individual counseling sessions. Payment for services in the Jenny Craig and LA 
Weight Loss Programs is required upon initiation of the program, whereas payment in the 
Weight Watchers Program is made on an ongoing weekly basis. Of the three, only the 
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Jenny Craig program requires additional purchases of prepared and prepackaged meals 
and snacks.
35
  
Of these three prominent commercial weight loss programs, only Weight 
Watchers has sponsored randomized controlled trials of its program in an effort to 
establish its effectiveness.
36
 Even in this case, there have been few studies conducted. In 
one study, 423 participants were randomly assigned to attend the traditional Weight 
Watchers program or to participate in a self-help intervention that included two visits 
with the dietician. The results showed that participants in the Weight Watchers program 
had lost 5.3 percent of their initial weight at one year. Participants were able to maintain 
3.2 percent of their weight loss at two years. This result was better than that realized by 
the participants in the group that had two visits with the dietician. Of that group, 
participants had maintained a loss of 1.5 percent at one year and 0 percent after two 
years. Weight Watchers members who attended the most meetings were able to maintain 
the greatest weight loss,
37
 although obviously no causal effect of Weight Watchers 
meeting attendance can be assumed.  
An important benefit of weight loss is the reduction of co-morbid disease. With 
regard to weight loss achieved by participants in Weight Watchers, it was found that the 
mean weight loss reported in the randomized controlled trials (5 percent) may be 
sufficient to ―prevent or ameliorate weight-related health complications‖ for its 
participants.
38
 The other two commercial weight loss programs have not been similarly 
studied, so adequate comparison of participant outcomes is not possible. Additional 
research should be undertaken to assess the outcomes of these programs with regard to 
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short- and long-term weight loss, maintenance of loss, and resolution of co-morbid 
disease states. 
Programs such as OPTIFAST and Medifast utilize very-low-calorie (420 kcal/d) 
or low-calorie diet plans (≤800 kcal/d).39 OPTIFAST originally offered the very-low-
calorie diet (420 kcal/d) but currently recommends its participants utilize the low-calorie 
(≤800 kcal/d) diet plan instead. Mandatory medical supervision is built into the 
OPTIFAST program.
40
 Medifast permits its participants to utilize either a very-low-
calorie choice or the low-calorie choice, and its lack of medical supervision within the 
Medifast program may also be cause for concern as medical supervision has been shown 
to be critical to the safe use of very-low-calorie diets.
41
 
Many randomized controlled research studies conducted in academic settings 
have examined either very-low-calorie or low-calorie diets. The initial results of 
programs utilizing these diets are promising with regard to short-term results. During the 
first three to six months, participants can expect to lose approximately 15–25 percent of 
their starting weight. However, very-low-calorie diets and low-calorie diets are often 
difficult for participants to maintain over a long period of time. For this reason, these 
plans tend to have high attrition rates.
42
 Therefore, it is difficult to assess long-term 
sustained weight loss and the improvements in or resolution of weight-related co-
morbidities associated with such severely calorie-restricted diets. Nevertheless, with the 
percentage of weight initially lost, it is plausible that if even a small portion of the initial 
weight loss is maintained there might be overall improvements in co-morbidities.
43
  
Costs for participating in these programs can be prohibitive. OPTIFAST can cost 
as much as $1,700 to $2,200 for the first three months alone.
44
 Participation in Medifast 
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is far less expensive, in part due to the absence of mandatory medical supervision within 
the program. The cost for Medifast is approximately $840 for a three-month period.
45
 
Even at that reduced rate, the cost may well be out of reach for many potential 
participants, as the program cost is generally not reimbursed by insurance. While 
program participation and thus severe restriction in calories are not meant to be sustained 
over the participant‘s lifetime, it is necessary to maintain the restrictions until the excess 
weight is lost. Participants are then taught how to increase their daily caloric 
consumption, with the goal being maintenance at the new healthier weight.  
 A.iii Pharmaceutical Interventions 
 Seeking weight loss through the use of anti-obesity drugs has become 
commonplace in the United States.
46
 The development of pharmacological interventions 
for the treatment of obesity reflects a dramatic shift in the normative framework 
undergirding efforts to ameliorate obesity. By employing a branch of medicine 
(pharmacology) to develop solutions for obesity and its subsequent co-morbidities, there 
appears to be an acknowledgement of factors beyond the individual‘s immediate control. 
Disordered biological systems, instead of disordered thinking or flawed character, are 
seen as being foundational components of an individual‘s obesity problem. The 
pharmacological focus is almost entirely forward-looking and results-oriented. Only 
those developing the interventions need be concerned with obesity‘s biological causal 
factors, and even these need not be entirely understood so long as the pharmacological 
intervention produces the desired effect. This particular normative view represents an 
evolution, as the approach is nonpunitive and nonmoralizing with regard to the obese 
person‘s weight. This evolved, normative view of obesity‘s causal factors and of obese 
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individuals requires and justifies particular biomedical-based interventions to address 
factors contributing to obesity. Drug manufacturers insist that pharmacological 
interventions must coexist with behavioral and lifestyle changes to facilitate successful 
outcomes.
47
 This view possibly reflects a greater understanding and acceptance of the 
multi-factorial nature of obesity which includes genetics, physiological systems, 
environment, and lifestyle. According to the Department of Health and Human Services, 
―prescription weight loss medications should be used only by patients who are at 
increased medical risk because of their weight. They should not be used for ‗cosmetic‘ or 
‗vanity‘ weight loss.‖48  
  The reason for this distinction between health-related and cosmetic or vanity 
weight loss is based on the increased risk profile associated with pharmaceutical 
interventions. The development of pharmacological interventions for significant weight 
loss has, thus far, unfortunately been hampered by dangerous, life-threatening side effects 
as well as limited long-term success.
49
 
 The therapeutic mechanisms of anti-obesity drugs fall into three categories. Some 
work as appetite suppressants, others increase body metabolism, and a third category 
interferes with the ability of the body to absorb specific nutrients in food such as fats 
(called lipase inhibition).
50
 The anti-obesity drugs on the market in 2009 included 
Xenical, (a lipase inhibitor available in prescription-dose Orlistat), Alli (a lipase inhibitor 
available over the counter as low-dose Orlistat), and Meridia (an appetite suppressant). In 
2009, global sales for each of these drugs were between $300 and $350 million. It is 
estimated that an additional $300 to $600 million in sales were generated by generic 
products such as phentermine, amphetamines, and sibutramine.
51
 Due in part to the 
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globally increasing problem of obesity and to recently published guidelines which 
recommend adjunctive drug treatments to improve weight loss in patients with a BMI of 
≥30, or a BMI of 27–29.9 (if medical co-morbidities are present), it is highly plausible 
that the use of anti-obesity pharmaceutical treatments will continue to increase.
52
 It is also 
likely that pharmaceutical companies will continue to work to develop more efficacious 
weight loss drugs. However, one significant problem with anti-obesity drugs thus far has 
been properly determining their risk-benefit ratio. Several drugs which were initially 
approved for use have since been pulled from global markets due to significant life-
threatening side effects which seriously overshadow the prospect of patient benefit.
53
 
 The use of pharmacology to reduce weight began in earnest in the 1990s.
54
 The 
mid-1990s saw doctors prescribing two drugs, either Redux or a combination of 
fenfluramine and phentermine, commonly known as fen-phen. The medical community 
was very optimistic following the approval of this drug combination in 1996 because it 
seemed to produce significant weight loss. Reflective of the optimism that this drug 
engendered, Time magazine reported in a cover story titled ―The New Miracle Drug?‖ 
that ―just three months after the introduction of Redux, doctors are writing 85,000 
prescriptions a week.‖55 But the optimism was short-lived. In 1997 Redux was removed 
from the market when the combination was found to cause severe and sometimes deadly 
damage to the heart valves, pulmonary atrial hypertension, and primary pulmonary 
hypertension. A 1997 New England Journal of Medicine study found that primary 
pulmonary hypertension is suffered in 1 in 500,000 people normally, but occurred in 1 in 
20,000 fen-phen users, indicating a greatly increased risk of suffering fen-phen-related 
deaths.
56
 The lethal side effects of this anti-obesity drug combination led to one of the 
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largest monetary settlements ever awarded.
57
 Currently, phenterimine (prescribed on its 
own or in combination with other drugs) is still available, as this drug has been shown not 
to have the same risks as its counterpart.
58
  
 Until recently there were only a few FDA-approved medications to promote 
weight loss: phentermine, sibutramine, and Orlistat.
59
 However, in recent months the 
FDA has approved two new drugs for weight loss, Belviq and Qsymia.
60
 These new 
offerings were approved in the summer of 2012 and will be discussed below. Of the 
older-generation FDA-approved weight loss medications, all but Orlistat are considered 
to be appetite suppressants. Orlistat‘s mechanism of action is to block the absorption of 
approximately 30 percent of ingested fats.
61
 Phentermine, diethylpropion, and 
phendimetrazine are approved for adult short-term use (up to twelve weeks). Orlistat is 
approved for longer-term use (up to one year) and is approved not only for adults but for 
children age twelve and older.
62
 These medications are considered to be moderately 
effective in assisting (in combination with changes in diet and exercise) with weight loss. 
Average users lose anywhere from five to twenty-two pounds over a one-year period.
63
 
While these numbers may not be considered significant for someone with a hundred 
pounds or more of excess weight, these medications have been shown to assist in modest 
weight reduction.
64
 The long-term health effects of using weight loss drugs have not yet 
been determined. The longest study conducted was a four-year study on the drug Orlistat. 
This study found that Orlistat was safe for usage up to one year. Other medications have 
been studied for shorter durations of between six and twelve months.
65
   
 Additional drugs have been shown to promote short-term weight loss in clinical 
studies and are being prescribed off-label. These drugs include some commonly used to 
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treat depression, seizures, and diabetes. Drugs such as bupropian (for depression), 
topiramate or zonisamide (for seizure treatment), and metformin (for diabetes treatment) 
have been prescribed for weight loss. Additionally, combinations of drugs are being 
prescribed as adjunct treatment for weight loss. These drug combinations generally utilize 
two drugs, such as a drug for depression combined with another drug, and are prescribed 
off-label as well.
66
  
 In response to continuing concerns around obesity, pharmaceutical companies are 
continuing to work on new formulations and new drug combinations. Recently, several 
drugs have been submitted to the FDA for approval. These include Onexa 
(phenterimine/toperimate), Lorquess (locaserin hydrochloride), and Contrave 
(Naltrexerone/bupopian). None of these newer-generation drugs received FDA approval 
when it was sought during 2010.
67
 However, since their original FDA review, two of 
those drugs have been approved. 
 Belviq was approved June 27, 2012, and Qysmia, formerly called Qnexa, was 
approved just under a month later on July 17, 2012. These are the new first diet drugs to 
be approved by the FDA in almost thirteen years. Both are intended to be used in 
combination with a reduced-calorie diet and exercise regime for weight management.
68
  
 Belviq (lorcaserin hydrochloride) is approved for use in adults with a BMI or 30 
or greater (obese) with no co-morbidities, or in adults with a BMI of 27 or greater 
(overweight) with at least one weight-related co-morbidity. Belviq works as an appetite 
suppressant by activating the serotonin 2C receptor in the brain. The activation of this 
receptor helps the person to feel full sooner after eating smaller amounts of food, leading 
to weight loss. Prescribing appropriate dosage levels of Belviq is important. At dosage 
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levels intended for weight loss, Belviq works as described above.
69
 At higher dosages it 
can turn on slightly different serotonin switches, the same as those responsible for the 
effects of hallucinogens (such as LSD) and other addictive drugs which can be abused. 
Higher doses of Belviq than intended for weight loss may trigger these switches, leading 
to both addiction and effects similar to hallucinogenics. For this reason, Belviq is being 
evaluated to determine whether it should be considered a controlled substance. If it is 
deemed a controlled substance, it will only be available through certified pharmacies 
when it does become available, which is expected to be later this year.
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 The safety of this drug was evaluated in three randomized placebo controlled 
trials.
71
 Combined, these trials included approximately eight thousand participants. 
Participants were either overweight or obese and could have a diagnosis of type 2 
diabetes or be diabetes-free. Participants were evaluated for 52 to 104 weeks. Compared 
with placebo, treatment with Belviq for up to one year was found to produce an average 
weight loss of 3 to 3.7 percent. For those without type 2 diabetes, 47 percent realized a 
weight loss in the 5 percent range, as opposed to 23 percent who received placebo. In 
participants with type 2 diabetes, 38 percent treated with Belviq saw a weight loss of 5 
percent, while only 16 percent who received placebo saw similar weight loss totals. 
Additionally, Belviq was found to produce positive changes in glycemic control in those 
with type 2 diabetes.
72
 For practical purposes, an obese person weighing 275 pounds and 
using Belviq for a year in combination with diet and exercise, using the high estimate of 
5 percent weight reduction, would lose approximately 14 pounds during the year. After 
one year they would weigh in at around 261 pounds. While any weight reduction might 
reduce the potential damage of co-morbidities, this modest weight reduction seems 
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unlikely to be able to ameliorate either the physical or social co-morbidities experienced 
by those seeking to significantly reduce their weight and hence potential further life-
threatening damage to bodily systems. Moreover, it is recommended that Belviq be used 
by patients for the rest of their lives.
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 It is recommended that Belviq be discontinued if after twelve weeks of treatment 
patients fail to lose 5 percent of their body weight. Belviq is contraindicated for pregnant 
women as it can cause harm to the fetus, and should not be used in combination with 
certain other medications such as some that treat migraine headaches and depression. The 
primary concerns with regard to this drug are that it may impair the user‘s attention or 
memory. Additionally, other common side effects experienced by nondiabetic patients 
included: headache, dizziness, fatigue, nausea, dry mouth, and constipation. In patients 
with type 2 diabetes, common side effects were low blood sugar, headache, back pain, 
cough, and fatigue. There is some further concern over the potential for other, possibly 
more serious side effects. This includes the potential for heart valve damage, based on 
past experience with fen-phen, the combination of fenfluramine and dexfenfluramine. As 
previously stated, this drug was ultimately removed from the market. Belviq has a similar 
mechanism of activation to fen-phen—both activate serotonin receptors, though in 
different locations. Fen-phen, which acted on the serotonin 2B receptors (Belviq acts on 
serotonin 2C receptors), was ultimately found to cause dangerous and life-threatening, 
irreversible heart valve damage. Heart valve function has been evaluated in Belviq. It was 
found that there was no statistically significant difference in the development of heart 
valve abnormalities between Belviq and placebo.
74
 However, the FDA has cautioned that 
Belviq should be used carefully in patients with congestive heart failure. Belviq clinical 
 62 
 
trials did not include patients with serious valvular heart disease, and so the manufacturer 
of the medicine, Arena Phamacueticals in Sweden, will be required by the FDA to 
conduct a series of post- market studies which include evaluation for negative long-term 
cardiovascular outcomes and to assess the risk for major adverse cardiac events such as 
heart attacks, stroke, or valve damage.
75
  
 Qysmia was first introduced to the FDA in 2010 as Qnexa but was initially 
rejected due to concerns about serious potential side effects.
76
 The drug is a combination 
of phentermine, which acts as an appetite suppressant, and topiramate, an anti-convulsant 
also found to cause weight loss in obese patients and produces better control of blood 
glucose and high blood pressure. Each of these drugs has been approved by the FDA for 
other uses, and each has been on the market for quite some time. Phentermine was once 
part of the drug known as fen-phen (see above). The combination found in Qysmia is not 
thought to have the same devastating side effects, though as with any drug, side effects 
do exist.
77
 These are discussed below. 
 Qsymia was found in clinical trials to assist those taking it in reducing their body 
weight by about 10 percent, and the anorectic feature of this weight loss drug reportedly 
works at the prescribed dosage for several weeks.
78
 The seemingly short duration of 
effectiveness concerns some who fear that as the anorectic effect diminishes, patients 
may seek or self-prescribe higher dosages of medication to get the same effect, thereby 
potentially causing themselves unforeseen and potentially irreversible damage. In the 
case of phentermine, its known side effects include spikes in heart rate and blood 
pressure. Its mechanism of action appears to ramp up the metabolism with similar 
physiological reactions to experiencing fear or excitement, potentially leading to heart 
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palpitations in those who take this drug. The other active ingredient found in Topamax, 
topiramate, reportedly causes a fairly high incidence of confusion, memory loss, 
concentration problems, and psychomotor slowing, resulting (among other things) in 
difficulty finding the correct words. Topiramate also carries warnings for depression and 
mood problems, fatigue, and sleepiness. Suicidal ideation is listed as one of the more 
concerning side effects of this portion of the weight loss drug cocktail. Generally, these 
side effects aren‘t considered as serious as the potential for heart damage, but they are 
significant in that they are experienced by a large percentage of those who take the 
drug.
79
 It is reported that 42 percent of those taking topiramate reported one or more 
cognitive or mental problems. Moreover, it has been found that babies born to mothers 
who took topiramate have a higher incidence of cleft palate.
80
 The potential side effects 
including the presence of memory loss (generally short-term) is irreversible and possibly 
quite troubling to the individual taking the medication and those around him or her.  
 Since each of the drugs found in Qysmia has been on the market separately, the 
rigorous testing which would be mandated for a novel drug is not needed for approval of 
this drug combination. The FDA is considering requiring post-approval testing of this 
new weight loss drug combination to ensure that heart damage is not found to be 
disproportionately burdensome among those who are taking Qysmia. With an anticipated 
weight loss of up to 10 percent of body weight, this drug may prove valuable to those 
who use it, at least in the short-term. As there is no long-term data available on its use 
and its ability to effect sustained weight loss. Additional weight loss drugs are set to be 
considered by the FDA in the near future. In all likelihood these drugs, like any 
technological intervention, will carry the potential for troubling, possibly irreversible side 
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effects for those who use them. The question will of course be whether the risks and side 
effects, both reversible and not, are worth the potential benefits of weight loss, for 
whatever period of time it is sustained. 
 There has been significant anticipation among those who participated in the 
various clinical trials of each of these newly approved drugs but who have not been able 
to access them since the end of the trials. Additionally, physicians seeking effective next-
generation drug interventions for their patients are eager to have new products upon 
which to draw.
81
 According to the FDA, there appear to be sufficient data to warrant 
approval of these medications to aid in the fight against obesity. However, both of these 
drugs have potentially irreversible and concerning side effects, both require patients to 
remain on them for the duration of their lives, and both have only short-term outcome 
data to assess the long-term risk of harm or benefit to those taking the medication. 
Moreover, the anticipated amount of weight loss appears to be modest for most.
82
  
 What seems apparent, however, is that pharmaceutical companies will continue to 
seek the magic pharmacological bullet for eliminating obesity which would provide 
significant financial remuneration as well as assisting to eliminate a thorny and seemingly 
increasing global problem. In addition to past and present risk-benefit concerns when 
using pharmacological interventions, the development and use of effective next-
generation pharmaceutical interventions may be hampered by misunderstanding and 
misuse of the drugs that are developed. Some overweight individuals may employ 
pharmacological interventions without the recommended interventions in diet/exercise 
and lifestyle, thereby rendering the interventions less effective. Yet social attitudes may 
also plague the realistic and nonmoralized acceptance of such pharmaceuticals. Some 
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may view use of weight loss drugs as an inappropriate ―quick fix‖ for weight loss. Rather 
than viewing weight loss drugs as part of an overall treatment plan, much as 
antidepressants can enhance the effectiveness of psychotherapy and facilitate 
development of different cognitive and behavioral patterns, the weight loss drugs may be 
used by some and criticized by others as an easy solution to a complex, multi-factorial 
condition. The societal conception of even effective weight loss drugs with a positive 
risk-benefit profile as a ―quick fix‖ or an ―easy way out‖ may decrease the acceptability 
of the drugs‘ usage among those who may indeed benefit from them.  
A.iv Physician-Supervised Weight Loss Interventions 
 Safe and effective pharmaceutical intervention, as well as some features of 
commercial and self-help weight loss programs, such as nutritional counseling, could be a 
part of physician-supervised weight loss interventions. Currently, however, ―physician 
supervised weight loss interventions‖ refers to primarily to behavioral counseling by 
physicians, usually in primary care settings, along with monitoring of weight lost.
83
 The 
U.S. Preventative Services Task Force has recommended that clinicians screen all adult 
patients for obesity and offer intensive counseling and behavioral interventions (at least 
two visits per month for the first three months) to promote sustained weight loss for 
obese adults.
84
 Additionally, the American Medical Association (AMA) and the 
American College of Physicians (ACP) have published guidelines for how clinicians 
might best manage this task with their patients.
85
 These guidelines suggest that physicians 
should engage the topic of weight with patients routinely in the normal course of 
conducting an office visit. Patients who are at a healthy weight should be encouraged to 
maintain the lifestyle supporting that weight. For those who are in danger of becoming 
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overweight, concrete suggestions should be provided regarding dietary changes and 
increases in exercise, which would reduce the risk of becoming overweight. 
Conversations should also include information on the potential for developing weight-
related co-morbidities. For those currently overweight or obese, regular counseling on 
dietary changes and modest increases in activity should be encouraged. Adjunctive 
pharmacological therapies should also be considered for those who have been 
unsuccessful with dietary changes and increased activity alone.
86
 It is suggested that the 
focus be on achieving modest weight loss goals.
87
  
 The placement of such behavioral counseling interventions within the healthcare 
setting explicitly acknowledges the potential importance of as yet unidentified medical 
interventions to effect long-lasting weight changes which serve to improve overall patient 
well-being. The focus in primary care physician (PCP)–provided intervention is on 
behavior, specifically on assisting patients in making positive and sustainable behavioral 
changes.
88
 Like most psychotherapeutic and especially cognitive behavioral counseling, 
this approach is forward-looking and solution-focused, eschewing attributions of personal 
blame for an individual‘s current overweight condition. A limitation of this individual-
level intervention is that it generally does not involve exploration or resolution of factors 
outside of those which are primarily behavioral in nature. It fails to consider causal 
contributions either at a broader social level or at the level of individual genetics and 
physiology.  
 Tsai and Wadden synthesized several studies of PCP—provided weight loss 
interventions and concluded that practitioners and researchers know little about the 
efficacy of behavioral weight loss interventions that can be delivered in primary care 
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practice.
89
 All studies included in the review were randomized controlled trials which met 
CONSORT criteria used to assess the overall quality of a study. One type of study 
reviewed utilized behavioral counseling conducted either by the PCP directly or by 
another provider (e.g., nutritionist or dietician) working in the PCP office. The amount of 
weight lost by patients participating in the low- to-moderate-intensity behavioral 
counseling efforts was not statistically significant—defined as ≥5 percent of initial 
weight.
90
 The authors note that ―current evidence does not support the use of low-to-
moderate-intensity physician counseling for obesity, by itself, to achieve clinically 
meaningful weight loss.‖91 Two studies reviewed met criteria for being both randomized 
controlled trials and providing behavioral counseling of higher intensity (at least twice a 
month). Of these two studies, in only one did subjects achieve clinically significant 
weight loss (7.7 kg). The other study which provided high-intensity behavioral 
counseling produced an average weight loss of 4.3 kg, which is not considered clinically 
significant weight loss.
92
 The authors conclude that research on the management of 
obesity in primary care is simply not yet advanced enough to provide data that may 
improve the provision of effective clinically significant weight loss services within this 
venue. The authors further point out that ―without effective therapies, greater resources in 
their practices, and more adequate reimbursement, PCPs alone cannot be expected to 
provide effective weight management for all of their patients who require it.
93
  
 In the section below weight loss interventions which utilize a higher level of 
physician technical skill along with the application of technology will be addressed. 
These interventions are broadly termed weight loss surgical interventions or bariatric 
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surgery. As the technology has evolved significantly since its initial use the review below 
focuses on improvements in technique and outcomes since their use began. 
B. History of Surgical Interventions for Weight Loss 
Similar to the genesis of pharmacological interventions, the application of 
medical knowledge and highly specialized medical skill has also been employed in the 
development of surgical weight loss interventions. Surgery for weight loss began in the 
1950s before the problem of obesity had reached its present proportions and become the 
public health concern—some would say crisis—which it reportedly is today.94 The use of 
laparoscopic surgical interventions has grown exponentially in the years since its 
introduction. It is estimated that approximately 200,000 people undergo bariatric surgery 
of some sort every year.
95
  
 Since the first WLS was performed, over fifty and possibly as many as one 
hundred variations of the surgery have been done.
96
 The surgical interventions currently 
available fall into three broad categories.
97
 The first category includes purely restrictive 
interventions, which reduce the capacity of the individual to ingest food by making the 
stomach pouch smaller.
98
 A second category includes primarily malabsorptive 
interventions. In this type of procedure, the individual‘s anatomy is altered so that the 
body is no longer able to absorb all of the calories and nutrients which are provided by 
the food ingested. In this way some nutrients are lost along with a portion of the calories, 
thereby reducing the individual‘s overall absorption.99 The third surgical variation 
incorporates both restrictive and malabsorptive properties.
100
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B.i Early Surgical Interventions 
 The following subsections discuss the progression and evolution of early surgical 
interventions for weight loss. The discussion will reveal improvements both in technique 
and patient outcomes since those first surgeries. The discussion will begin with a review 
of the earliest documented procedures.  
B.i.a The 1950s—The first documented bariatric surgical procedures 
 By the early 1950s, years of clinical observation had shown physicians that a 
shortened gut leads to weight loss. Physicians began to wonder whether short-gut might 
be induced as a treatment for those who were morbidly obese.
101
 The most noteworthy 
clinical observations had come from surgeries dating as far back as 1884 on patients who 
required surgery to repair gastric ulcers. For these patients, a portion of the 
gastrointestinal system was bypassed or shortened to remove the diseased tissue. From 
coincidental clinical observations of subsequent weight loss came early attempts to 
harness this surgical side effect. The use of this clinical observation to develop surgical 
options for the treatment of people with obesity turned a negative and unintended side 
effect into a potential medical benefit for an unrelated population of patients. 
 The first effort at surgical weight loss intervention has been attributed to Victor 
Henrikson of Sweden. He published his efforts in 1952 in the Journal of Nordisk 
Medicine. His article was translated as ―Can Small Bowel Resection Be Defended as a 
Treatment for Obesity?‖ in 1994.102 In this article Henrikson briefly and rather 
unscientifically, by modern standards, describes a small bowel resection performed on a 
―thirty-two-year-old woman suffering from obesity, constipation, something that slowed 
her metabolism (without myxedema) and the inability to complete a weight loss program 
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successfully.‖103 By his own admission, the surgery had a ―numerically bad result‖ in that 
the patient did not lose weight from the surgery as hoped and in fact reportedly weighed 
two kilograms more fourteen months postoperatively than she had preoperatively. 
Henrikson further reported, however, that the patient was, ―subjectively speaking, 
content, and feels healthy and energetic.‖104 This initial pioneering effort was the first 
attempt at utilizing a bariatric procedure to induce weight loss and reduce co-morbidities. 
 In the United States, the first surgical intervention performed on a human was a 
malabsorptive procedure which was only briefly mentioned in a veterinary publication 
discussing the small intestines of dogs. In that 1954 article, a brief reference was made to 
a patient who had received a jejunoileal bypass (JIB, a malabsorpitve procedure) for 
weight loss.
105
 In fact, the 1950s ended without any detailed published report of the first 
American surgeries, their outcomes, or the specific procedures done. The lack of 
publication on this surgical intervention is thought to ―reflect a lack of interest by 
surgeons and others in this concept.‖106 No reason for this perceived lack of interest is 
proposed. Perhaps these efforts were seen as having limited use, as the number of patients 
for whom this intervention might be efficacious was minimal at the time. Perhaps the 
lack of interest in surgical weight loss interventions was a product of a societal view that 
overweight and obesity were primarily caused by personal moral failings or character 
defect on the part of the patient, and therefore medical intervention in obesity would be as 
foreign as employing Antibuse to treat alcoholism, which was also perceived at that time 
as a problem of weak will and poor character. The seriousness of the surgical side effects, 
along with the rudimentary knowledge base of best practices at this time, made the 
widespread discussion and utilization of this option premature.
107
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B.i.b The 1960s— Attempts to reduce side effects and standardize pouch size 
 The next decade saw continued evolution of the surgical interventions available. 
Efforts undertaken during this time period were primarily focused on reducing the 
deleterious side effects of the surgery, which often necessitated its reversal, and on 
standardizing the size of the remaining stomach pouch. Both malabsorptive procedures 
and restrictive procedures evolved during the 1960s. The primary operation at the 
beginning of this decade was the continuation of the JIB surgery. During this decade, 
numerous surgeons were involved in developing surgical variations on a theme in an 
effort to reduce the debilitating side effects of this type of surgery.
108
 Side effects were so 
serious that they often necessitated reversal of the surgery, which also reversed any 
weight loss the patients had seen.
109
 The goal of the surgical interventions developed 
during this period was to achieve the obese individual‘s desired weight loss without 
causing him or her to overshoot the weight loss target, which would then likely require an 
additional surgery to restore more typical gastrointestinal functioning once the patient 
had achieved ideal body weight. It was not uncommon in the early years for two surgeries 
to be required. One surgery was to initiate the weight loss, and a subsequent surgery was 
performed to halt the weight loss and restore more typical function once the nimiety of 
weight had been lost. In 1969 surgeons Payne and DeWind reported that ―we and others 
have tried to develop a technic [sic] which could be applied with safety and would avoid 
the necessity of a second operation to restore intestinal continuity with consequent 
serious weight gain.‖110  
 Another surgical option which evolved during the latter 1960s was both 
malabsorptive and restrictive. This surgery, done by Mason and Ito at the University of 
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Iowa, involved reducing the size of the stomach pouch in addition to bypassing a portion 
of the small intestine. The efforts of Mason and Ito are marked in weight loss surgical 
history as the original gastric bypass procedure. The gastric bypass surgery decades later 
―easily supplanted the jejunoleal bypass but was not free of problems.‖111 Complications 
from this surgical variation included iron deficiency, anemia, dumping (rapid gastric 
emptying), vitamin malabsorption leading to secondary medical problems, increased 
potential for bowel obstruction that could potentially cause rupture if left untreated, and 
loss of ability to visualize the bypassed parts of the stomach.
112
 Variations on a surgical 
theme focused on determining the correct size to which the stomach pouch should be 
reduced. Stomach pouch alterations during this time were either too large or too small. 
By the end of the decade, the first standard size (50 ml) was recommended. At the end of 
the 1960s, the JIB surgery was still the most prominent option, but that trend would 
eventually change.
113
 
 The 1960s saw more extensive pools of patients receiving surgical weight loss 
interventions. Patient outcomes were followed more closely, with various surgical 
techniques and the individual case outcomes being compared against each other in an 
effort to discern more scientifically best patient outcomes, reduce risk, and maximize 
patient benefit.
114
  
 In applying the bioethics and medical calculus of benefits versus burden, the 
benefits did not seem to outweigh the burdens for patients at this time because the side 
effects of the surgery made typical gastrointestinal functioning almost impossible for the 
patient post-surgery.
115
 Additionally, since the complications were potentially life-
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threatening, the intervention often had to be reversed, and any gain seen was eventually 
lost as patients regained their formerly obese status.  
B.ii Surgical Interventions for Weight Loss Refined 
 Following on the footsteps of the earliest weight loss surgeries which often 
produced unfavorable results and side effects for patients those earliest interventions 
began to be improved. Increased skill in technique as well as changes in the tools used to 
conduct the surgery began to produce superior outcomes. The following subsections 
explore various areas of improvement in technique, reductions in side effects, and overall 
patient outcomes. 
B.ii.a The 1970s—New procedures developed 
The volume and speed of development of surgical treatments for weight loss 
increased during 1970s. The efforts of this decade included the development of a new 
malabsorptive procedure called the biliopancreatic diversion (BPD) and work done on 
various ways to partition the stomach to maximize patient outcomes.
116
 Additionally, 
refinements to established malabsorptive and restrictive surgeries continued, the 
procedural forerunners of what would become gastric banding took place, and modern 
malabsorptive procedures were developed.
117
 Specifically, additional work was done to 
improve technique in the JIB surgery in an effort to reduce complications. Ultimately 
however, during this decade, the JIB surgery was supplanted by a different malabsorptive 
surgery—the biliopancreatic diversion. The primary work done on this surgery was 
performed by Dr. Scopinaro.
118
 One of the goals of this new surgical technique was to 
induce a state of malabsorption without the potentially dire side effect seen in the JIB of 
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bacterial overgrowth which led to serious, sometimes life-threatening liver damage. In 
this surgery,  
―bile and pancreatic fluids released into the duodenum to digest food and break 
 down fats, carbohydrates and proteins are diverted away from ingested food—
 hence the name biliopancreatic diversion. The digestive enzymes eventually join 
 the ingested food—but at a point in the distal small intestine where there is much 
 less chance for complete breakdown and absorption.‖119  
 
BPD requires the physical removal of a large portion of the stomach, up to 70 percent. 
The side effects of this surgical procedure also had many unappealing and life-limiting 
side effects which made the surgery an unattractive option to patients who suffered from 
undigested fats which cause gas and loose, foul-smelling bowel movements.
120
  
 During this decade, work by Alden and Griffen altered how the stomach was 
partitioned. These efforts built on the earlier work of Mason from the previous decade.
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The modifications to this malabsorptive/restrictive surgery, called the Roux-en-Y 
gastrointestinal bypass, allowed patients to achieve the same levels of weight loss as the 
JIB surgery with fewer and less serious complications. The modifications were reported 
to have changed the face of bariatric surgery and for the next two decades established 
gastric bypass as the dominant operation in this field.
122
 Mason turned his work towards 
restrictive operations during the 1970s. His work during this time was on a purely 
restrictive operation called gastroplasty, which partitioned the stomach using the newly 
introduced mechanical staplers. These operations were designed to avoid the 
complications of the JIB, but this purely restrictive bypass did not seem to result in 
sustained or satisfactory long-term weight loss.
123
  
During the same period, the procedural forerunners of what would become gastric 
banding took place. Wilkinson placed the first nonadjustable mesh band around a portion 
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of the stomach to separate the upper portion of the stomach from the lower portion. While 
this surgery was not successful in the long run, as the upper pouch eventually stretched 
and permitted patients to ingest larger quantities of food, variations on this theme would 
advance and become prominent several decades later.
124
  
Other innovations in the 1970s attempted to alter the lateral hypothalamus to 
cause weight reduction. Efforts by Quaade et al. in 1974 were described as ―stereotaxic 
stimulation and electocoagulation of sites in the lateral hypothalamus.‖125 These efforts 
produced transient results, but the weight lost was significant in the short-term. Literature 
on the use of jaw wiring as an intervention for weight loss, although not specifically 
surgical, began to be seen during this decade as well.
126
  
B.ii.b The 1980s—Gastric bypass surgery: variations on a theme 
 The scientific advancement of 1980s occurred in three primary areas: the 
evolution of several forms of gastric bypass surgeries, including multiple variations of the 
Roux-en-Y gastric bypass first performed in the previous decade; progress in vertical-
banded gastroplasty; and the development of the precursors to what would become 
gastric banding.
127
 Variations in gastric bypass techniques included such things as 
dividing and stapling the stomach vertically instead of horizontally, adding a band to 
reinforce the outlet, the introduction of a long-limb variation designed to produce better 
results in treatment for the ―super obese,‖ and the addition of a silastic ring as part of the 
procedure, among other improvements. The Roux-en-Y surgery is still considered by 
many to be the ―gold standard‖ of surgical interventions for weight loss.128   
 During this time period, numerous surgical variations were undertaken on vertical 
banded gastroplasty. Gastroplasty is a restrictive procedure in which the stomach is 
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modified by dividing it in order to reduce its size and capacity without bypassing portions 
of the intestine. Some variations which were also being seen in partitioning the stomach 
as part of the Roux-en-Y surgical techniques described above were also being undertaken 
in gastroplasty. These included partitioning the stomach vertically with the use of 
surgical staples, or using both staples and surgical sutures, or in some instances 
introducing polypropylene mesh or a silastic ring at the site of the partition.
129
  
 Pitombo et al. note that ―clinical progress with gastric banding, a purely restrictive 
procedure, in the 1980s was rather dormant; however, the basic interventions necessary 
for the popularity of gastric banding were introduced during this decade.‖130 The 
technical innovations which were introduced into gastric banding would eventually 
increase the popularity of this weight loss intervention. The first adjustable gastric bands 
were used on patients during this decade. Kuzmak devised a gastric band which was lined 
with an inflatable balloon in 1986. The balloon essentially allowed for the adjustment of 
the band to either tighten it to increase weight loss or loosen it to reduce weight loss.
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These bands were placed during open surgical procedures. 
B.iii Introduction of Laparoscopy 
 A series of discoveries led to the eventual adoption of laparoscopic techniques for 
surgery. These techniques used in many different types of surgeries began to be used in 
bariatric surgeries as well. The evolution of weight loss surgeries utilizing laparoscopic 
techniques is discussed below.  
B.iii.a The 1990s—A Less invasive technique 
 Surgical innovations during the 1990s included the introduction of laparoscopy, a 
modification to the biliopancreatic diversion called the duodenal switch (found primarily 
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in the United States), and the first attempts at electrical pacing of the stomach to induce 
weight loss. The introduction of laparoscopic procedures has been enduring and lauded as 
an advancement which has improved patient outcomes and reduced patient risk.
132
  
Historical precursors to laparoscopic surgery can be traced to Philip Bozzini as far 
back as 1805. He was the first to attempt to use candles and reflecting mirrors to direct 
light into internal body cavities for better visualization. Decades later, Maximilian Nitze 
and Josef Leiter introduced the first rigid endoscope, introduced in 1879, the same year 
Thomas Edison invented the light bulb. The first rigid endoscope contained a built-in 
light, but it was not until the 1990s that the technology had advanced sufficiently for 
practical application in this venue.
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 Laparoscopic procedures, whose first reported use in weight loss surgical 
interventions was published in 1994, utilized several small openings in the patient‘s 
abdomen through which a camera would guide the movements of the surgeon performing 
the procedure without requiring the surgeon‘s hands to physically enter the patient‘s 
body.
134
 The standard until that time had been open surgery during which a large incision 
was made vertically along the patient‘s abdomen through which the surgery would be 
performed. Laparoscopy permitted specially trained surgeons to use less-invasive surgical 
techniques that reduced patients‘ recovery time and reduced the complications associated 
with open surgery.
135
 Gastric bypass procedures using the laparoscopic technique began 
to be widespread during this decade. While it was not and is still not possible to perform 
all WLS via laparoscopy, this significant advance has served to reduce patient risk and 
shorten patient recovery times.
136
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The introduction of laparoscopic surgery also facilitated the popularity of 
adjustable gastric banding. Adjustable gastric banding, considered less invasive and more 
easily reversed than other surgical interventions, had been hampered by the need to place 
the band during an open surgical procedure. The introduction of laparoscopy reduced the 
reliance on that invasive technique and permitted more patients to have easier access to 
the placement of adjustable gastric bands for weight loss.
137
  
 Continued evolution in malabsorptive surgeries, which had begun late in the 
previous decade, continued in the 1990s.
138
 Specifically, Hess and Marceau worked to 
introduce the duodenal switch (DS) in the United States. This surgical innovation was 
designed to be an improvement on the earlier BPDs which were prominent in the 1970s 
and 1980s. The primary difference between the BPD and the DS is the shape of the 
stomach that remains. In the BPD the stomach is cut horizontally, while in the DS the 
stomach is cut vertically. This change was introduced because the duodenum has better 
resistance to acid, and therefore the incidence of ulcers was thought to be decreased as a 
side effect from this new modification.
139
  
 There remain sustained efforts to improve techniques and outcomes for patients. 
Additionally, there remain areas of debate and contention regarding WLS. These are 
addressed here. 
B.iv Current Efforts and Current Debates 
 Nearly sixty years following the introduction of surgical interventions for weight 
loss, most surgeries are performed laparoscopically, and the surgical options are more 
varied than ever.
140
 Malabsorptive, restrictive, and combination malabsorptive/restrictive 
surgeries continue to be performed. The most common procedures include gastric bypass, 
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adjustable gastric band, and biliopancreatic diversion with duodenal switch. Most of 
these procedures are performed laparascopically using minimally invasive techniques.
141
  
 While some of the original procedures have fallen by the wayside, several others 
(e.g., adjustable gastric banding), considered less invasive and more reversible, have 
grown in use.
142
 Early surgical weight loss procedures did indeed have side effects that 
may have seriously overshadowed the potential benefits to the patient, but current 
surgical interventions have been refined such that surgical risk is now largely predictable 
and manageable.
143
  
 In addition to the acknowledged risks of any type of surgery, such as 
complications which develop from general anesthesiology or exposure to hospital-
acquired infections, there are complications and risks specific to bariatric surgical 
procedures. These complications can be divided into three general categories: 
postoperative complications generally related to the surgery itself, short-term 
complications (occurring within the first year following surgery), and long-term 
complications (including surgical, metabolic, and nutritional concerns).  
 Immediate postoperative risks can include increased susceptibility to infection at 
the surgical site or intra-abdominal infection, as well as leaks, venous thrombosis, and 
bowel obstruction causing acute gastric distention. Additionally, the development of 
gallstones and the persistent presence of nausea and vomiting can also be observed 
immediately following surgery for weight loss. Longer term complications can include 
those listed above as well as nutritional and metabolic concerns caused by malabsorption 
of key nutrients.
144
 A study conducted by Abell and Minocha examined the most often 
seen complications from obesity surgery. They identified the ten most commonly 
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reported complications found in restrictive procedures or procedures combining 
restrictive and malabsorptive features. In general, the more complex the surgical 
procedure, the greater likelihood that complications will manifest. The most commonly 
seen complications, irrespective of the type of procedure performed, are, in descending 
order of prevalence: dumping (rapid emptying of gut contents into the small bowel, 
which can cause nausea, cramps, and vasomotor symptoms), vitamin/mineral 
deficiencies, vomiting/nausea, staple-line failure, infection, stenosis/bowel obstruction, 
ulceration, bleeding, splenic injury, and death.
145
 Additionally, the authors reported that 
there may be other issues related to rapid weight loss, including bacterial overgrowth and 
diarrhea. Abell and Minocha note that ―since the complications of bariatric surgery are 
treatable once proper diagnosis is made, all physicians seeing post-bariatric surgery 
patients need to be aware of potential complications so that diagnosis and therapy can be 
promptly made.‖146  
 Mortality is a concern of all surgical procedures, including bariatric surgery. In a 
review of 110,000 bariatric surgeries performed by 495 bariatric surgeons associated with 
American Society of Metabolic and Bariatric Surgery (ASMBS) Centers for Surgical 
Excellence, it was reported that the postoperative in-hospital mortality rate was 
approximately 0.14 percent immediately following surgery. The postoperative mortality 
rate reported at thirty days was 0.29 percent, and at ninety days was 0.35 percent.
147
 Data 
gathered from a variety of other studies reporting on hospital mortality and postoperative 
mortality rates at thirty and ninety days post–WLS show similar results.148 In yet another 
study conducted by the agency for Health Care Research and Quality, it was reported that 
the death rate from bariatric surgery is 0.5 percent.
149
 The mortality risk immediately 
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following WLS is approximately equal to that of patients undergoing gallbladder 
surgery.
150
 This statistically small risk has been shown to be offset by a gain in lifespan 
of one to six years depending on the patient‘s age at time of surgery. Younger patients 
experienced a higher gain in lifespan.
151
   
 The current risk-benefit analysis appears to be favorable for those choosing 
bariatric surgery. Research has been conducted on outcome measures which have 
established the positive impact of WLS on co-morbid, obesity-related diseases such as 
type 2 diabetes, heart disease, and sleep apnea. In two separate studies on the potential of 
gastric bypass surgery to resolve type 2 diabetes, it was found that this particular type of 
intervention resolved diabetes in approximately 80-90 percent of patients.
152
 Gastric 
banding surgery was found to resolve type 2 diabetes in approximately 73 percent of 
patients.
153
 Another major health risk for those who are obese is coronary artery disease. 
The risk of developing obesity-related coronary artery disease was cut by 50 percent in 
those who underwent gastric bypass surgery.
154
 Additionally, sleep apnea was resolved in 
more than 85 percent of gastric bypass patients.
155
 
 In a prospective study that followed patients who received surgical intervention 
for weight loss, 119 subjects were studied between January and December of 2005. The 
study noted that there was a large reduction medication usage in subjects across co-
morbid conditions. Diabetes medication usage was reduced by 72 percent, and depression 
medication use was reduced by 50 percent at one year post-surgery. The authors estimate 
that the cost of the surgery can be recouped in approximately seven years based solely on 
the cost savings from reduced medications.
156
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 A well-known study, the Swedish Obese Subjects Study, followed patients at 
various intervals post-surgery. The research matched bariatric surgery and conventionally 
treated patients. The study was designed to examine the amelioration of metabolic and 
cardiovascular risk at various time intervals post-intervention. The authors concluded that 
compared with conventional therapy, bariatric surgery appears to be a viable option for 
the treatment of severe obesity. It results in long-term weight loss, recovery from 
diabetes, improved lifestyle, and the amelioration of risk factors which had been elevated 
at the point of surgical intervention.
157
  
 Patients undergoing these interventions were also found to improve life 
expectancy by 89 percent and to reduce the risk of premature death by 30-40 percent.
158
 
Co-morbid death risks from diabetes, cancer, and coronary artery disease were reduced 
by 92 percent, 60 percent, and 56 percent respectively.
159
 Surgical interventions have thus 
established themselves as ―the first effective therapy for the disease of morbid 
obesity.‖160 Weight loss surgical interventions are intended to be used as a tool in the 
arsenal used to fight severe obesity. In addition to surgical intervention, those undergoing 
WLS are reminded that, similar to other types of weight loss technologies, ongoing diet 
and exercise changes must be incorporated in order to sustain long-lasting results.
161
 
In spite of the reported low long-term success rates of self-help, pharmaceutical, 
and commercial interventions, the more successful option of WLS continues to be a 
contentious and confounding intervention. The debate continues to rage over whether 
WLS should be widely promoted as a solution for individuals struggling with obesity and 
its potentially life-threatening co-morbidities.
162
 Weight loss surgery is sometimes 
criticized for focusing at the individual level, rather than on the social and environmental 
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causes of obesity associated with viewing obesity as a public health problem. Weight loss 
surgery, like pharmacological interventions, is also criticized for being a ―quick fix‖ for 
what is viewed as either a complex, multi-factorial health problem or a failure of 
willpower and character. But in fact, surgical interventions seem to recognize obesity as a 
complex health problem involving genetic and other physiological factors as they interact 
with the current social and physical environment. The utilization of WLS as a treatment 
and as a potential cure for secondary life-threatening co-morbidities effectively treats 
obesity as a medical condition for which moralizing, dependence on a higher power, or 
application of purely behavior modification programs have been shown to be ineffective 
and inefficient.
163
  
One debate has centered on the appropriateness of utilizing a physically invasive 
technique such as surgery to treat obesity. This stance assumes that other technologies are 
significantly less invasive simply because they are not physical in nature. The following 
section articulates this debate and argues that it misunderstands various forms of 
invasiveness and their potential for irreversibly altering lives.  
B.v The Exceptionalism Debate  
 The term ―exceptionalism‖ was first used in an article published in 1991 on 
human immunodeficiency virus (HIV) testing and results.
164
 Since its entrance into our 
healthcare vernacular, the concept has been applied as a critique of treating a medical 
condition or particular healthcare information as being so unique or special, so different 
from the norm, that the application of more stringent ethical and legal standards and 
safeguards is warranted.
165
 By elevating the level of suspicion with which particular 
interventions or information is regarded, it then follows that the development and 
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application of additional safeguards, designed to protect the patient, would be prudent. 
Thus, exceptionalism can be used to justify a person‘s or group‘s choosing to not 
recommend or even consider a common idea or activity that has widespread 
acceptance.
166
 In other words, exceptionalism can be used in attempts to justify 
paternalism.  
In the case of HIV testing, exceptionalism has meant that the information gleaned 
is thought to be qualitatively distinct from other medical data, such as height or blood 
type, and therefore requires additional safeguards in order to protect the individual from 
harm that might occur due to the misuse of such sensitive and potentially easily 
misconstrued information.
167
 Specific harm such as discrimination in insurance coverage 
and employment opportunities, as well as potentially rash behaviors on the part of the 
patient such as attempting to harm himself in light of the information, have been cited as 
reasons to treat such information as being exceptional and therefore subject to additional 
levels of ethical consideration and regulatory safeguards.
168
 In the case of HIV test 
results, genetic information, and neuro-imaging, claims for such exceptional treatment 
have largely been rejected, save for a few legal safeguards.
169
 Critical analyses of the 
factors once thought to justify exceptionalist treatment of such information have 
determined these factors to be insufficient reasons for exceptionalism. Some of these 
reasons are centered on the disease itself or the characteristics of the people diagnosed. 
Exceptionalism has been deemed inappropriate. 
Exceptionalism has also been applied to surgery.
170
 Surgical exceptionalism 
means that this surgical intervention is thought to be essentially different from other 
interventions and thus warrants enhanced safeguards and limitations—or particularly 
 85 
 
strict criteria—for its use. Those who engage in surgical exceptionalism see surgery as 
radical, invasive, irreversible, immediately life-threatening, and fraught with the potential 
for adverse effects in a way and to a degree not true of other interventions. For those who 
would adopt an exceptionalist position, surgery is a last-resort intervention to be avoided 
whenever possible.  
The exceptionalism applied to surgery is based in part on a narrow and strongly 
held physicalist view of the risks and other characteristics associated with a spectrum of 
medical interventions. Surgery is indeed a physical somatic intervention. It generally 
requires damaging the body by cutting into it in some fashion. In the case of surgery, the 
body experiences not only the sought-after transformation but also collateral damage. It is 
necessary to do harm in order to achieve a desired intermediate outcome—e.g., removal 
of a tumor or the restructuring of a valve─which is thought to (re)establish superior 
physiological outcomes or functioning with the ultimate goal of the patient‘s improved 
health and functioning. Surgical exceptionalists‘ preoccupation with the physical—
physical bodily invasion, physical collateral damage, physical repair, which are 
admittedly required to restore the patient‘s functioning through surgical means—may 
nevertheless disguise them from nonphysical but otherwise similar aspects of nonsurgical 
interventions.
171
 
A purely physicalist understanding of alteration and change grounds the view that 
surgery is irreversible and deflects attention from the ways in which, for example, 
psychotherapy can irreversibly alter a patient‘s self-concept, worldview, responses to 
others, or values and priorities. Psychotherapy ―may utilize insight, persuasion, 
suggestion, reassurance, and instruction so that patients may see themselves and their 
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problems more realistically and have the desire to cope effectively with them.‖172 
Through the process of psychotherapy, the emotional defenses of the person receiving 
treatment are often stripped away, laying bare much of the individual‘s capability to 
protect herself psychologically. This therapeutic technology relies on an invasive 
technique as surely as surgical weight loss. One key difference is the degree to which the 
invasion is readily observable. During a surgical procedure such as WLS, the wounds 
brought to bear on the body from the laser or the scalpel when the instrument cuts into 
the patient are readily observable. There is blood loss, and upon completion of the 
intervention, wounds are sealed by stitches, surgical glue, or other means. In contrast to 
the invasiveness of psychotherapy or the effects of hormonal pharmacological 
interventions, surgery is an invasion which is physically apparent. In the case of 
psychotherapy the invasion may be equally life-changing and invasive, but it is easier to 
perceive this intervention as noninvasive or less invasive because there may well be no 
physical remnants of the intervention. There are likely no discernible physical scars, no 
observable bandages, and no residual traces of the invasion and its aftermath. 
 Psychotherapeutic interventions, like surgical ones, are not readily reversible, 
however. In fact, much of the basis of psychotherapy has the purpose of effecting lasting 
or irreversible personal change which fundamentally alters the way in which the patient 
might view, approach or respond to the world or situations in the world.
173
 Collateral 
damage may be experienced as the changes in the individual further cause lasting 
changes in intimate relationships and friendships. In many instances, psychotherapy has 
been known to facilitate ending relationships that, while perhaps comfortable, are no 
longer productive or that might in fact be damaging. The changes can indeed be life-
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altering and the aftermath may be irreversible. Accessing psychotherapy does not require 
more stringent criteria for its use. In fact, as long as one can afford such an intervention 
either through insurance or private pay, and assuming the availability of a therapist, there 
are no restrictions applied to accessing psychotherapeutic interventions. 
 Claims that surgery is exceptional and warrants special safeguards or a higher bar 
to warrant its use must be predicated on comparison to other relevant interventions.
174
 In 
the case of obesity, technologies relevantly comparable to WLS include diet and exercise, 
pharmacology, commercial weight loss programs, and behavioral interventions. Weight 
loss surgery and the obese seeking it must be sufficiently different from other weight loss 
interventions or other patients seeking surgical remedies for their conditions as to warrant 
a more robust application of ethical analysis or stricter criteria for its use.
175
 In order for 
this surgery to warrant a more suspect and cautionary approach, and for stricter criteria to 
be applied to obese patients seeking WLS than to other patients seeking surgical 
solutions, the argument goes; WLS and obese patients must be of a different order than 
other interventions and other patients. But such claims of difference are mistaken, though 
their origin may be understandable. The obviousness and physical nature of the collateral 
damage resulting from surgical intervention—e.g., damaged tissue, loss of functioning 
organ tissue, perhaps iatrogenic infection—eclipse recognition of the ways in which other 
weight loss interventions also are invasive, risky, irreversible, and may involve collateral 
damage or adverse consequences when they are ineffective, even when they do provide 
sustained weight loss. 
 For instance, the application of diet and exercise, either by an individual or 
through a more guided experience such as commercial weight loss programs whose goal 
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is to ameliorate obesity, will require a long-term alteration of the obese person‘s 
resources, both financial and time.
176
 Perhaps time formerly spent at work earning money 
will need to be curtailed in order to apply the necessary level of intensity to the activities 
of exercise or food preparation required to lose weight. The financial effect may not be 
insignificant in the overall picture. Choosing healthier foods or paying for a gym 
membership will likely add an additional financial burden to the obese person and his 
family.
177
 The obese person will need to come to see himself differently as well. Family 
activities that focus on meals or food will need to be changed in some manner to 
accommodate the new focus on diet and exercise. Once the obese person loses weight 
through these various technologies, he may have different expectations of his life and his 
partnerships. What had formerly been acceptable may no longer be for the person who 
has lost one hundred pounds. Familial relationships might be put to the test or altered in 
irreversible, not always better ways. As new patterns are established, old patterns that 
involve others will out of necessity change.
178
 These irreversible changes may or may not 
be acceptable in those relationships. These relationships may be improved or damaged in 
response to those changes. Indeed, there may be a cascade effect seen in applying 
something as seemingly uncontroversial as changes in diet and exercise.  
This is true of other technologies for weight loss as well. Pharmacological 
interventions, as seen in the past, have had the irreversible effect of damaging the body in 
a manner so significant and so unanticipated as to jeopardize the life of the patient who 
uses this type of intervention. Additionally, pharmacological interventions are meant to 
be combined with diet and lifestyle changes and so would be subject to many of the other 
ramifications discussed above. For those seeking weight loss by employing one of the 
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self-help groups such as OA, accepting a higher power and admitting their relative 
powerlessness involves an irreversible alteration in their worldview and self-concept. 
Although this is not a physical change, the potential ramifications should be noted. For 
each of the technologies that might be applied for weight loss, there will likely be 
irreversible changes, sometimes drastic and long-lasting, which will be both necessary 
and potentially deleterious to the individual physically and emotionally.
179
 Since these 
changes, though irreversible and life-altering, are often not readily perceived, the obese 
person seeking to lose weight is generally not subject to stricter criteria for accessing 
these technologies. 
 Patients seeking WLS are not relevantly different from others seeking surgical 
intervention to solve a medical condition or disease. Candidates for WLS in the majority 
of cases cite concern over health as their primary motivation.
180
 In each case, the surgical 
candidate must meet some set of clinical criteria for the surgery. The question asked is, 
will the surgical intervention have an acceptable probability of resolving the medical 
problem relative to other possible interventions?
181
 As part of this analysis, the surgical 
candidate, regardless of the type of surgery sought, is evaluated for physical 
appropriateness for the intervention. Activities to assess the strength of the cardiac 
system, lack of active infection, and other possible contraindications are considered. 
Additionally, some evaluation of the patient‘s ability to follow up with appropriate post-
surgical changes will likely be considered by the medical team. Whenever surgery is 
considered an option, the medical evaluation should be based on appropriate medical 
criteria and done in keeping with standards of care.
182
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 The recognition that each technology for weight loss intervention carries with it 
potentially irreversible and life-altering ramifications, and the fact that the obese patient 
is not relevantly different from other patients seeking surgical intervention, should be 
especially troubling with regard to adopting an exceptionalist position. This knowledge is 
especially relevant in light of the fact that WLS has been shown to produce superior 
results in comparison to other types of weight loss technologies.
183
 Since each of the 
possible technologies that could be applied carry with them irreversible and life-altering 
consequences which might not always be positive or desirable, and given the fact that the 
greatest chance for long-term weight loss is with surgical intervention, the surgical 
exceptionalist demand for a higher bar before considering the use of surgery must be 
questioned. Earlier in this chapter, the success measurements of WLS relative to other 
interventions were discussed in detail. Weight loss surgery produces sustained weight 
loss for longer periods of time, along with superior amelioration of disease and 
psychosocial co-morbidities than other interventions.
184
  
Surgical exceptionalist reservations regarding WLS may decrease the likelihood 
that clinicians will discuss WLS with patients. Together with other value-laden social 
attitudes associated with responsibility for obesity and its treatment, the surgical 
exceptionalist view of WLS may lead clinicians to withhold information about it.
185
 They 
may do so in the mistaken belief that they are preventing patients from choosing an 
unnecessarily risky, radical, irreversible intervention. This paternalistic approach is not 
only unwarranted because it is not clear that avoiding WLS is in the best interests of 
obese patients, but it is also perhaps motivated by value-laden perspectives on both WLS 
and obesity. These issues are explored further in chapter three. 
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The efficacy of surgical weight loss interventions has been established.
186
 The 
interventions ameliorate obesity along with its health and quality of life co-morbidities. 
However, there appears to be ongoing and significant societal ambivalence in accepting 
this medically beneficial intervention with manageable risks. The following chapter will 
outline and discuss various social, cultural, and theological constructs influencing societal 
ambivalence toward both weight and obesity interventions.  
C. Conclusion 
This chapter explored the numerous technologies and their associated normative 
frameworks which have been employed to treat obesity. Each of these technologies has 
met with varying degrees of success. Where possible, the chapter addressed available 
research data on the overall success of each program or intervention both in assisting 
obese people to lose weight and ameliorating physical and quality of life co-morbidities. 
Among organized self-help initiatives and commercial programs, it was found that 
Weight Watchers, Inc. provided participants with superior weight loss results which may 
assist in diminishing co-morbidities associated with excess weight. Overall, self-help 
initiatives and commercial weight loss companies have a normative framework of self-
reliance, with some additional guidance offered to assist in overcoming a problem with 
myriad contributory factors. Often these programs choose to diminish one or several of 
the identified factors which are beyond an individual‘s direct control but which have been 
associated with the development or maintenance of obesity. In general, rigorous 
assessment of the efficacy of self-help initiatives and commercial weight loss programs is 
difficult because of particular features of these programs such as participant anonymity or 
a paucity of research. Largely disappointing or failed efforts at pharmacological 
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interventions were reviewed as well. Pharmacological interventions for obesity have 
traditionally suffered from either poor overall results or from an imbalanced risk-benefit 
ratio for patients prescribed these medications. The result of this imbalanced equation has 
been serious and irreversible patient outcomes which have necessitated the removal of 
some weight loss drugs from the market. Two new medications have been introduced, 
Belviq and Qysmia, which are thought to hold promise to overcome the serious concerns 
found earlier-generation weight loss drugs. However, as two of these drugs were 
introduced just recently, their long-term efficacy is at present unknown. The use and 
development of pharmacological treatments have advanced the normative framework to 
include an understanding that obesity may require a more robust intervention than diet 
and exercise alone can produce. Indeed, obesity may be amenable to medical 
technologies. Finally, this chapter reviewed the development of various surgical 
interventions for weight loss which have developed over the course of the past half-
century. Data were provided from various research studies that indicate that surgery for 
weight loss thus far provides the best long-term outcomes when combined with 
subsequent lifestyle changes, and that the risks of surgery have been greatly diminished 
to the point of being considered manageable and similar to those experienced by patients 
when the gallbladder is removed. In spite of the efficacy of WLS and its manageable 
risks, exceptionalism has been and continues to be erroneously applied to this 
intervention. The application of exceptionalism to WLS is inappropriate and should be 
avoided in the same way that charges of exceptionalism to genetic information or HIV 
status were ultimately determined to be unfounded. Continued exceptionalism applied to 
WLS likely has the effect of the intervention being viewed as too radical, and hence real 
 93 
 
discussion of this intervention at a clinical level between patients and physicians may be 
thwarted. Chapter three will take up the ethical principles and social constructs which 
inform an understanding of obesity and WLS. 
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Chapter Three: Social Constructs and Theological Concepts Applied to Obesity 
 
 As shown in Chapter Two, there are many unsettled issues and diverse opinions 
surrounding the etiology and treatment of obesity; however, there is near uniformity of 
social opinion regarding the negative valence with which obesity and obese individuals 
are regarded.
1
 To explain the development and implications of this negative consensus, it 
is useful to employ feminist epistemological concepts and approaches to understand how 
obesity has been framed. This is important because how a problem is conceptually 
framed constrains the range of solutions that are recognized as viable. 
  This chapter will argue, with reference to key feminist epistemological concepts, 
that how obesity is framed—the currently dominant understandings of those who are 
obese—is flawed and inadequate. Dominant understandings of obesity neglect or 
explicitly discount important perspectives which must be considered in order to provide a 
more complete picture of the problem and its potential solutions. This chapter will argue 
that secular and theological social norms inhibit development of a more nuanced and 
complete understanding of obesity, as well as a wider acceptance and promotion of 
weight loss surgery (WLS). By examining the social construction of obesity, through the 
corrective lens of feminist epistemology, it is possible to identify current flaws in the 
construction of the obese identity, injustice in the treatment of obese people, and 
implications for the embrace of weight loss solutions. 
Section A will explore the concepts, goals, and approaches of feminist 
epistemology. It will be argued that feminist epistemology‘s focus on social context and 
power relationships affords a more accurate formulation of the problem of obesity and its 
potential solutions than is currently employed. Feminist epistemology and its methods as 
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discussed in this first section will be applied throughout this chapter to illuminate errors 
in the construction of obesity and articulate the values that inform them. Section B will 
examine gendered notions of appropriate bodies. To illustrate the way such norms 
thoroughly infiltrate and inform social attitudes, this section will examine normative 
constructions of bodies by the popular media and religious concepts. Section C will 
integrate previous feminist conceptual analysis with concerns about the stigmatization of 
obesity. This section will employ feminist attention to particularity and narrative to 
present concrete examples of the material implications for obese individuals of these 
phenomena grounded in the socially constructed norms of the body. The final section 
elucidates different senses of responsibility and argues that confusing causal with moral 
responsibility, as well as failing to distinguish appropriately between different goals of 
assigning responsibility, has led to inappropriately moralized views of obesity. These 
confusions, in turn, lead to ambivalent social attitudes towards WLS and failure to 
embrace it as the most effective clinical intervention currently available. The following 
section discusses the ways in which feminist epistemology can be used to correct the 
present construction of obesity. 
A. Applying Feminist Epistemology to Analyze the Social Construction of Obesity 
 It is a fundamental tenet of feminist epistemology and ethics that standpoint 
matters.
2
 Where one stands in relation to an issue—one‘s normative commitments, the 
values that inform one‘s point of view—matter as much for conceptualizing social issues 
as where one literally stands at the back or front of an animal one is asked to describe. 
―The insights of feminist standpoint theory,‖ writes feminist bioethicist Mary Mahowald, 
―provide a corrective to the nearsightedness, unselfconsciousness, and arrogance that 
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arise in health care and in bioethics, as in other areas of life and work.‖3 Mahowald 
explains that although she ―focuses on sexism, similar arguments apply to racism and 
classism‖, and there is obvious overlap in application. ―The common element is that the 
differences between groups are the grounds by which one group obtains and maintains 
advantages or power over another.‖4 This section focuses on the difference between those 
with normal or socially appropriate bodies and those who are obese.  
 The first subsection utilizes feminist standpoint theory to explicate how attending 
to the perspective of actual obese individuals can begin to correct the dominant 
understanding of obesity. The second subsection uses the work of Iris Young to explain 
how, at a conceptual level, dominant understandings are socially constructed. The third 
subsection employs Young‘s theory to analyze power relationships between dominant 
and marginalized groups. The fourth subsection explores the ethical and epistemological 
significance of the intersection of multiple marginalizations to describe the material 
implications of intersectionality for obese individuals. The fifth subsection integrates 
standpoint theory with narrative approaches drawn from sociology and ethics.  
A.i Standpoint, Partiality, and Privilege in Constructing a View of Obesity 
 ‗Standpoint‘ is a term used to define any ―perspectival view of the world.‖5 
According to Mahowald, ―feminist standpoint theory is based not only on the notion that 
human knowledge derives from situated perspectives, but also on the realization that 
some perspectives are privileged in comparison with others.‖6 In other words, knowledge 
is situated and partial. What and how something is seen reflects the viewer‘s situation and 
is both partial qua incomplete and partial qua serving the particular interests of the 
viewer. Some standpoints are privileged. ‗Privilege‘ is understood in two senses. First 
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and most obvious is the privilege of power. ―Because the dominant group generally 
defines and evaluates the world according to its own limited perspective, the only 
possibility for expanding and correcting that view is through the standpoints of those who 
are dominated.‖7 Thus, feminist standpoint theory accords privileges to the perspectives 
of non-dominant groups and individuals.  
 Paying attention to the observations, opinions, and experiences of members of 
non-dominant groups corrects the nearsightedness and unselfconsciousness reflected in 
the opinions and observations of those occupying a dominant perspective. As explained 
further in the next subsection, power—social, political, economic, and physical—is 
possessed by some people over others. These more powerful (at least vis a vis some less 
powerful others) are said to occupy the dominant position or perspective and are termed 
the dominant group, and have power. Those with social, political, economic, and physical 
power have vested interests in maintaining that power, and exercise what power they 
have to do so. Similarly, these interests and this power enables them to insulate 
themselves from challenges to their epistemological authority. What Mahowald terms 
nearsightedness and unselfconsciousness result.  
Nearsightedness, unselfconsciousness, and arrogance are related flaws, each 
reinforcing a natural tendency to construe one‘s partial perspective as the full 
picture. By nearsightedness, I mean that none of us, as finite, situated individuals, 
can see all of the parameters of the decisions we make.
8
 
 
But, even as she recognizes the epistemological privilege of the powerful or dominant 
perspective, she foreshadows the epistemological privilege of the non-domiant. She 
continues: 
This limitation [of nearsightedness] says something positive as well as negative. I 
allow that we at least see what is near, even though we cannot see what is beyond 
our range of vision …9 
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Thus, feminist epistemology argues, there is value in attending to particular, albeit 
nearsighted, perspectives. Doing so, Mahowald argues, helps to correct for 
unselfconsciousness, ―used here to mean the lack of a sense of one‘s limitations. Some 
unselfconscious persons assume themselves capable of ‗point-of-viewlessness, defining 
their particular views as universal.‖10 Those in positions of social, economic, and political 
power—members of the dominant group or culture—tend to be unaware of the partial 
nature of their perspective, their worldview. 
 Thus it is with people who have normal sized bodies. While those who are obese 
may be acutely aware of the bodily norms that they fail to achieve, normal-sized people 
tend to think less about the existence of such norms and generally expend less energy 
trying to achieve them or to compensate for failing to do so. Those who are obese may 
have a constant, at least low-level awareness of the impact of their genes, diet, and 
environmental stresses on their bodies. Not fitting into the dominant group of normal 
bodies, those who are obese are forced to be the opposite of epistemologically unself-
conscious: ―a self-conscious person acknowledges her weaknesses as well as strengths, 
and acts accordingly.‖11 Again, Mahowald does not find that this epistemic position of 
the non-dominant all negative. Self-consciousness in this sense affords obese individuals 
a different sort of epistemic privilege. They are those who either themselves recognize, or 
who provide the epistemic material for others to theorize, how bodily norms are socially 
constructed and operate to create dominant/normal and non-dominant/abnormal 
categories and social groups. Elizabeth Grosz and Iris Young are feminist theorists who 
explain how these categories are created at a conceptual level and how they are applied to 
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create material conditions of oppression. The next subsection examines their accounts of 
this process. 
A.ii Dichotomous Thinking, Logic of Identity, and the “Moralizing” of Obesity 
 According to feminist philosopher Elizabeth Grosz, the process of ―dichotomous 
thinking naturally hierarchizes and ranks the two polarized terms so that one becomes the 
privileged term and the other its suppressed, subordinated, negative counterpart.‖12 She 
notes that this ―bifurcation‖ is not merely a ―neutral division of an otherwise all-
encompassing descriptive field.‖13 Dichotomy itself ―contains inherent explanatory force 
which, if naturalized and used reflexively, can operate to predetermine the meaning of the 
nature of A and Not-A, and the relation between them.‖14 The predilection of Western-
style human reasoning to understand the world in terms of dichotomous categories, 
either/or binaries, or polar opposites—terms used by feminist psychologist Helen 
Haste
15—is explained in detail by Iris Young. 
 According to Young, the ‗logic of identity‘ is at once an account of the 
intellectual and psychological process of understanding the world and a theory of social 
discourse, the ―Western philosophical and theoretical discourse that denies and represses 
difference.‖16 The logic of identity is ―one construction of the meaning and operations of 
reason: an urge to think things together, to reduce them to unity.‖ 17 To understand, 
explain, or ―give a rational account is to find the universal, the one principle … covering 
the phenomena to be accounted for. Reason seeks essence, a single formula that classifies 
concrete particulars as inside or outside a category.‖18 
The logic of identity denies or represses difference. … Any identifiable something 
presupposes a something else against which it stands as background, from which 
it is differentiated. … Understood as different, entities, events, meanings, are 
neither identical nor opposed. They can be likened in certain respects, but 
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similarity is never sameness, and the similar can be noticed only through 
difference. Difference, however, is not absolute otherness, a complete absence of 
relationship of shared attributes. 
 
The logic of identity flees from the sensuous particularity of experience, with its 
ambiguities, and seeks to generate stable categories. Through the logic of identity 
thought aims to master that sensuous heterogeneous embodiment by bringing the 
object fully under a concept.
19
 
 
This account may begin to explain the social construction and dominance of norms of 
appropriate bodies. Bodies come in all shapes, sizes, and colors. Human bodies are a 
quintessential of the theorized ―sensuous heterogeneous embodiment‖ to which Young 
refers. To make sense of this heterogeneity and to make a place for one‘s own body 
among such obvious difference, Young argues that human reason compares and 
categorizes. 
This project of reducing the heterogeneity of sensuous particulars to the unity of 
thought itself submits to a relentless logic of identity, as thought itself, the 
thinking subject, must be reduced to unity. Such a subject is conceived as a pure 
transcendental origin … it is self-generating and autonomous. … The logic of 
identity also seeks to reduce the plurality of particular subjects, their bodily, 
perspectival experience, to a unity, by measuring them against the unvarying 
standard of universal reason.
20
 
 
People as thinking subjects come to be conceived in terms of their reason, as 
fundamentally, essentially reasoners. That they also feel, love, use their five senses, and 
experience emotions become secondary characteristics. People as embodied also are 
subjected to this logic of identity, and as embodied people norms of appropriate bodies 
apply to them, creating a narrow range or unity that marks an acceptable body and that 
marks as outside that category all other bodies, including the obese.  
 Young then explores the negative implications of this process of understanding 
and describing the world, including people and their bodies, in terms of falling inside or 
outside narrowly constructed categories. She writes that ―the irony of the logic of identity 
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is that by seeking to reduce the differently similar to the same, it turns the merely 
different into the absolutely other.‖21 In some cases, she explains the human response to 
the absolutely other is anxiety, fear, revulsion, and abjection.
22
  
The logic of identity‘ inevitably generates dichotomy instead of unity, because the 
move to bring particulars under a universal category creates a distinction between 
inside and outside. Since each particular entity or situation has both similarities 
and differences with other particular entities or situations, and they are neither 
completely identical nor absolutely other, the urge to bring them into unity under 
a category or principle necessarily entails expelling some of the properties of the 
entities or situations.
23
 
 
This process is witnessed, as will be explained further below, in the process of 
constructing bodily norms and, in contrast, the obese identity. Because fat people do not 
fit within the category of the normal body, despite all of their similarities to those with 
normal bodies—their talents, intelligence, interests—those similarities are stripped away 
from their identity as they are understood. As a result of this process at a conceptual 
level, obese individuals are themselves expelled from social groups and relationships, and 
excluded from opportunities, to which they might otherwise have access. Young 
continues to explain the pernicious effect of this way of thinking. 
Because the totalizing movement always leaves a remainder, the project of 
reducing particulars to a unity must fail. Not satisfied then to admit defeat in the 
face of difference, the logic of identity shoves difference into dichotomous 
hierarchical oppositions: essence/accident, good/bad, normal/deviant.
24
 (emphasis 
added) 
 
Faced with threat to its own coherence, the logic of identity transforms difference into 
dichotomies. Therefore, faced with threat to their dominant status as normal bodied and 
with the material threat to their normality represented by perhaps becoming overweight, 
the non-obese cast obese individuals as very negative, polar opposites to themselves. 
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 The final step in this process of conceptualizing the world is the gendering and 
moralizing of the categories. The first differences that children are taught as differences 
are the difference between good and bad, right and wrong, and boys and girls. Good/bad 
and right/wrong are taught as explicitly normative moralized differences. The difference 
between boys and girls is taught as a natural difference, one of the first, out-there-in-the-
world, differences that does not depend on what you or anyone else thinks. Theories of 
biological sex (e.g., chromosomal vs. anatomical) aside, biological sex has been largely 
relegated by even feminist theorists to the natural world. Gender, on the other hand, what 
makes a person a man or an occupant of a male social role, is considered a matter of 
socially constructed norms. By applying the logic of identity to its own dichotomous 
categories, the moralizing and gendering of seemingly morally neutral, sexless, and 
gender-free categories can be explained. In Western discourse, Young argues, the many 
―mutually exclusive oppositions‖ the logic of identity constructs and justifies—e.g., 
mind/body, male/female, nature/culture, normal/abnormal—―are structured by the 
dichotomy good/bad, pure/impure.‖25 
The first side of the dichotomy is elevated over the second because it designates 
the unified, the self-identical, whereas the second side lies outside the unified as 
the chaotic, unformed, transforming, that always threatens to cross the border and 
break up the unity of the good.
26
  
 
In short, in an attempt to think things together, to unify even its dichotomous categories 
into a simply binary, one pole of each supposed polar opposite is categorized as good. Its 
opposite is marked as bad. This may explain how in some discourse at least what is 
natural, intellectual, or normal is marked as good, i.e., the moralizing of categories that 
are not on their face matters of morality. It does not explain what feminists term the 
‗gendering‘ of the categories.  
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 Beyond boy/girl, male/female, and perhaps attributes associated with men versus 
women, the attribution of gender to categories may seem obscure. This is true if ‗gender‘ 
is linked primarily to biological sex and apparent differences between the two opposite 
sexes.
27
 If instead gender is understood in terms of power or position within social 
hierarchy, rather than in relation to biological sex, the gendering of seemingly sex-neutral 
binaries is explained. Somewhat confusingly, but for lack of better terms, the terms of 
‗male‘ and ‗female‘ are still employed, but they are best interpreted as male=more 
powerful=dominant versus female=less powerful=non-dominant. Thus the gendering of 
the nature/culture, science/art, and normal/abnormal binaries can be understood. The 
natural, scientific, and normal are coded as male, dominant, mainstream, and at least 
putatively good. Matters of culture are more suspect. ―It is an art, not science‖ marks 
what is being described as more subjective, soft. The abnormal therefore stands in need 
of correction and normalizing.  
By considering gender in terms of various power relationships and relational 
intersections,
28
 feminist epistemology and feminist scholarship more generally employ 
gender as an analytic category. While feminism first focused on women‘s experiences 
and concerns, with ―a feminist standpoint … being one that reflects the perspectives of 
women while challenging the social dominance of men‘s perspectives,‖29 but feminist 
approaches have gradually been refocused to analyze other relationships of relative 
power, such as those grounded in aspects of race, class, poverty, and sexual identity. 
With this expanded focus, gender has become a category of analysis, useful for 
understanding associations of power and oppression, and the way that such relationships 
serve to inform perspectives and construct reality.
30
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Thus far in this section feminist standpoint theory has been employed to assert 
that the dominant view of obesity is partial in the senses of being incomplete and of 
serving the interests of the dominant group. Examination of the processes of dichotomous 
thinking and the logic of identity has explained how obesity acquires a normative, 
moralized valence. The next subsection examines the interests of the normal bodied 
dominant group in maintaining the moralized binary between normal and obese, their 
experience of obesity as a threat, and the implications of these interests and experience 
for obese individuals. 
A.iii Dominant Responses to Obesity: Abjection and Border Anxiety 
Even though the social, economic, or political power places some people in 
powerful positions or dominant groups, and even though the logic of identity creates 
dominant categories used to construct prevailing dominant perspectives on the world, 
there is the threat of instability or impermanence in those dominant positions, categories, 
and perspectives. The messy heterogeneous world intrudes on the neat categorizations, 
and for example, a more powerful normal bodied person may recognize particular 
similarities between himself and an obese counterpart. He may think, ―There but for the 
grace of God, or my genes, or my circumstances, go I.‖ For some this may occasion 
empathy, but feminist scholarship suggests that, instead, a common response is to feel 
and defend against threat. Those in the epistemologically dominant group experience 
what Young terms ―border anxiety,‖ a fear or insecurity about the ability to maintain the 
dominant position.
31
 Border anxiety is the result of recognizing that an individual in the 
dominant position stands to lose advantage or status afforded them by this membership. 
 Border anxiety for those who are thin may be the result of several factors. First, 
 113 
 
historically the clinical diagnostic definition of obesity has changed, as has the fad of 
what body types are in-style or out-of-style. At one time those who had been seen as 
normal were reassigned to the category of deviant with the seemingly arbitrary 
realignment of BMI categories.
32
 Moreover, while thin bodies have dominated recent 
social norms of beauty, normality, and desirability, such has not always been the case. 
The seemingly arbitrary nature of who is defined as being obese at any given moment in 
time may heighten the experience of border anxiety by those who presently reside in the 
dominant group. It seems reasonable that recognizing the costs associated with the loss of 
such status would fortify efforts to maintain such an advantage. Second, for those 
considered to be marginally acceptable, the border between fat/marginalized and 
thin/privileged may be seen as being dangerously permeable. In this case it would be easy 
for a thin person to cross that border simply by gaining a few pounds, thus becoming 
obese and a member of the oppressed group with diminished power and status. This 
border crossing would likely have serious negative consequences for the individual at a 
social level in addition to potentially negative health consequences. Third, those who are 
considered firmly within the category of the normal bodied by societal standards become 
more aware of the advantage such status affords them when confronted by those lacking 
such status. Having benefited from being considered thin, they are committed to 
maintaining strong boundaries between those inside and outside the category of thin 
because doing so helps to ensure their advantage. Anxiety regarding the conceptual and 
material borders between thin and overweight thus spurs members of the dominant (thin), 
to maintain their advantage, feeds the dominant group‘s efforts to maintain the 
conceptual, social, and even moral border between themselves and the other.
33
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 Obese individuals thus challenge social norms, even though their existence 
presents a difference in contrast to which the dominant norm is constructed. As concrete 
individuals who are not only different from their normal bodied counterparts, but also 
similar in some ways and thus threatening, obese individuals may occasion strong 
emotional reaction. Abjection is an emotional response that is partly the result of deeply 
ingrained dichotomous thinking. Feminist philosopher Julia Kristeva explains that 
abjection ―does not radically cut off the subject from what threatens it—on the contrary, 
abjection acknowledges it to be in perpetual danger.‖34 
Abjection is the feeling of loathing and disgust one has in encountering the 
abject—certain images, phenomena, matter, and even fantasies that seem so 
horrible that one can only respond with aversion, nausea and distraction. The 
abject is at the same time fascinating; it draws the subject in order to repel it.
35
  
 
Abjection serves to construct and reinforce the dominant opinion of those labeled as the 
Other.
36
 Obese people occasion such abjection in others. It reinforces the universalizing 
of negative characteristics of the obese. The intensity of the reaction encourages those 
experiencing it to attribute fundamental disgustingness to those who occasion it. 
 Obese people defined as essentially and absolutely Other may also experience 
internalized abjection. Internalized abjection is the acceptance of the feelings of 
disgustingness or hideousness felt by those in the dominant group towards the 
marginalized group.
37
 The obese person takes those initially perceived and externally 
projected negative feelings of the dominant group and begins to accept them as authentic 
and deserved. She may come to believe that she is inferior because she violates a variety 
of norms constructed as appropriate by the dominant group and therefore is deserving of 
societal distain, her own self-loathing, the diminished opportunities afforded her by 
society, and perhaps even the poor health outcomes associated with her obesity. As 
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discussed later in this chapter, obese individuals may come to believe that their obesity is 
indeed evidence of moral failing and hence justifiably subject to social sanction. The 
dominant view of the obese along with the abjection it produces comes to be seen as 
natural, deserved, and appropriate by those in the authoritative group and those in the 
marginalized group. 
With an increasing portion of the population identified as overweight or obese, it 
would seem that the dominant view of obesity, constructed from the perspective of the 
normal bodied, would be challenged by the sheer number of those who literally occupy a 
non-dominant obese perspective. However those who are obese also, somewhat 
confoundingly upon initial analysis, sometimes experience abjection of their obese peers. 
Relevant to this phenomenon is Young‘s explanation that ―members of culturally 
imperialized groups—themselves often exhibit symptoms of fear, aversion, or 
devaluation toward members of their own group and other oppressed groups.‖38 Subject 
to the same dichotomous thinking, logic of identity and incentives to align themselves 
with what positive poles of the dichotomous categories they can, members of oppressed 
groups find reason to subdivide their own marginalized, non-dominant group. Thus, 
African-Americans distinguish between light and dark-skinned blacks, or between those 
of African or Caribbean descent. To address the impact of this intragroup divide and 
conquer by categorizing strategy, as well as to analyze the impact of power relationships 
on members of multiple marginalized groups or identities, feminist scholars have begun 
to examine the intersection of different marginalizations. The next subsection employs 
intersectionality to examine these implications for developing a more complete 
understanding of the social construction of obesity. 
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A.iv Obesity at the Intersection of Multiple Marginalizations 
 Since feminist epistemology attempts to consider multiple standpoints, each 
privileged in a different way (e.g., one dominant, another experientially informed by less 
empowered voices, another medico-scientifically informed, and so on), employing 
feminist epistemological approaches enables us to consider the intersectionality of 
multiple standpoints and multiple marginalizations. The term intersectionality was coined 
by Kimberle Crenshaw, a legal scholar, in the late 1980s.
39
 The term was intended to 
underscore the multi-dimensional nature of marginalized subjects‘ lived experiences.40 In 
feminist epistemology, ‗intersectionality‘ is typically used to refer to the combination, 
and subsequent synergistic exponential effect, of occupying several oppressed groups, 
social positions, or conceptual categories simultaneously.  
Intersectionality originally served to inform the ways in which two particular 
identities, race and gender, interacted to shape various dimensions of Black women‘s 
lived experiences.
41
 The approach initially recognized that the specific marginalizations 
which apply by virtue of being a woman are intertwined with those marginalizations 
associated with being Black. The overlap of marginalizations thus manifests itself 
differently, though likely exponentially, given the number and intensity of intersecting 
vectors. The purpose of intersectionality analysis is to diminish common analytic binaries 
such as race/gender, obesity/gender, obesity/class in order to enable a more robust 
examination of these various identities and their influence on marginalizations.
42
 Its 
underlying insight is feminist standpoint theory‘s recognition of the privilege perspective 
of non-dominant individuals. Feminist legal activist Mari Matsuda contends that ―those 
who have experienced discrimination speak with a special voice to which we should 
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listen.‖43 Jennifer Nash, whose work focuses on Black feminism, states that ―for 
intersectional theorists, marginalized subjects have an epistemic advantage, a particular 
perspective that scholars should consider, if not adopt, when crafting a normative vision 
of a just society.‖44 As a tool of feminist research, intersectionality analysis has been 
criticized for being too narrowly based on the prototypical experience of Black women, 
having an inadequately defined methodology, possessing ambiguity with regard to the 
definition of intersectionality itself, and lacking coherence between various intersections 
and lived experience. Nonetheless it provides a viable means for the complex analysis of 
the implications of power relationships related to the convergence of numerous 
discounted identities.
45
  
 A more evolved application of intersectionality permits the analysis of an almost 
unlimited array of marginalizations.
46
 This fact is particularly important for the correction 
of the dominant understanding of obesity, as the intersection of numerous oppressive 
circumstances and identities must be considered to more fully inform and understand the 
experience of those who are obese. In fact, the dominant social construction of obesity or 
an obese identity serves as yet another of the oppressive attributions that may intersect 
with other oppressive identities based in gender, class, or sexual orientation. A white man 
who is poor and obese may likely have a very different experience, and thus different 
perspective or knowledge, than an African-American obese man who is wealthy, or a 
Latino woman who is obese and poor. Similarly, the additional experience of having been 
sexually abused or food insecure may have very different synergistically oppressive 
effects depending on whether one is rich or poor, male or female, white, black or brown. 
Compared to the effects of race, sex, and gender, the effect of social class has been 
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relatively recently introduced into bioethical analysis, but theorizing the effect of class on 
experiences of health, morbidity, and healthcare helps to illuminate the non-individual 
systematic variation in experience of those at the intersection of multiple marginalities.
47
  
The intersection and synergistic effects of multiple marginalizations are evident in 
the lives of obese individuals. Within a conceptual framework constructed by 
dichotomous thinking, categories do not mix. Within the world, however, individuals 
occupy multiple categories. It is partly for this reason that feminist epistemology has 
stressed the importance of attending to the lived experience of individuals and to the 
particularity of their experience and perspectives. The next subsection examines how 
these insights and approaches of feminist theory integrate with goals of social science to 
support their attention to particularity and their integration of narrative approaches. 
A.v Epistemological and Ethical Reasons to Attend to Particularity and Narrative 
Concepts drawn from feminist epistemology—dyadic reasoning, epistemic 
privilege, standpoint, and partial knowledge help to articulate a more accurate 
understanding of obesity, its various treatments, and the social construction of these. The 
less powerful, non-dominant, experientially informed perspective of those who are 
obese—like the perspective of other non-dominant groups, such as those who are poor or 
abused or who are members of a minority identity group—is subverted by the socially 
dominant perspectives of those who seek to maintain their dominant position within a 
socially constructed hierarchy. It is through the inclusion of narrative provided by those 
who are obese that the partiality of the dominant view of obesity may be seen and 
challenged.
48
 Erroneous assumptions both about the nature of obesity itself and 
inappropriate assumptions about those who are obese can be revealed by incorporating 
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these subordinate voices.
49
 The well-regarded qualitative research tradition can be drawn 
upon to support the inclusion of personal stories and narratives which highlight 
particularity in understanding complex social phenomenon more fully. In this way the 
inclusion and analysis of personal accounts of obesity act as a much needed counter-
balance to dyadic reasoning on the topic. This method has been utilized and refined for 
nearly a hundred years. 
The Chicago School of Sociology developed qualitative research methods in the 
early part of the twentieth-century, one of which utilizes personal interview, more 
broadly conceived as personal narrative or case study, in order to seek a holistic 
understanding of problems experienced by marginalized individuals.
50
 Originally these 
qualitative methods were used to generate data about the historical issues of race and 
class. The goals of incorporating ethnography or interviewing were to evaluate more fully 
the individual experience and particular circumstances of those who suffered from some 
stigma or injustice and, in the longer-term, to improve inadequate social systems or 
treatment. These methods were incorporated as a counter-balance to strictly quantitative 
empirical research methods which had been found to provide insufficient insight into the 
lived experience of those within a particular subjugated population.
51
 The Chicago 
School of Sociology believed that quantitative data collection was a good beginning 
point, but an inadequate endpoint if the goal was to effect positive change in the lives of 
those marginalized. It would be through the understanding of the particulars of the lived 
experience captured through narrative that adequate levels of knowledge could be gained 
and inroads made toward design of interventions and solution of complex social 
problems. Feminist researchers, among others, subsequently adopted and adapted this 
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qualitative research method as they too found that it provided the particularity necessary 
to understand the lived experience of the marginalized. In a textbook by Pauline Young, 
trained in this method at the Chicago School of Sociology at the University of Chicago, 
she articulated the foundation of the method as follows: ―When people are least 
interrupted when they can tell their stories in their own way…they can react naturally and 
really and express themselves fully.‖52  
In short, the stories of individuals, when properly attended to and incorporated 
into an understanding of a social problem, can provide the type of highly nuanced and 
contextual information which is unavailable to us through other methods. First, these 
individual accounts challenge the accepted dominant understanding of obesity offered by 
other sources grounded in reductionistic and inadequate dyadic reasoning. Second, 
feminist ethics and epistemology have established the value of attention to particularity. 
It is not just statistically significant information, but also particular, nuanced information 
that can appropriately serve to inform discussion of a topic and the power relationships in 
which the topic and the parties to it are embedded.
53
 Young observes: 
Moral reason certainly does require reflection, an ability to take some distance 
from one‘s immediate impulses, intuitions, desires, and interests in order to 
consider their relation to the demands of others, their consequences if acted upon, 
and so on. This process of reflection, however, does not require that one adopt a 
point of view emptied of particularity, a point of view that is the same for 
everyone; indeed, it is hard to see how such a universal point of view could aid 
reflection that leads to action at all.
54
 
 
Thus, the goal of accurate understanding and the goal of ethical action both embrace 
appropriate attention to particularity. 
 At several points in this dissertation, first-person narratives relating the 
experiences of living as an overweight or obese person and of utilizing various weight 
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loss technologies are included. The inclusion of personal stories is in keeping with these 
well-established feminist research methods and methods of feminist ethics. They provide 
vital, highly particular information both in the subjective individual sense and with regard 
to the social, historical, and cultural context of the lived experience of those who are 
obese. Though not generating, providing, or even reporting statistically significant data, 
the inclusion of these individual narratives provides additional information and sources to 
afford a more nuanced understanding of the experience of members of this subordinated 
group. What these narratives describe is not generalizable on the basis of statistical 
significance, but nevertheless vividly present general themes without which an adequate 
understanding of the experience of obesity and weight loss is incomplete and inadequate. 
 The next section turns to the social construction of gendered norms regarding 
bodies and obesity. The section will explore how norms constructed in part by popular 
media and religious concepts impair the lived experience of obese individuals and impede 
their utilization of weight loss interventions. 
B. Socially Constructed Norms of Appropriate Bodies and the Problem of Obesity 
 Feminist epistemological approaches reveal how norms of appropriate bodies are 
socially constructed, moralized, and operate to the disadvantage of obese individuals. The 
influences on social norms concerning the body come from multiple sources including 
the media, religious teaching, and social institutions. Subsection B.i illustrates the social 
construction of appropriate male and female bodies. This discussion illustrates the 
intersectionality of gendered social roles, sex, embodiment, and relative power to reveal 
not only the different norms applying to men and women, but also their application to 
obese bodies. Subsection B.ii emphasizes the role of religious influences and the media 
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on this social construction. Subsection B.iii analyzes the impact of norms on obese 
individuals with particular attention to the stigmatization of obesity and its 
internalization. Personal narratives from obese individuals will illuminate these 
processes. This section‘s focus on the moralizing of body norms and obese bodies sets 
the stage for discussion in Section C regarding ascriptions of responsibility for obesity. 
B.i Gendered Beauty and Boundaries 
 The majority of Americans, including those who are overweight, maintain the 
opinion that overweight and obese people are lazy and undisciplined.
55
 Characteristics 
such as unintelligent, unmotivated, unattractive, gross, immoral, sinful, inferior, and 
primitive are often attributed to them,
56
 and these, frequently, go unchallenged by either 
the obese individual or society.
57
 In addition, gender mediates and complicates social 
understanding of body size and overweight.
58
 The way in which overweight and obese 
people are regarded differs based upon weight-associated gender expectations coupled 
with the individual‘s degree of deviation from gender norms.59 This subsection illustrates 
the intersectionality of gendered social roles, sex, embodiment, and relative power and 
reveals not only the different norms applying to men and women, but also their 
application to obese bodies. Comparative analysis of the norms governing male and 
female bodies illustrates how all bodies are subjected to such norms and the relationship 
of the norms to structures of relative power and control.
60
  
 As discussed in Chapter Two, the ideal of what constitutes an appropriate female 
or male body has changed throughout history. Until recently there was greater cultural 
dependence and variability in these norms, but with the ascendency of Western cultural 
hegemony in arenas of fashion, media representations, and associations of norms of 
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beauty with economic prosperity and political power, norms of appropriate embodiment 
have become more homogenized.
61
 The fluidity with which norms and idealization of 
bodies has changed over the course of history indicates their socially constructed nature, 
and the specific changes demonstrate the relationship between bodily norms and power.  
For women especially, social status and social opportunities have long been 
influenced by changing bodily norms. In some historical periods, rounded fleshy female 
bodies were perceived as being both healthy and erotic and were the most highly 
desired.
62
 Current research on body images reflected in international media reveals that 
body ideals are increasingly standardized with fewer acceptable variations based on 
cultural preferences.
63
 Recently the feminine body ideal for both European white women 
and African-American women has tended toward a seemingly impossible standard which 
simultaneously integrates thinness and curvaceousness.
64
 Curvaceousness is characterized 
by medium to large breasts, a thin narrow waist, and wide hips or large buttocks. In other 
words, the current ideal is the classic if somewhat exaggerated hourglass shape. For 
women in wealthy, primarily white, dominant cultures, being thin has been seen as a 
highly desirable attribute for over fifty years.
65
 Possessing this body ideal has been 
associated with youth, social attractiveness, and self-control or self-discipline. Failing to 
meet this standard, or indeed becoming fat after having once met the standard, has 
implications for overall acceptability of the woman.
66
  
The construction of gendered social roles and norms of appropriate bodies are 
obviously intertwined. Iris Young analyzes the social construction of gender and the 
development of socially acceptable behaviors, affect, and gender-specific body 
comportments by girls and boys. She argues that instead of being biologically natural, 
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sex-associated differences in ways of behaving are shaped by social norms reflecting 
beliefs about what is gender-appropriate and therefore good. Differences between the 
way boys/men and girls/women walk, sit, dress, smile, throw a ball, and use their bodies 
is influenced less by biological differences in a body than by social norms governing 
behavior and social roles.
67
 Over time, those in positions of power—men, adults, elders, 
teachers, clergy, fashion trendsetters—either approve or disapprove of behaviors, 
adornments, or ways of behaving, and do so differentially with regard to boys and girls. 
(That some of those in power are female, or that some powerful social roles are occupied 
by women, e.g. nuns or grade school teachers, does not negate the fact that they have 
typically internalized social norms shaped by male privilege.) These gender-sanctioned 
behaviors and appearances become both descriptive and prescriptive social norms. With 
time, what is approved and then prescribed as gender-appropriate becomes naturalized, 
i.e., appears natural and is erroneously perceived as being biologically determined and 
thus free from social influence. The gendered norms come to be viewed as descriptive of 
a natural phenomenon, rather than as socially-constructed prescriptions.
68
  
Some behaviors, appearances, and ways of being become so routine and uniform 
that they are viewed as essential attributes of one gender or the other, e.g., the wide-
spread belief that men are emotionally strong and women emotionally weak. 
Essentializing of gender differences leads to viewing deviations as deeply problematic, as 
―unnatural‖ in a pejorative and moralized sense,69 because they challenge both dominant 
notions of gender identity and the plausibility of accepting that gender differences are 
anything but natural or biologically determined. Social responses to disruptive challenges 
to gendered norms may have severe implications for the self and social identity of men 
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and women. Violations of prescribed and proscribed behaviors and modes of bodily 
comportment impose costs on the violator, including stigmatization, discrimination, and 
shame, discussed below.
70
 
The social construction of body and weight is particularly complex for women, as 
women‘s bodies must satisfy the roles of both subject and object.71 A woman‘s body is 
subject, in that it is the vehicle through which she interacts with the world. It is through 
her body that she walks, talks, works, loves, bears children, relates to, and otherwise 
interacts in the universe. A woman‘s body is also perceived as object, and expected to 
fulfill appropriate gender roles aimed at gaining the status of wife and mother. A 
heterosexual woman must adequately satisfy the sexual desires of the male gaze with her 
body.
72
 She must be visually pleasing as an object or adornment—all the while doing so 
unselfconsciously. 
Through the male gaze, a woman is objectified. Jeremy Bentham‘s concept of the 
panopticon elucidates how the male gaze functions to constrain a woman‘s behavior and 
construct norms governing her body.
73
 The term panopticon was originally used to 
describe an institution in which observers (e.g., prison guards) can oversee the observed 
(e.g., prisoners) without their knowing whether or not they are being watched at any 
particular moment. With regard to the surveillance of women‘s bodies and habits, 
‗panopticon‘ connotes a similar continual societal surveillance of women.74 The outcome 
of universalization of the male gaze is that the bodies of women are always both the 
object of another‘s gaze while simultaneously the material aspect of the subject (the 
woman) acting upon the world by vehicle of the body. 
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Foucault explored this social phenomenon and concluded that the outcome of 
such societal surveillance is twofold. First, the constant surveillance provides a policing 
of behaviors of the individuals being observed. Second, the individual who is under 
scrutiny begins to behave as if she were being observed even when she is not. This 
internalization of societal surveillance means that eventually the constant observation is 
no longer required as the individual perceives it even in its absence and responds as if it 
were present. In this case, the observation-cum-ownership of the female body becomes a 
part of a broader system of societal control.
75
 The female body is no longer under the 
woman‘s own control but is now influenced by those who see her as object and by the 
internalization of their scrutinizing gaze.
76
 
For the obese woman, the experience of societal surveillance is frequently more 
explicit. That her very presence violates social norms is readily apparent, and social 
responses to that violation are frequently explicit. For obese women social surveillance 
has been described as harassment. One woman writes: 
If you met me, one of the first things you'd notice about me is that I'm fat. Not 
like, ―Oh darn, Anthroplogie doesn't have this in a 12!‖ kind of fat, but rather the 
kind of fat that has to shop in the special fat-lady store. The kind of fat that has to 
consider the structural integrity of thrift-shop furniture. And, unfortunately, the 
kind of fat that elicits public humiliation and harrassment [sic] more often than I‘d 
prefer to face. 
 
Going on to describe her response to particular forms of surveillance she notes,  
The aggressive stuff I can deal with -- I can eviscerate a jerk like a boss. I‘ve had 
a lot of practice. The most recent instance took place in a Home Depot parking 
lot, where I was walking to my car with a bag of potting soil. Some dude who 
apparently spends his days hanging out in his car in the Home Depot parking lot 
with his equally-pathetic dudebro friends saw his opportunity and seized the 
moment, hollering at me, ―DAMN BITCH, YOU ARE HUGE.77  
 
She uses humor to deflect the harmful effect of this interaction, 
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You know, I like a little creativity in my harrassment [sic]. If you‘re gonna yell, 
make it something good. Ideally something I can laugh about later when I‘m 
telling the story to my friends. The standard harrassment [sic] is just boring. 
―SURPRISE, YOU‘RE FAT! LIKE IN CASE YOU FORGOT FOR A MINUTE. 
I‘M REMINDING YOU. YOU‘RE WELCOME.‖ (Harrassers [sic] speak in all 
caps, all the time, I have decided.) 
 
My usual response is to shout back, ―YES!‖ or "IT'S SO TRUE!" or, if I‘m 
feeling especially sassy, to wag my ponderous ass in their direction whilst 
smacking same.
78
  
 
Nevertheless she labels others‘ comments as harassment, as comments intended to 
disturb, upset, and persecute. The narrator continues,  
Sometimes fate takes the wheel. There was the time a guy called me a ―fat slut,‖ 
evidently for failing to cross the street quickly enough in front of his car, and in 
his haste to zoom away, he drove into a curb and busted a tire. I like to think I 
made that happen with my mind.
79
  
 
In these exchanges, the response of others to her obesity and her response to them, are 
characterized by aggressiveness, physicality, and even violence.  
 The visceral response of others illustrates what Young suggested about the 
concept and response of abjection on the part of dominant others to those both less 
privileged and potentially threatening of the boundary between dominant and 
marginalized. This writer also articulates the connections drawn by Young between 
power and the violation of body norms and gender roles. 
….Street harassment is ultimately about entitlement -- it‘s about a dude (usually a 
dude, though women are occasionally guilty of it too) who is emboldened by 
gendered power dynamics into feeling as though your body is public property, 
and he has a right to comment on it, whether he thinks he‘s paying you a 
―compliment‖ for which you ought to be grateful, or trying to tear you down for 
not being attractive according to his exacting specifications.
80
 
 
It is power, and the fact that men have generally held more of it than women, that 
explains why men have generally not been subject to the same level of intense scrutiny. 
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Where they are subject to similarly exacting social norms, however, the explanation 
resides in relationships of relative power. 
Overweight and obese men are subject to societal surveillance and may 
experience the panopticon gaze as well. However, men are generally given more 
flexibility than women with respect to violating gender-based norms for weight.
81
 Up to a 
point, violations of gender-based norms of corporeal appropriateness for men increase 
perceived masculinity. Men are expected to be larger, stronger, and more muscular than 
women.
82
 Therefore, overweight or obese men are more often than women given socially 
appealing attributions related to their size. They are seen as being powerful, masculine, 
and if it not too fleshy, athletic. Before negative social attributes are employed as 
descriptors of them, men are allowed greater deviation from the ideal.
83
 Specifically, 
researchers have found that men begin to experience noticeable increases in weight bias 
when their body mass index (BMI) reaches 35 or higher, while women begin 
experiencing notable increases in weight discrimination risk at a BMI level of 27.
84
  
Nevertheless, despite greater latitude in deviations from the ideal body image for 
men, once serious violation of the norm has occurred, these men are considered effete.
85
 
Significantly obese men lose the social advantages afforded to most typical males and 
come to be regarded much as women are, with diminished authority and power to act 
upon the world. Sufficiently obese men lose their privileged position in the eyes of 
society, and their authority and power gradient diminishes to more closely resemble that 
of women. This connection among weight, sexuality, and power is evident in the case of 
Al Roker, a prominent African-American man who has hosted the NBC Today show for 
many years. After struggling with his weight he lost a significant amount. His wife 
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described his hug before his weight loss saying that ―he was always a cuddly hug,‖ while 
after his weight loss she commented, ―Now, he‘s this strong and sexy hug.‖86 His weight 
loss seems to have moved him from diminished sexual status to a stronger, more sexual, 
and more typically male status. Mrs. Roker‘s perceptions should not be criticized for 
reflecting a dominant perspective on the obesity, sexuality, masculine power connection. 
Her stated perceptions were influenced by the social construction of obesity and its 
ascribed character traits.  
The above examination underscores the socially constructed nature of bodily 
norms. The following subsections will discuss various influences on this social 
construction, beginning with the media. Further, theologically informed concepts are 
examined to elucidate their role in explaining alleged causes of obesity and to reveal 
moralizing about obese bodies.  
B.ii Influential Sources for Social Norms Governing Bodies 
 This subsection discusses how norms of appropriate bodies—appropriate size, 
image, and comportment—are explicitly shaped by several social sources. The first is the 
constellation of media that mark normal, abnormal or aberrant, and beautiful bodies. 
These media sources include art, fashion, news outlets, and the entertainment industry 
which portray idealized unattainable bodies as the norm.
87
 The second source is religious 
institutions that explicitly teach about the appropriate care and use of bodies.
88
 It will be 
argued that religious teaching has been used explicitly to moralize the particular body 
norms advocated. Together, these sources provide a framework upon which norms of 
acceptable bodies have been constructed and within which actual bodies are evaluated.  
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B.iii Media Representations of Male and Female Bodies  
The current ideal male body type is similar to that observed in ancient Grecian 
sculpture, and the standard of the male ideal has deviated less over time than has the ideal 
of the female form.
89
 It is described as a muscular mesomorphic shape with well-
developed musculature across the arms and upper torso, and a narrow waist and hips. The 
ectomorph body type is thin and angular with less developed or obvious musculature. At 
the other end of this spectrum is the endomorphic body type, which would best describe 
those men who are overweight or obese.
90
 For the most part the modern idealized male 
body norm is to be generally lean with moderate muscles.
91
 Research on male body ideals 
has primarily addressed body image concerns, most often stated in terms of muscularity 
instead of body weight or thinness.
92
 Research suggests that while muscularity is the 
ideal, the boundary of acceptable muscularity has limitations. An extreme level of 
muscularity, such as that found among professional bodybuilders, was perceived as being 
unnatural, largely unattainable, and reflective of a conceited or narcissistic personality.
93
 
Additionally, lower levels of body fat are an important part of the idealized male body as 
this permits the proper viewing of muscles on the male form. Too much adipose would 
obscure the view of the muscles while too little is generally inconsistent with well-
developed muscles.
94
 Flat, firm torsos are idealized. 
 The present dominant perspective on appropriate female bodily norms comes, in 
large measure, from media representations which promote unnatural leanness to the 
exclusion of more typical, attainable, and healthy ideals of beauty.
95
 In research 
conducted to reveal media trends in depicting feminine beauty, Sypeck et al. examined 
images shown in the most popular women‘s fashion magazines.96 The retrospective 
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review revealed that between 1959-1999 among fashion models in three of the four high 
circulation women‘s magazines there was an increasing trend towards thinness. 
Additionally, the research concluded that a  
 …strong message communicated by the print media over the last 40 years 
 regarding female beauty seems to have changed from one espousing the 
 importance of a pretty face to one that additionally emphasized an extremely thin 
 figure, as women have been increasingly exposed to models‘ bodies and as these 
 bodies  have become progressively thinner.
97
  
 
In a 2012 ABC evening news segment, Diane Sawyer reported that most of 
today‘s runway models meet the body mass index criteria for anorexia. Twenty years ago 
the disparity between the average women and fashion models was less pronounced. At 
that time the average fashion model weighed about 8 percent less than the average 
woman. Current fashion models weigh approximately 23 percent less than the average 
woman today. This does not accurately depict the proportions of a typical woman.
98
 
Research conducted on pervasive female images in the media found that the cultural ideal 
of female beauty emphasizes the desirability of thinness, with content analysis 
confirming the desirability of tall, young, and extremely thin models. A number of 
studies have demonstrated that female centerfolds featured in Playboy magazine have 
shown a significant decrease in body weight over the past 40 years.
99
  
Video games‘ depictions of bodies also exert influence. Martins et al. found that 
among the 150 top-selling video games in the United States, games rated at high levels of 
photo realism contained imagery of females who are systematically thinner than the 
average female. Comparing the proportions of females depicted in the games with actual 
anthropometric data, the authors concluded that video games which have a high degree of 
photo realism may pose a threat to development of positive body images and may 
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promote body dissatisfaction among females routinely exposed to them.
100
 As the next 
section discusses, overweight and obese people are not represented favorably by the 
media. 
B.iv Media representations of Overweight and Obese People 
 Depictions of overweight and obese people help to reinforce particular 
conceptions of individuals in each of these groups. Research examining body 
characteristics of characters in prime-time television shows, revealed that of 1,018 major 
television characters, 14 percent of females and 24 percent of males were overweight or 
obese, which is less than half the prevalence of obesity found in the general population. 
Overweight or obese female characters were less likely to be considered attractive, to 
interact with romantic partners, or to show physical affection. Overweight and obese 
male characters were also less likely to have romantic partners and friends or to talk 
about dating; they were also more likely to be shown eating than engaged in more 
physically active endeavors. Larger characters were more likely to be ethnic minority 
group members, older, married, and unemployed. Larger characters were also more likely 
to be guests on shows rather than be main characters and were more likely to be shown in 
comedic than in dramatic roles. The study concluded that ―overweight and obese 
characters are associated with specific negative characteristics.‖101  
  The following narrative personalizes the lived experience discussed above.  
If you look at the way we are portrayed on TV we supposedly like being 
identified by our fat. It makes us funny. It makes us stupid comic relief. It makes 
us acceptable for other people to acknowledge our existence. In fact I've come 
across people who have actually tried to cite TV characters as proof that there is 
nothing wrong with being a fat guy (and let me tell you I'm making myself use 
"fat guy" as much as possible in order make myself okay with using it). Yeah 
Homer Simpson, Peter Griffin, and Kevin James' character on King of Queens 
prove that everyone is fine with the existence of fat guys.
102
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It seems that this blogger is frustrated by his designation as an obese male and by the 
social implications of that part of his identity.  
When obviously uninformed people make silly comments like that I just want to 
commit violence. But then I'd be the crazy fat guy (and remember I‘m black so 
I‘d become the Big Scary Black Man) and it would be my fault for ―taking it 
personally.‖ Yeah.103  
 
His range of socially acceptable responses is further constrained by the social 
construction of another factor—namely, his race.  
Repeated exposure to particular media content leads the viewer to accept the 
portrayals as representations of what is real.
104
 Continued viewing of an ultra-thin body 
ideal has been shown to lead to increased body dissatisfaction among those whose bodies 
least resemble the images being portrayed. A meta-analysis of studies on the role of the 
media in the development of body image concerns strongly supports the notion that 
exposure to mass media depicting the thin body as ideal is related to women‘s 
vulnerability to disturbances in body image.
105
 This was true across studies employing 
both experimental and correlational designs, and across multiple measures of women‘s 
body image, eating behaviors, and beliefs. Research suggests that men are affected 
similarly by idealized male body images in comparison to their own perceived body 
disparities from that ideal.
106
  
The social construction of male and female body norms involve the attribution of 
character traits to both ideal and deviant body images. Various culturally constructed 
norms of what is implicitly alleged to be the appropriate male or female body influence 
the dominant view of beauty, the degree of acceptance of what falls beyond those norms, 
and thus, what is likely to be rejected by a given society.  
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As analyzed in the next section, another powerful mode of developing and 
transmitting social norms of acceptability of the body is found in religious teachings. 
Various religious teachings have served to define what constitutes an appropriate body 
and to imbue bodies—appropriate or inappropriate—with moral significance.  
B.v Theological Constructions of Appropriate Bodies 
 Theologically grounded concepts help to construct the societal understanding of 
all bodies including those that are overweight. This section illuminates how the 
theological concepts of human dignity, embodiment, and sin, as well as theological 
norms governing the proper use of food, influence the construction of obesity. 
Theological teachings present the norms governing appropriate bodies in a 
particularly moralized manner associated with godliness or a lack of godliness. This 
theological influence is often implicit and even operates in secularized ways and 
contexts. Theological influences have infiltrated American culture in ways that influence 
lives, shape the ways in which people strive to live, or frame the meanings people find in 
their existence, whether or not they consider themselves religious. For many people, 
theologically grounded concepts may be almost seamlessly embedded, sometimes 
subconsciously, in both their self-identities and their ways of viewing other people and 
their circumstances. 
A colloquial expression of these theologically inspired ideas is that one‘s body is 
a temple and as such, it deserves respect and care. This belief informs the admonishment 
that one should be careful what one does with (or puts into) one‘s body. Respect for the 
body has traditionally been included in the theological conceptualization of human 
dignity. Respect for the body flows from belief that the body is the earthly home of the 
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soul and that the human being is the embodied divinity of the creator.
107
 The concept of 
imago dei, or in the image of God, as found in the Old Testament in the book of Genesis 
states, ―So God created man in his own image, in the image of God he created him; male 
and female he created them.‖108 While some faiths specifically hold that the physical 
form of God is similar to that of humans, this passage from Genesis is uniformly 
interpreted as setting humans apart from other, seemingly less complex creatures. It 
suggests that humans possess unique characteristics such as reasoning, creativity, 
consciousness, personality, and abstract thinking, which are intended to be used in order 
to establish a relationship and be in union with God.
109
  
In Jewish writings, the Tzelem Elohim or Imago Dei is the infused divine value 
that all humans have, and this value gives rise to the sanctity of life. According to Rabbi 
Doron Shultziner, ―God implanted in human beings a sacred kernel of worth, and 
demanded that we protect human dignity in us and in others, and thus, damaging human 
dignity is a direct offence to God.‖110 Maintaining human dignity requires the proper care 
of body through the proper use of food. The President‘s Council on Bioethics suggested a 
place for human dignity bioethical analysis and highlighted the religious foundations 
upon which the concept is based.
111
 
[T]he human being has special dignity because he shares in the godlike powers of 
reason, freedom, judgment and moral concern, and as a result lives a life freighted 
with moral self-consciousness—a life above and beyond what other animals are 
capable of. Speech and freedom are used, among other things to promulgate moral 
rules and pass moral judgments, first among which is that homicide is to be 
punished in kind because it violates the dignity of such a moral being. We reach a 
crucial conclusion: that the inviolability of human life rests absolutely on the 
higher dignity-the-god-likeness of human beings.
112
  
 
The following discussion reveals the pervasive social influence of non-secular 
conceptions of the body and human dignity.  
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The bible is replete with stories of the evils related to violations of God‘s laws for 
the proper use of food. The story of Adam and Eve is a widely known example of the 
misuse of food which according to scripture, leads to original sin causing the vast 
separation between humans and God.  
So when the woman saw that the tree was good for food, and that it was a delight 
 to the eyes, and that the tree was to be desired to make one wise, she took of its 
 fruit and ate; and she also gave some to her husband, who was with her, and he 
 ate.‖113 
 
While obesity was not an issue, the violation of the proper usage of God‘s abundant 
resources and His laws surrounding food was. 
Narrowly understood, obesity can be said to result from the improper use of food. 
In a book of biblical limericks the implied connection is exposed:  
The fruit of that tree, do not try it. 
Give an order and man will defy it. 
Those very first bites 
Left us laden with plights 
Sin, death, and opinions on diets.
114
  
 
Whether one is a person of theologically-based faith or not, this story of the good and evil 
nature of food and the concept of human greed has been culturally wide-spread. 
Another biblical story refers to the temptation of Jesus with food following his 
baptism in the River Jordan. Scripture recounts that Jesus was led by the Spirit into the 
desert where He fasted. After fasting for forty days He was obviously hungry, and Satan 
approached Jesus and said, ―If you are the Son of God tell these stones to become bread.‖ 
He answered, ―Man does not live on bread alone, but on every word that comes from the 
mouth of God.‖115 Jesus is understood to be saying that food has a proper place and that it 
is not only food that should fill us. Of more importance is God‘s word.  
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Improper use of food in both of these instances is understood to have the potential 
to cause a chasm between humanity and God. In the story of Adam and Eve, it was food, 
obtained outside of the law of God, which caused the downfall of humanity. While 
improper use of food in this instance is simply the vehicle for the betrayal of God‘s laws, 
the story seals a strong and ongoing prohibition against using food improperly. The story 
of Jesus in the desert provides evidence that desire for food should be considered, at all 
times, secondary to regard for God and that a valuing of food ahead of God‘s word would 
be a grievous misalignment of God‘s ideal order and the place of food within it.  
Religious teachings often espouse an obligation for an intimate autonomous 
relationship with God. Anything that comes between or separates an individual from 
God, including those things which might be described as offending human dignity, are 
considered sinful.
116
 These things are to be avoided since they distance the individual 
from an intimate relationship with their creator. Additionally, religious teachings often 
hold that believers have social responsibilities which are communitarian in nature, or 
meant to reflect a broader societal obligation of individuals, one to another. Societal 
obligations, as discussed by Rabbi Shultziner, might include acting for the greater good 
of the community even if that entails making personal sacrifices for the betterment of the 
whole.
117
 These religious concepts, both individual and societal, provide another 
framework within which individuals or particular behaviors can be judged as good or 
evil. Religious concepts therefore provide an additional layer of surveillance and 
modification of human behavior in accordance with one‘s adherence or deviance from 
socially constructed religious ideals.
118
 It is partly within this broad theological 
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understanding of an individual‘s obligation to God and to society that obesity is 
constructed as a sign of character flaw, immorality, and godlessness.  
Given the belief that the body houses one‘s divinity, a moral obligation to care for 
the body follows straightforwardly.
119
 Within a theologically informed framework, 
failure to care for the body appropriately by being overweight or obese is construed as 
evidence of committing the sin of gluttony. Obesity is viewed as prima facie material 
evidence of sin—specifically, the sin of lacking respect for one‘s self, one‘s body, others 
in the community, and God. Sin can be defined as a violation of our obligation(s) to 
God.
120
 Indeed, gluttony is considered one of the cardinal sins; and thus overweight and 
obesity are both evidence and the result of this vice or character flaw.
121
 There is some 
textual support that the original meaning of the word gluttony in the Bible was meant to 
encompass more than simply overconsumption of food. Gluttony was initially construed 
as a preoccupation with materialism or as the perversion of natural God-given appetites, 
such as love being distorted into lust, or self-esteem being transformed into pride. St. 
Thomas Aquinas further defined the sin of gluttony. He writes, ―Gluttony denotes, not 
any desire of eating and drinking, but an inordinate desire...leaving the order of reason, 
wherein the good of moral virtue consists.‖122  
 Pope Gregory the Great during the 6
th
 century was the first to articulate the seven 
deadly sins: lust, gluttony, greed, sloth, wrath, envy and pride. He outlined five actions 
which were considered to be gluttonous. These actions included: eating before the time of 
meals in order to satisfy the palate; seeking delicacies and better quality of food to gratify 
the sense of taste, which he referred to as vile; seeking after sauces and seasonings for the 
enjoyment of the palate; exceeding the necessary amount of food; and taking food with 
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too much eagerness, even when eating the proper amount, and even if the food is not 
luxurious.
123
 It has been said, that ―the concept of obesity as a moral imperfection 
originated with the theological philosophy of this great early church leader.‖124 The 
common understanding and usage of the term gluttony has now been relegated almost 
exclusively to the misuse of food.
125
 
While these influential theological writings on gluttony do not specifically 
address obesity, obesity is thought to be a clear manifestation of such gluttonous, sinful 
behavior. Additionally, these theologians point to the fact that gluttony is the gateway to 
other sinful behaviors such as sloth or unchaste sexual appetites.
126
 The Ten 
Commandments‘ injunction against killing is understood to prohibit killing oneself as 
well as killing others. Since obesity along with its co-morbidities has been shown to 
reduce one‘s lifespan, being obese may be seen as killing oneself and therefore would be 
considered similarly sinful.
127
  
 Thus one interpretation of obesity is that those who are obese are morally 
flawed—sinners. Obesity is an affront to God‘s image because it damages the body 
which is the earthly home of the spirit. As humans are thought to be created in God‘s 
image, destruction of that image is an example of distancing of oneself from God. A 
logical conclusion then might be that the overweight and obese should indeed be 
condemned by society for violating these obligations to God, to themselves, and to 
society. Stigmatization, the topic of the next section, has thereby been perceived as being 
morally justified on theological grounds. 
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C. Stigmatization, Internalized Stigma, and the Formation of the Obese Identity 
The following section discusses the impact of socially constructed norms of the 
body, with particular attention to the stigmatization of those who are obese. Indeed, 
prejudice based on an individual‘s body size is seen as the last socially acceptable arena 
of discrimination: ―bias against overweight people has grown at the same time the 
prevalence of obesity has increased.‖128  
The first subsection discusses stigma and shame resulting from social 
recognition—or an individual‘s own recognition—of the disparity between the 
overweight individual‘s actual state and what is perceived as normal and acceptable. 
Stigmatization and the feeling of shame are inherently relational; here they presuppose a 
relationship—a negative one—between the overweight marginalized individual, 
dominant others and society itself.
129
 The stigmatization of obesity is the concomitant 
phenomenon and conceptually opposite dyad of valorizing of norms of beauty and 
appropriate bodies. The second subsection describes from the obese individual‘s 
perspective how stigma functions like the disciplining panopticon, criticizing 
inappropriate bodies even in the absence of material discrimination. The stigma of 
obesity becomes internalized and functions as a means of self-evaluation by which obese 
people limit themselves and their opportunities. While substantial attention has been paid 
to internalized stigma of age and race,
130
 less attention has been paid to internalized 
stigma associated with obesity. The following subsection reveals the stigma of obesity 
and its effects. 
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C.i The Stigma of Obesity  
Sociologist Erving Goffman, who pioneered work on the mechanisms of stigma 
development and the consequences of stigmatization, defined stigma as ―the phenomenon 
whereby an individual with an attribute is deeply discredited by his/her society and is 
rejected as a result of the attribute. Stigmatization is a process by which the reaction of 
others spoils normal identity.‖131 Fat serves as such a stigma.  
Stigmatization—and, in turn, an individual‘s experience of stigma or of being 
stigmatized—occurs when the stigmatized person is identified as deviant.132 Stigma 
refers to the negative beliefs, attitudes, and conceptions held by the general population, 
which lead to stereotyping, prejudice, and discrimination, for example, against 
individuals who are obese.
133
 Sociologist Gerhard Falk states that existential stigma 
derives ―from a condition which the target of the stigma either did not cause or over 
which he has little control.‖134 In contrast achieved stigma is ―stigma that is earned 
because of conduct and/or because they contributed heavily to attaining the stigma in 
question.‖135 Both may attach to obesity, depending on which attributions of obesity‘s 
underlying causality are made. If obesity is attributed primarily to genetics rather than to 
individual choice or lifestyle, for example, then existential stigma would apply.  
Lifestyle is frequently regarded as something which is chosen when instead it may 
determined by social factors of class, economics, opportunity, and geography.
136
 
Nevertheless, ‗lifestyle‘ implies individual choice and autonomy, in contrast to fatalistic 
genetic determinants. Research found that the more that people believe that weight is 
voluntary (i.e., can be controlled by willpower and discipline through diet and exercise), 
the more negative is the attitude of prejudice expressed towards the overweight 
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individual.
137
 As the final section of this chapter discusses, embracing different causal 
accounts of obesity and different assignments of responsibility for being obese results in 
different, though largely negative, social attitudes toward people who are obese.  
April Michelle Herndon relates her own experience as a ―self-identified Fat 
woman and a Fat Studies Scholar‖ who inadvertently lost a significant amount of 
weight.
138
 Working with a dietician, her primary goal was to avoid diabetes, not to lose 
weight. In the process she lost a significant amount of weight, but was unprepared for the 
social response. Formerly obese Herndon offers a unique before and after perspective on 
the experience of the stigma of obesity. 
 Prior to her weight loss she had become inured to the negative comments she 
would routinely receive regarding her fatness. Following her weight loss, she reports 
―feeling like I‘m in disguise has been especially hard for someone like me, a person who 
hasn‘t bought the traditional narrative of why people are fat.‖139 After what she describes 
as ―slipping onto the world of thin privilege,‖140 she found that ―losing weight seems to 
have signaled to those around me that I must have always or must now believe these 
stereotypes of fat people; my weight loss also seems to have suggested to them that it is 
now OK for them to admit they believe those stereotypes.‖141 Herndon concludes, ―The 
knowledge I‘ve gained in the privileged class is both oddly comforting, because it means 
that as a fat person I wasn‘t imagining what was happening, and also disconcerting, 
because it says to me….that things are worse than I thought.‖142  
 Another woman describing the experience of obesity in her blog connects her 
obesity with the attribution of other negative traits: 
Harrassment [sic] doesn‘t always take place on the street, either. A few weeks ago 
I was sitting in a museum cafe, eating a salad, when I noticed a table occupied by 
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three young men staring and pointing at me and giggling to one another in a 
manner so lacking in subtlety that I was less upset that they seemed to be talking 
about me in first place, and more offended that they thought I was too intensely 
stupid to notice.
143
  
 
Such attributions wound and anger, yet because they are not explicit, the object of such 
attributions cannot directly respond or refute them. The woman continues: 
Sometimes I think this sort of thing is worse than being catcalled in public by 
dudes -- at least with the yellers I can yell back and exorcise my fury, even though 
this is not always the wisest nor the safest course of action…144  
 
 Empirical research supports the themes revealed in these narratives. People do 
attribute negative character traits to those who are obese.
145
 A study of employers found 
that managers routinely prefer to hire otherwise equally qualified non-overweight 
employees because those who are overweight are perceived not to work as hard, cost the 
company more money, take more breaks, and take more time off of work.
146
 Overweight 
and obese people are often further regarded as being of lower intelligence in both 
employment and other settings.
147
   
C.ii Internalized Stigma and Implications for Care-Seeking Behaviors 
Internalized stigma refers to the perceived devaluation, shame, secrecy, and social 
withdrawal experienced by those who deviate from social norms, such as those 
constructing appropriate bodies. Living in an environment which approves the 
stigmatization of people who are overweight, an overweight individual may come to 
accept and internalize these attitudes and believe she is deserving of such treatment.
148
 
Lower self-esteem, lower social expectations, and a reinforcing cycle of social 
withdrawal and rejection result. 
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One blogger describes his experience of others‘ stigmatization and details the 
attribution of negative stereotypes to him, based on his being situated at the intersection 
of multiple sources of marginalization. 
You see as a fat guy people like to draw conclusions about you. You‘re an athlete 
(and let me tell you that assumption is not as cool as it sounds). You‘re not very 
smart (I don‘t know how the association between fat and stupid makes sense). 
You have unhealthy eating habits. You are gonna die young. You hate exercise 
and physical activity (totally conflicting with the assumption of being an athlete). 
The list goes on.
149
  
 
He recounts how his particular experience of obesity stigma is different because he is a 
man, and as such a different set of socially constructed gender based norms regarding 
emotional expression apply to him. 
And I get the feeling that there is an extra bit of pain that fat guys feel. You see as 
part of the script of being a man we are not only not supposed to let things like 
that hurt us but in the event that they do we are not supposed to talk about it. Not 
show it. Just keep it bottled up inside let people pick on us and then go home and 
cry ourselves to sleep at night. And the way fat guys are shown on TV its [sic] no 
wonder people go around thinking it‘s all good in the hood to tease, pick on, and 
otherwise harass us.
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He explains how the persistent stereotyping has changed him.  
For longer than I can recall now this is the type of stuff I‘ve heard and I‘ve taken 
it in so deeply that I actually pray for the very invisibility that people say they are 
burdened with. Maybe its [sic] a sign that something is wrong with me but I don‘t 
feel invisible with my fat. In fact I feel like I‘m the elephant in the room (yeah 
you see what I did there right?). And elephant that wishes he were a fly. 
 
To be so hurt by a simple characteristic you wish you could fade into the 
background. No to be so hurt by the way people put so much stock in a simple 
characteristic you wish you could fade into the background.
151
  
 
He has internalized the public stigma of obesity; the stigmatizing nature of that which 
stigmatizes him has become a part of his self-identity.  
 The internalization of stigma serves to justify and naturalize others‘ negative 
reactions to obese individuals. In turn, obese individuals‘ responses are rendered 
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unjustified. The dominant perspective of obesity thus exerts influence publicly and 
privately, socially and psychologically. The precise nature of that stigmatization depends 
in part upon the stigmatizer‘s understanding of the etiology of obesity and the degree to 
which the obese person is held responsible for his condition. The next section explores 
these ascriptions of responsibility.  
D. Ways of Being Responsible and Ascriptions of Responsibility for Obesity 
 Among the social norms that inform attitudes toward obesity are norms 
concerning assignment of responsibility. The first subsection considers different senses of 
responsibility—causal and moral—and related concepts of causation, control, agency, 
blame, liability, and ―taking care.‖ The second subsection the attempts to use these 
concepts to untangle the frequently conflated senses in which people are considered 
responsible for their obesity. It explores the implications of confusing backward-looking 
ascription of causal responsibility with a moralized ascription of personal responsibility, 
i.e., confusing causal and moral responsibility, as well as confusing ascription of 
backward-looking agent-responsibility (AR) with a forward-looking, empowering sense 
of responsibility-taking.
152
 The third subsection analyzes social manifestations of 
different ascriptions of responsibility for obesity. These manifestations include a 
―personal responsibility for health‖ movement, sin-taxes, and ineffective doctor-patient 
communication regarding obesity. The subsection argues that appropriate ascriptions of 
responsibility would instead support improved communication and access to WLS for 
those who medically qualify to benefit from it. It is critical, however, to begin with the 
clarification of different senses of responsibility. 
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D.i Ascriptions of Thing-Responsibility, Agent-Responsibility, and Blame
 Philosopher Kurt Baier provides a useful taxonomy for considering different 
senses of responsibility. When we claim that failed brakes or an icy road are responsible 
for an auto accident, he states, we ascribe ―thing-responsibility‖ (TR), whereby: 
[T]he central idea is to single out the decisive factor that must actually be 
operative when an undesirable event is being prevented or a desirable one 
produced. This factor may be singled out because it is the most easily controlled 
[the brakes]… or perhaps because it is abnormal [icy conditions] …Even when 
the factor identified as responsible is not itself controllable, knowledge of its 
responsibility may be of some, albeit limited, practical use, since it may prevent 
us from wasting our efforts on controllable factors which are not efficacious, or 
may warn us that there is nothing we can do …153 
 
Baier notes that ―the rationale of ascribing responsibility is thus ultimately forward-
looking, to improve the future; but the actual ascribing of TR is backward-looking.‖154 
Ascribing TR is akin to, but not identical with, identifying a cause.  
 As discussed in Chapter Two with regard to obesity‘s etiology, accurately 
ascribing TR is often a difficult empirical matter. Nevertheless, ascribing backward-
looking AR is more conceptually complicated. Moral agents cannot only be blamed, but 
also be blameworthy; they may be at fault, be culpable, be liable for damages, or be 
deserving of condemnation. The complexity lies in the fact that backward-looking AR 
can only be appropriately ascribed when the agent has failed to fulfill a forward-looking 
AR. While brakes become thing-responsible for an accident simply by being its cause, a 
driver is agent-responsible only if she failed in a forward-looking AR, for example, by 
failing to fulfill her duty or the standard of care. ―The forward-looking aspect of agent-
responsibility consists in a social requirement, whether customary, legal, or moral.
155
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Being the cause is neither necessary nor sufficient to be agent-responsible. In cases of 
vicarious AR, for example, the party responsible for a harm is not the party who caused 
it. It is a failure to fulfill the previously ascribed social requirement that makes an agent 
agent-responsible for harm and other negative outcomes. (In like manner, it would seem 
that fulfillment of some social role, requirement, or norms is requisite for appropriate 
ascription of AR for praise-worthy, positive outcomes.)  
 The rationale or goal for assigning AR is also more complex. The goal of 
ascribing backward-looking AR may be to blame, condemn, or punish, or it may be to 
identify a source of resources to address the problem for which the party is agent-
responsible. A party may be held responsible in the backward-looking agent-responsible 
sense without being subjected to blame or being found blameworthy in a moralized or 
punitive sense. Further, an agent may be ascribed—or may assume—responsibility in a 
forward-looking agent-responsible sense. An agent may be ascribed or assume a forward-
looking AR—a social requirement—simply because he is identified as having the 
resources to fulfill the requirement, or because he cares and assumes the responsibility to 
take care of a problem. Sometimes mustering those resources must involve identifying a 
cause, ascribing TR, or ascribing backward-looking AR (including failure to fulfill the 
forward-looking social requirement). Sometimes one or more of these investigations will 
divert resources from taking care of what needs to be done. The next subsection 
addresses notions of responsibility for obesity. It also expresses concern about the 
impairment or diversion of resources—financial, intellectual, and emotional—that can 
occur for the sake of ascribing responsibility for obesity and blaming the culprit. 
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D.ii Ascriptions of Agent-Responsibility for Obesity and Moral Agency 
As Chapter Two established, substantial effort and financial and social resources 
are expended to try to explain obesity‘s etiology. Yet identification of the cause of 
obesity, the assignment of TR to a single modifiable cause, is proving a futile goal, 
because myriad things contribute to obesity. This is true of the so-called obesity epidemic 
and is likely true of any particular individual‘s condition of overweight or obesity. Yet 
much media attention, many social policies, and even scientific studies approach obesity 
with the logic of identity, focusing on one factor to the exclusion of most or all others. 
Take for example New York City‘s recently overturned regulations which sought to 
outlaw large portions of low nutritional value soft drinks.
156
 This soft drink ban would 
have failed to enact similar portion control safeguards for other calorically-dense 
nutritionally-poor foods, which continue to be available, unrestricted. Such efforts 
misapply single source responsibility to what is a multi-factorial condition. Additionally, 
research conducted on obesity often focuses on one particular factor of obesity‘s 
development such as genetics, or diet, or exercise to the exclusion of other contributory 
factors.
157
 
The gold standard of research—randomized clinical trials—and genomic research 
studies rely on controlling for, or assuming the consistency of, confounding factors; 
however, outside of these rarified experimental environments, confounding factors mix 
with the factor under study. Research must always simplify, but as the trend toward 
translational research acknowledges, it is important to begin to study the causes of health 
conditions and the effectiveness of interventions in the actual lived environments of the 
people those interventions are intended to benefit. 
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The drive to identify the ―but for‖ cause of obesity—as in, ―but for this single 
contributing factor, this person would not be obese‖—seems to derive from not only the 
difficulty of studying multiple contributing factors at once, but also the impulse to ascribe 
moralized responsibility for the problem. Where effective intervention in, correction of, 
and prevention of a problem are the goals, as Baier argues, the rationale for identifying 
the cause or causes is to intervene for the sake of future improvement. When multiple 
contributing factors are identified, the low hanging fruit, the factors that are most easily 
or efficiently susceptible to intervention tend to be addressed. Indeed, it is frequently not 
important to identify all contributing factors in order to commence intervention in some.  
Popular understandings of obesity—and indeed some more scholarly treatments 
of obesity—frequently fail to appreciate obesity‘s actual complexity.158 The 
overwhelming popular opinion is that overweight and obesity are voluntary conditions 
brought about primarily by malleable lifestyle habits.
159
 Even if genetic contributions to 
obesity become better established, it seems likely that the social construction of obesity 
will not shift to incorporate the TR of genes as a first-order explanation for an 
individual‘s obesity. It seems obvious that a person is neither agent- nor thing-responsible 
for her genes. Thus if obesity were solely caused by ―bad‖ genes, then a person would 
and should not be held agent-responsible for her obese condition. But, obesity is a 
complex multi-factorial condition, not merely a genetic condition. Moreover, even if 
there are genes that increase risk for obesity or that affect metabolism in such a way that 
a person with a severely restricted caloric diet would still become overweight, human 
beings need to ingest and metabolize nutrition. There is reason to suspect that were some 
individuals‘ obesity shown to be strongly genetically associated, even genetically 
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―caused,‖ they would still be unreflectively blamed for eating. Eating is still a voluntary 
behavior, even if without doing so one would die. 
Obesity is not the only health condition for which a genetic component is likely to 
fail as a condition excusing the person from AR for manifesting it. Consider the 
following ―genetic conditions.‖ People born with genomic anomalies e.g., 
phenylketonuria (PKU) or cystic fibrosis are not held responsible for their conditions. 
Even when particular behaviors complicate management of a condition—for example, 
when a person with cystic fibrosis visits an environment that exacerbates her respiratory 
problems—the ascription of AR for that behavioral contributing factor may not carry 
blame. In contrast, when a condition known or even just assumed to have strongly genetic 
components is also experienced by people with a socially disparaged identity, they are 
less likely to have access to the excusing condition of being not-agent-responsible. And 
any ascription of AR is likely to carry blame as well. It is well-documented, for example, 
that when African-Americans with sickle cell disease, a condition known to be genetic, 
experience sickle cell crisis requiring prescription of strong pain-relievers (frequently, 
narcotics), they are frequently regarded with suspicion in emergency departments as 
putative drug-seeking addicts.
160
 Racism—and frequently class-based norms—combine 
to construct the person as a likely addict, and the social construction as addict warrants 
refusal of pain relief. Similarly, even when an individual‘s obesity is viewed as being the 
result of a combination of genetic predisposition and behaviors (e.g., diet and exercise), 
blame typically accompanies ascription of AR. In contrast, it is frequently considered 
―understandable‖ that the person with cystic fibrosis would nevertheless visit a horse 
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barn, or that a teenager with PKU eats pizza, triggering symptoms of their genetic 
conditions.
161
 
Therefore, ascriptions of personal AR and blame—based on belief in person-as-
thing-responsible and as agent-responsible for failing to fulfill some social requirement—
complicate and undermine efforts to address obesity in a manner similar to other health-
related conditions.
162
  
The stigma attached to obese individuals because of their ostensibly obesity-
causing conduct complicates efforts both to identify obesity‘s multiple causal 
components and to devise and implement interventions to address it. This dissertation 
argues that the impulse to ascribe moralized AR serves as a barrier to embracing WLS. 
The search for the thing-responsible culprit, the cause, takes on a dual social goal. 
Identifying the cause is not only to serve the forward-looking rationale of improving the 
future but, also to ground ascription of AR and blame. AR is ascribed as soon as the 
agent, the obese person, is identified as involved in the causal chain leading to her 
obesity, which of course she must be, because she must eat. 
American culture is heavily invested in the myth of the self-made man.
 163
 The 
depth of cultural investment may be due to the erroneous belief that if one is not 
completely thing- and agent-responsible for the good things one enjoys, then one does not 
merit them. Recognition of the role in one‘s own economic success of, for example, 
social infrastructure or one‘s ancestors‘ wealth or educational attainments is considered 
by some to suggest that one does not merit one‘s attainment. The suggestion that a 
complex web of factors, including one‘s effort and agency, is responsible for one‘s 
success seems to threaten the pleasure and satisfaction some take in their positive 
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circumstances. Failing to hold people responsible for their negative circumstances, 
including health conditions like obesity, would similarly threaten this worldview and 
sense of merited pleasure such people take in the positive aspects of their lives. As a 
consequence, Americans tend to view their fates as of their own making—even when 
there is legitimate evidence to the contrary, as is the case with obesity.
164
  
Two paradoxes result from applying to the problem of obesity these notions of 
identifying backward-looking TR, ascribing backward-looking AR for failure to fulfill a 
forward-looking social requirement, and blaming/being blameworthy. First, 
paradoxically, even as obese individuals are frequently blamed for their obesity, they are 
regarded as having diminished capacity for moral agency due to the lack of self-control 
and self-governance of the body evidenced by their obesity. Having moral agency is 
predicated on being able to control oneself in light of one‘s understanding of what is right 
and what is wrong informed by accepted social norms. Without such ability to control, 
one lacks agency.
165
 ―Slenderness symbolizes being in-control.‖166 Obesity functions for 
obese people as evidence of both their having made wrong judgments with regard to their 
bodies and their being incapable of self-control. While being incapable of self-control 
might in other contexts serve as an excuse for wrong action due to impaired or absent 
judgment, for obese people, lack of self-control serves to compound their 
blameworthiness and serves as a quasi-causal pathway for their culpable behavior. 
Obesity has come to serve as a social marker of inferior moral character, as well as 
inferior social status, because of its association with poverty.
167
  
Second, if an obese person exercises agency and assumes forward-looking AR for 
her obesity, i.e., undertakes to reduce her weight and improve her health, she is likely to 
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be ascribed backward-looking AR and blame for becoming overweight in the first place. 
In the context of obesity, the moral position of assuming the responsibility of taking care 
of a problem cannot be blamelessly occupied by an obese person herself.
168
 This paradox 
may help to explain why WLS is socially constructed as an illicitly easy way out of 
obesity, even though the post-surgical protocol requires substantial effort. Compared to 
dietary restriction and the exertion of exercise, WLS does not look sufficiently like 
penance for the sin of gluttony.  
The next subsection examines implications of these paradoxes for both obese 
patients‘ care-seeking behaviors and physicians‘ treatment of obese patients.  
D.iii Implications of Misplaced Ascriptions of Responsibility for Obesity 
 This subsection analyzes clinical implications and social manifestations of 
ascribing responsibility for obesity inappropriately. These manifestations include a 
―personal responsibility for health‖ movement, sin-taxes, and ineffective doctor-patient 
communication regarding obesity. 
Recently, a growing trend towards ascribing personal responsibility for obesity 
has been observed.
169
 The Patient Protection and Affordable Care Act and the 2012 
Presidential election focused on questions of ―socializing‖ medicine in America, with 
public discussion and state initiatives seeking to encourage personal responsibility for 
health, particularly weight-related ill health. One line of reasoning seeks to impose 
increased healthcare costs through increased insurance rates based on violating insurance 
norms for weight.
170
  
To address the additional healthcare costs associated with overconsumption of 
high calorie low nutrient foods, a number of states are considering enacting sin taxes on 
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junk foods in an effort to diminish their appeal.
171
 By enacting sin taxes, states deter 
consumption, encourage healthier selections, and receive some compensation for 
anticipated healthcare costs associated with obesity.
172
 The monies realized from food 
sin-taxes would be used to promote public health initiatives aimed at the amelioration of 
obesity related disease, such as diabetes or hypertension. Since sin-taxes have shown 
some past success, as in the case of tobacco, there is a superficial plausibility from a 
public health perspective to this line of thought.  
However, there are several problems with taxation of junk foods. First, food, 
unlike tobacco, is necessary for survival. Second, it is not uncontroversial to determine 
with precision and fairness which foods are junk foods and therefore subject to the tax. 
There is a lack of objective criteria on which to base determinations of sin tax appropriate 
foods. Third, food taxes often disproportionately impact those of limited financial means, 
which generally includes substantial minority populations. The outcome of such taxes 
would place a greater financial burden on those already experiencing exaggerated 
economic hardships, who have been shown to be the most vulnerable to obesity, and who 
have the fewest options to obtain healthful foods in their communities.
173
 Fourth, 
revenues from such taxes intended to fund public health programs are often diverted from 
the appropriate disease-ameliorating programs to cover general budget deficits. Finally, 
sin-taxes can increase stigmatization and internalized stigma among those who purchase 
such foods and beverages. While stigma and shame have altered the consumption of 
tobacco products; however, for food and obesity, stigmatization has not yet had the same 
effect.
174
 Additional stigma and subsequent internal shame may not serve the purpose 
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intended nor may sin taxes on junk foods provide the same retrenchment to responsible 
behaviors as has been seen in other areas.  
Perhaps the most important social manifestation of the social construction of 
obesity and ascription of moralized personal responsibility for it may be witnessed within 
clinical medicine. When physicians subscribe to the societal norms of appropriate bodies, 
they may treat unjustly those who present as overweight or obese in their practices. This 
injustice can manifest in any number of ways including failure to discuss the medical 
problem of obesity, dismissal of symptoms because it is assumed that weight is the cause, 
or judgmental or disrespectful tone and affect with the patient. The problem of addressing 
obesity becomes especially intractable when physicians confuse patients‘ contributions to 
the causal pathway resulting in their obesity with moral responsibility for their condition. 
The problem is exacerbated when physicians, like other members of the dominant 
culture, universalize the ―character faults‖ marked by obesity and attribute other negative 
characteristics to their patients, including laziness, voracious appetites, sloppiness, and 
carelessness with regard to appearance or health.
175
 
Physicians are traditionally the trusted experts and irreplaceable supports to those 
who are diagnosed with disease. From the time of diagnosis throughout various treatment 
interventions for many patients with disease, physicians fill this role. However, in the 
case of patients who are overweight or obese this supportive experience is often lacking. 
When inappropriately moralized ascriptions of responsibility or negative character 
attributions come from those in medicine, they are not simply emotionally painful to the 
obese person; they are clinically counterproductive and may negatively influence the 
implementation of potentially effective weight loss interventions.  
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In his Memoirs of an Obese Physician, formerly obese physician Joseph Majdan, 
M.D. tells of his own stigmatizing experiences both as a medical student and later as a 
practicing physician at the hands of student and professional colleagues.
176
 His 
recollections reveal the liminal space he occupied as both an outsider, as an obese person, 
and insider, as a medical practitioner. He recounts indignities and prejudices he suffered 
for many years due to ―constant, insensitive, unprofessional attitudes of fellow colleagues 
who preached empathy to their students and residents.‖177 but showed little to him. 
Majdan recounts losing large amounts of weight through various diet programs only to 
regain the weight each time. He tells of inappropriate jokes at his expense by mentors, 
colleagues, and other medical students. Majdan, a cardiologist and award-winning 
educator, describes other physicians who shared that their refusal to refer patients to him 
was because of his weight. He recounts one story of a patient who, due to his reputation 
for good medical care, specifically requested a referral to him. The physician responsible 
for making the referral reportedly responded to the patient, ―Why do you want to go to 
him? He‘s fat.‖178 It can perhaps be argued that the medical profession might be tougher 
on one of their own because a fellow physician is a representative of medicine and 
therefore reflects negatively upon the profession as an obese person. Nonetheless, his 
story of stigma and the shame he experienced due to ongoing bias at the hands of 
colleagues within this ostensibly caring profession remain, at the very least, unsettling.  
Majdan also recounts episodes throughout his obesity of people feeling 
comfortable in offering him unsolicited advice regarding proper ways to solve his weight 
problem. He states that people would approach him and comment negatively about the 
food on his tray or suggest that he exercise more or even pursue particular weight loss 
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technologies.
179
 His actions were under near constant scrutiny. These recollections are 
poignant examples of how obese individuals are transformed from subject in their own 
life to object through the panopticon of the societal gaze. As object, the body norm-
violating obese person becomes public property, a social object for critique, because of 
their perceived deviance and lack of appropriate self-control. As the obese person, 
Majdan is to be helpfully managed and controlled by well-meaning and responsible 
concerned medically-trained professionals and good citizens. His obesity stripped him of 
his own professional identity. He was placed under societal surveillance due to what was 
perceived as his obvious diminished moral agency. 
While Majdan‘s experience could be anomalous, research indicates that these or 
similar experiences may be quite common. Similar to the general public, physicians hold 
negative attitudes about obese individuals.
180
 Researchers surveyed 5,000 primary care 
physicians about their attitudes toward obese patients and the causes and treatments of 
obesity. Of the 620 respondents, at least 50 percent agreed with statements indicating that 
they found obese persons to be ugly, non-compliant, awkward, and unattractive. 
Approximately 30 percent of the same group indicated that obese individuals are lazy or 
sloppy. In the same study general practitioners rated physical inactivity as the most 
important factor in obesity, whereas obesity experts rated genetic factors as being the 
most important contributor.
181
 Others in the healthcare field including nurses, dieticians, 
and nutritionists showed attitudinal patterns similar to general practitioners, along with a 
marked dislike of caring for patients who are obese.
182
 In research designed to ascertain 
medical student perceptions of patients through the use of derogatory or cynical humor in 
the clinical setting it was found that patients were categorized as appropriate objects of 
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humor and deemed to be ―fair game‖ based upon obesity or other conditions which are 
thought to be self-inflicted.
183
  
Another study found that physicians play a significant role in lowering the quality 
of health care that both overweight and obese patients receive. These more recent studies 
confirm work done by Mizrahi in the 1980s.
184
 It was confirmed that among medical 
residents ―patients whose afflictions were the consequence of self-abuse were evaluated 
as less ‗worthy‘ of care than those whose pathology was perceived as no fault of their 
own.‖185 As previously discussed obesity is often perceived as a self-inflicted condition. 
Even those medical professionals working in the field of obesity treatment and 
research have revealed complex implicit and explicit bias against the overweight and 
obese patients with whom they work.
186
 On both implicit and explicit bias health 
professionals working in the field of obesity associated the attributes lazy, stupid, and 
worthless with obese people.
187
 This is a group of professionals who are supposed to 
understand that obesity is caused by the interaction of genetic, environmental, and 
lifestyle factors and is not simply a function of irresponsible individual behavior and 
inappropriate personal choices. The stigma of obesity appears to be so dominant that even 
those most knowledgeable about the condition make the judgment that obese people are 
to be blamed for their problem because they are lazy. Furthermore, these biases extend to 
the characteristics of intelligence and personal worth.
188
  
 As discussed earlier, obese individuals are more at risk for developing particular 
cancers than people with more typical weights or BMI.
189
 In light of this fact, there 
should be an added imperative for people who are obese to receive adequate surveillance 
for cancers. However, research indicates that many obese people do not undergo 
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diagnostic examinations for these diseases at the same rate as those whose weight is 
considered normal.
190
 In a study on colorectal cancer (CRC), the third most common 
cancer in the United States and the third leading cause of cancer death, it was found that 
obese patients are less likely to receive CRC surveillance.
191
 This is especially troubling 
since obese people have 50 percent or greater risk of developing CRC compared to 
normal weight people, including as much as a 90 percent greater risk of mortality from 
CRC. Yet, if diagnosed early the 5-year survival rate is approximately 90 percent.
192
  
 Research regarding routine surveillance of other diseases disproportionately 
diagnosed in those who are obese have found similar outcomes regarding the lack of 
surveillance.
193
 While many reasons for the avoidance of routine health screenings have 
been considered, research has found that the stigma associated with obesity and 
evidenced in physician-patient interactions is routinely identified as a factor impeding 
disease surveillance. Patients report general feelings of disrespect, embarrassment, 
negative attitudes of providers, medical equipment that is inadequate for the patient size 
and unsolicited advice on how to lose weight.
194
 Given the stigma experienced by 
individuals who are obese in daily life circumstances, it seems highly plausible that 
seeking treatment for the problem of obesity is fraught with additional stress and 
legitimate fear of stigmatization. For those individuals who might otherwise seek the 
supportive counsel of their physicians to assist them in weight loss efforts, experiences of 
stigma in other medical encounters may color patient expectations and diminish the 
likelihood of their pursuing this avenue of potential assistance.
195
 In essence, the 
opportunity for the patient to make effective decisions and life plans is further impaired 
by the bias and stigma of previous medical interactions. The obese person‘s ability to 
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learn about and choose freely among potential treatment solutions is constrained by past 
experience. The obese patient‘s assumption of an empowering forward-looking 
responsibility for her future health is rendered more difficult and less likely because of  
inappropriately moralized ascriptions of responsibility for her current obesity. As chapter 
four details, WLS, for various reasons, is especially unlikely to be recommended to her as 
a means of assuming such forward-looking, care-taking responsibility.  
E. Conclusion 
 This chapter revealed several prominent ways in which obesity is a socially 
constructed phenomenon. It argued that dominant understandings of obesity neglect or 
explicitly discount important perspectives which must be considered. By utilizing 
feminist epistemological frameworks it was possible to identify current flaws in the 
construction of obesity, injustices in the treatment of obese people, and impediments to a 
wider acceptance of WLS. 
The first section showed that feminist epistemology‘s focus on social context and 
power relationships affords a more accurate formulation of the complex problem of 
obesity. The second section explored gendered notions of appropriate bodies and the 
influence of media and theological teaching on the social construction of obesity. The 
third section integrated feminist conceptual analysis with the phenomena of 
stigmatization and internalized stigma. This section employed attention to particularity 
and narrative to reveal the concrete implications for obese individuals of these 
phenomena. The final section returned to the questions posed earlier regarding the 
etiology of obesity and moralized questions of assigning responsibility for it. This section 
argued that confusing causal with moral responsibility, and failing to distinguish clearly 
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between different purposes of assigning blame lead to ambivalent social attitudes towards 
WLS. Chapter Four will take up issues of justice regarding the use of WLS as an 
individual-level clinical intervention.  
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Chapter Four: The Concepts of Utility as Applied to Weight Loss Surgery 
 
 Commonly employed bioethical considerations such as justice, fairness, and 
autonomy have not been adequately engaged in evaluating the appropriateness of 
employing the technology of weight loss surgery (WLS). Moreover, it appears that what 
ethical considerations have been engaged have focused almost exclusively on its social 
utility—its overall benefit to the broader problem; the potential for WLS to significantly 
diminish the public health problem of the epidemic of obesity, as the problem is often 
framed. Even with regard to these considerations of utility, rigorous analysis of the 
potential benefits of WLS has been at best insufficient and often inappropriate. This lack 
of rigorous analysis appears to be a departure from levels of bioethical attention 
traditionally devoted to emerging healthcare technologies and its more recent (e.g., since 
the mid-1990s) attention to issues affecting relatively disempowered patient populations.
1
 
This relative lack of attention may evidence bias against those who are obese, even on the 
part of bioethicists, or it may suggest that bioethicists fail to recognize the myriad ethical 
implications of obesity and its interventions as well as the social disempowerment of 
obese individuals. 
 Indeed, interventions initially regarded as radical or exotic, such as transplantation 
or dialysis, have received extensive attention in the field of bioethics.
2
 The attention 
given to these interventions, including significant bioethical analysis, began almost 
immediately following the initiation of their use and in many instances occurred during 
developmental phases of the technology. Moreover, the pre-occupation of bioethics with 
the next new technology has often been a criticism of the field.
3
 The same cannot be said 
of the bioethical attention afforded WLS, which rivals transplantation technologies for at 
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one time being regarded as a new ―high-tech‖ intervention, even as its history is 
approximately as long as that of organ transplantation. WLS is distinctive for its dearth of 
immediate and rigorous bioethical attention. A review of the literature to specifically 
identify ethical analysis of WLS reveals few articles. Further, it is notable that in spite of 
the long history of surgical weight loss procedures significant ethical consideration and 
analysis of these procedures appears to have been only recently initiated.
4
 These few 
recent articles do attempt to address the ethical challenges of WLS, including a bias in 
favor of public health efforts, issues of informed consent, patient autonomy, and some 
considerations of justice;
5
 they serve as a much delayed starting point for such ethical 
analysis.  
 This fourth chapter builds upon this modest initial body of ethical analysis by 
evaluating WLS based upon various ways of conceptualizing and assessing its utility. 
This chapter will apply three senses of utility—social, clinical, and personal—to establish 
the usefulness of WLS in these different, albeit overlapping domains. Social utility refers 
to the usefulness of WLS at as a population-level intervention for obesity. The clinical 
utility of WLS refers to its benefit in serving individual patients in addressing their 
medical problem of obesity. Finally, personal or individual utility is used to refer to the 
non-medical benefit individuals receive from WLS. Recognition of both the distinction 
between these senses of utility and their points of interconnection is critical to appreciate 
the value of WLS as an effective clinical intervention and yet understand why WLS has 
not been more widely embraced or been deemed more socially acceptable since its 
emergence. 
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 In concrete terms, this chapter argues that it is inappropriate to dismiss WLS as a 
valid intervention for obesity treatment based on its failure to address the public health 
problem of obesity or its relative lack of social utility in comparison to macro-level 
public health interventions. The chapter argues that such a dismissal of surgical 
interventions for obesity is based on an erroneous application of public health goals to 
what is also, fundamentally, an issue of clinical medicine. The chapter argues that this 
category mistake—of demanding direct and primary public health benefit of a 
fundamentally clinical intervention—is obscured by both modern moralizing public 
health rhetoric and the ethical attraction of solving the problem of obesity through 
preventive public health intervention. The chapter reveals the fallacious reasoning that 
enables obesity to be cast and quantified, alternately, as a population-level problem and a 
problem of individual ill health. Both characterizations serve to undermine the legitimacy 
of individuals‘ utilization of WLS.  
 This chapter further argues that those who primarily advocate public health 
approaches for ameliorating obesity are choosing to disregard a more immediate moral 
obligation to the individual with co-morbid disease related to being obese in favor of 
developing or altering systems to alleviate this condition for future generations and as yet 
unidentified individuals. This is itself a departure from the usual bioethical and medical 
response whereby the individual diagnosed with a condition in the present is generally 
seen to have a stronger claim on medical support and intervention than those in future 
generations.
6
 This suggests that obesity short-circuits usual sympathies for those so 
afflicted in a way not seen in the majority of other conditions. As discussed in the 
previous chapter this again suggests that obesity results in abjection.
7
 The failure to 
 174 
 
properly regard, categorize, and support appropriate individual-level efficacious obesity 
treatments, including surgical interventions for weight loss, violates the moral obligation 
to the individual patient which has been the hallmark of clinical medicine. 
 Assessing the utility of WLS is complicated by the fact that obesity is 
conceptualized and addressed within two health-related enterprises: public health and 
clinical medicine. In reality, these enterprises are and should be complementary.
8
 With 
respect to obesity, however, they may be seen as competing, with a normative bias in 
favor of public health approaches. At the very least, each offers a competing way of 
conceptualizing the root causes of obesity and interventions This chapter argues that it is 
a category mistake, with substantial ethical sequelae, to apply only or primarily a public 
health paradigm to address obesity, given the number of obese individuals who already 
need clinical intervention to prevent co-morbidity and mortality. Even if it could be 
agreed that prevention is (always or usually) superior to treatment, this aphoristic 
commitment yields two ironies in the context of obesity where support for population-
based approaches exceeds and undermines acceptance of WLS as appropriate treatment. 
First, this view fails to recognize that WLS functions as a preventive intervention albeit at 
an individual-level; it seeks to prevent further or worsening co-morbidities in the 
individual.
9
 Second, successful treatment of an individual‘s obesity, including WLS, 
frequently has a positive weight and health-related impact on the population surrounding 
him, e.g., family and friends.
10
 
 The conflation of public health goals with those of clinical medicine in this case 
inappropriately diverts the attention of bioethical analysis away from the usefulness of 
WLS as the primarily individual-level clinical intervention it is intended to be. Further, 
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the conflation leads those who do consider the appropriateness of WLS to criticize it for 
failing to address the population-level obesity problem. Coupled with social attitudes 
toward obesity as evidence of individual moral failing, as discussed in the previous 
chapter, this conflation seems to underwrite further stigmatization and blaming of obese 
individuals, which in turn warrants refusing to recognize WLS as an appropriate 
intervention for them. In contrast, accurately assessing the usefulness of WLS to address 
the clinical medical problem of individuals‘ obesity supports viewing it as both ethically 
and medically appropriate. Foreshadowing the argument of chapter five, it may be noted 
here that for other life-threatening health conditions, such as heart or kidney disease, 
there is little evidence of a social impulse to choose between promotion of public health 
approaches and endorsement of effective individual-level clinical interventions as that 
would be seen as a violation of justice. 
 This chapter will begin by addressing WLS in light of public health practices. It 
will show that the public health paradigm which requires direct population-level social 
utility is misplaced in evaluating the individual-level technology of WLS. The second 
section will discuss the benefits of WLS as an individual-level treatment intervention for 
obesity, i.e., its clinical and personal utility for individuals. The third section will reframe 
the utility of WLS within its more appropriate clinical medical context to argue that the 
concept of utility must be understood and applied at an individual-level to support WLS. 
A. Obesity as a Public Health Concern and the Utility of Weight Loss Surgery 
 After presenting an overview of the history of public health problems, tools, and 
the normative framework of a ―public health approach,‖ this section argues, first, that it is 
a mistake to demand direct social utility of WLS because it is fundamentally an 
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intervention to treat an individual‘s health problem just like other surgeries or using 
statins to prevent heart disease or anti-virals to treat infection. Second, the section further 
argues that even though WLS is an individual-level therapeutic intervention, it is also 
properly considered and evaluated as a preventive clinical intervention. Third, the section 
discusses the positive externalities associated with successful surgical weight loss, again 
paralleling population-level benefits that result from individual interventions, like 
preventing others‘ infection. 
  ‗Public health‘ as a noun or adjective has many meanings. As a system it is ―a 
broad social enterprise, more akin to a movement that seeks to extend the benefits of 
current knowledge in ways that will have the maximum impact on the health status of a 
population.‖11 The health status of a population—typically within a geographically 
defined context—may also be referred to as the public health or the public‘s health. Used 
as an adjective to modify an approach to or way of conceptualizing a problem, ‗public 
health‘ emphasizes this population focus. One of the earliest definitions, provided by 
Charles-Edward A Winslow, defined public health as:  
  the science and the art of preventing disease, prolonging life, and promoting 
 physical health and efficiency through organized community efforts for the 
 sanitation of the environment, the control of community infections, the education 
 of individuals in principles of personal hygiene [and] the organization of medical 
 and nursing services for the early diagnosis and treatment of disease.
12
  
 
  More recently the Institute of Medicine stated, ―Public health is what we, as a 
society, do collectively to assure the conditions for people to be healthy.‖13 Key points in 
each of these definitions include the focus on the health status of populations of people, 
and the tenet that societal efforts are made to ensure environments in which people are 
able avoid developing diseases. These characteristics will be of particular importance in 
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properly analyzing the usefulness of WLS below. The following section briefly explores 
key historical problems which gave rise to the public health system with its unique focus, 
framework, and tools of intervention. 
A.i History of Public Health Problems and Interventions, and the Emergence of the 
Contemporary Clinical Obligation of Individual Care 
  Since its beginning, public health has focused on the prevention of diseases, 
injury, and avoidable disability at the population-level. Historically, public health 
problems included sanitation, provision of clean water, vaccination, and the eradication 
of disease.
14
 The first public health efforts have been traced to ancient Roman and Greek 
civilizations. It was during these historical periods that a rudimentary understanding of 
disease contributors such as polluted water and poor sanitation systems began to 
emerge.
15
 These cultures‘ attempts to understand and address diseases manifesting within 
large sectors of citizenry are considered the foundations of what would become public 
health. The association between the presence of swamps and development of wide spread 
malaria was established during this time, even though the reasons for the association and 
effective interventions were then unknown. Even in antiquity, the focus was on the 
prevention of population-level diseases by altering the environment. In subsequent 
centuries, additional advances too extensive to detail eventually evolved to become 
modern public health. In the 18
th
 and 19
th
 centuries those advances began to be more 
systematically tied to improving societal health by eradicating population-level diseases 
resulting from infection and pathogens.
16 
 Modern public health efforts are traced globally to the 18
th
and 19
th
 centuries with 
major advances seen in Britain and the United States.
17
 In Britain, public health efforts 
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were prompted by the smallpox and cholera epidemics of those two centuries. 
Devastating parts of Europe, the smallpox epidemic was reportedly responsible for the 
deaths of almost a half of a million people in the 18
th
 century. Smallpox was eventually 
eradicated through development and use of widely distributed vaccinations. Edward 
Jenner, a naturalist, is generally credited with the first scientific attempt to control an 
infectious disease by the deliberate use of vaccination. Strictly speaking, Jenner did not 
discover vaccination, nor is he thought to have been the first to use vaccination for 
smallpox, but he was the first person to elevate the practice to a scientific tool and persist 
in its rigorous investigation.
 18
 
 In the 30 years following Britain‘s first confirmed case of cholera in 1831, there 
would be four cholera epidemics. Initially thought to be caused by miasma or bad air, 
cholera was eventually believed to result from contaminated water sources. John 
Sutherland and John Snow separately advanced theories of cholera‘s pathology, with 
Sutherland believing that finding clean water sources was essential to the health of the 
public. Snow advanced thinking on the particular mechanisms of cholera transmission, 
which eventually led to the now famous removal of the water pump handle at Broad 
Street. It was not until after Snow‘s death over three decades later that the true cause of 
the cholera epidemics, cholera bacillus was described by Robert Koch.
19
 
  In the United States, the first settler‘s struggles with diseases such as smallpox, 
malaria, and influenza established the colonies‘ initial need for public health efforts. 
Though the settlers had some immunity, Native Americans, who had not previously been 
exposed, generally succumbed to these diseases. The American civil war in 1861 
―enforced a national consciousness of epidemic disease: two-thirds of the 360,000 Union 
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soldiers who died were killed by infectious diseases rather than by enemy fire‖.20 In the 
post-war period, industrialization brought new diseases which were the result of the 
movement of masses of people into urban settings without the understanding or benefit of 
the sanitation systems for waste disposal. The rise in deaths due to potentially avoidable 
industrial accidents also became a growing concern of public health efforts at this time.
21
 Public health also began to concern itself with the class stratification resulting 
from wealth gained by some industrialists. Public health sought ways to reduce the 
health-related disparities between the wealthy and others, including laborers. Social 
reform initiatives on child labor, maternal health, and improved housing became a focus.  
  Following World War II, when public health addressed malaria, to which large 
numbers of troops were routinely exposed,
22
 the focus of public health became less well-
defined. Immediate threats were no longer to be found among communicable diseases or 
large scale industrial mishaps. Shifting attention from health threats whose social 
destructive power was immediately evident to health risks like poverty and obesity, 
whose intricacies do not permit silver bullet solutions like vaccination or sanitation has 
complicated modern public health efforts. As public health law and ethics commentator, 
Lawrence Gostin states, ―Somehow, America lost its commitment to public health in the 
latter part of the twentieth century.
23
 More recently, public health has sought to re-define 
itself in light of its numerous accomplishments in overcoming its original adversaries.
24
 
  In the early days of public health and medicine few lifesaving interventions were 
curative once a disease like cholera, small-pox, tuberculosis, or influenza had taken hold. 
With no means to cure those already afflicted, the only options were palliation and 
prevention to avoid the spread of disease. Patterns of behavior and environmental factors 
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were observed to be associated with disease and its spread.
25
 The identification of the 
Broad street water pump as the source of transmission, the presence of mosquitoes in 
malaria-affected areas, recognition of the so-called natural immunity from smallpox of 
dairy-maids, and the observation that doctors did not seem to contract disease directly 
from their patients, attributed to their hand-washing (personal sanitation) practices, are 
examples of such observed patterns.
26
 Altering environmental conditions and personal 
behaviors in response to such observations—a preventive strategy—emerged in part 
because of the impossibility of curative intervention in the disease course of those already 
afflicted.  
 However, once individual-level interventions such as penicillin were developed, 
both attention and prestige within the medical profession shifted from population-focused 
prevention to the treatment and cure of individual ill patients.
27
 The contemporary 
medical ethos of a physician owing her primary fiduciary duties to her individual patient, 
articulated by Hippocrates, was reinforced and has remained largely unchallenged until 
recently when concern about escalating healthcare costs and limited effectiveness of 
some interventions had led to the notion of physicians as stewards of healthcare resources 
for the good of all.
28
 Historical and ethical analyses have argued that, with few exceptions 
(e.g., battlefield triage) it is unethical to withhold individual-level healthcare or medical 
intervention for the sake of the greater good or in pursuit of public health goals. Other 
individual-level sacrifices—e.g., of personal liberty in the case of necessary quarantine—
may be required for the sake of public health, but the sacrifice of individual health in 
favor of public health was deemed contrary to the goals of both clinical medicine and 
public health.
29
 When reasonably efficacious individual-level technologies were 
 181 
 
discovered or developed, providing them became a moral imperative in clinical medicine. 
The imperative to provide the appropriate individual-level intervention did not negate 
broader public health obligations to prevent and ameliorate the disease at the population 
level, but neither was it seen as appropriate to withhold individual-level interventions and 
technologies if individually appropriate based on their potential individual benefit.  
 The ethical failures in the Tuskegee Study of Untreated Syphilis in the Negro Male are 
often cited to illustrate the importance of not violating the obligation of individual care in 
the interest of pursuing public health goals, including research goals. Once penicillin was 
found to be an effective treatment for syphilis, withholding this efficacious individual-
level intervention from subjects was eventually determined by history to be morally 
reprehensible and fundamentally unjust. Withholding access to penicillin from the 
Tuskegee research subjects in the interest of answering the question posed regarding the 
natural course of untreated syphilis in the Negro male violated the clinical obligation of 
individual care, prevented the men from making informed decisions about their own 
healthcare, and in so doing, unjustly failed to treat these men according to the same 
standard of care afforded to others outside of the study.
30
 
A.ii The Goals, Normative Framework, and Tools of Public Health 
 The normative framework of public health is different from that of clinical 
medicine. Public health efforts necessitate ―utilitarian, paternalistic and communitarian 
orientations,‖ whereas clinical medicine favors ―civil liberties and individual 
autonomy.‖31 The public health normative framework requires that efforts put forth are in 
service to providing the overall greatest benefit, typically the avoidance of disease for 
most members of a particular population. The public health framework permits and 
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sometimes requires intrusions into otherwise personal actions by making compulsory 
particular activities undertaken for the good of the wider community though they may 
burden particular individuals.
32
 In contrast, clinical medicine focuses not at the societal 
level but at the individual-level and seeks the individual‘s health-related good. There is 
generally no obligation that considerations of societal benefit be included in that which is 
considered clinical medicine. 
 Public health practice and clinical medicine have different goals. Public health 
directs its efforts at populations to ―create conditions under which all members of the 
population can experience the maximum degree of good health, within the limits which 
may be imposed by economics, genetics, or the state of our knowledge‖.33 The success of 
interventions is measured in terms of the aggregate effect on the identified population, 
even if individuals are affected in the process (as when individuals are vaccinated to 
avoid disease or required to wear seatbelts or motorcycle helmets to avoid injury). Public 
health interventions are generally broad and are intended to change systems—social, 
environmental, biological— which in turn, change the outcome, incidence, or intensity of 
disease and disability.
34
 
 Early and contemporary public health initiatives employ information 
dissemination, persuasion, and as a last resort, coercion and intrusions into areas of 
personal privacy. Quarantine, compulsory vaccinations, and other paternalistic intrusions 
which constrain the liberties and even override the rights of individuals were and are 
justified by the greater societal benefit.
35
 A determinable link between behaviors which 
lead to broader contamination and interventions to prevent disease spread justify 
intrusions into what would otherwise be seen as matters of personal regulation. 
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According to Gostin, public health tactics, particularly those that infringe personal 
liberties, must be matched to the scope and immediacy of the threat, with the least 
restrictive alternative chosen among the range of possible interventions.
36
 
 Prevention efforts are elucidated in terms of their target. One framework, 
proposed by the Commission on Chronic Illness in the 1950‘s, elucidates two types of 
disease prevention,
 37
 to which a third was later added. Primary, secondary, and teriatry 
prevention are explained in the Journal of Public Health Reports: 
Three decades have elapsed since a working group under the Commission on 
Chronic Illness proposed the classification of disease prevention into the 
categories primary and secondary. An additional term, ‗tertiary prevention,‘ has 
gained currency since, and the classification is now ubiquitous in textbooks of 
epidemiology and preventive medicine. These classes are summarily defined as 
primary-practiced prior to the biologic origin of disease; secondary-practiced after 
the disease can be recognized, but before it has caused suffering and disability; 
and tertiary-practiced after suffering or disability have been experienced, in order 
to prevent further deterioration.
38
 
 
This classification system, as envisioned at the time of its development, recognizes a 
variety of appropriate interventions depending on whether or not disease had manifest or 
was merely a risk. Complete avoidance of disease is one of public health‘s highly 
desirable goals, however, the framework recognizes that disease avoidance is not always 
feasible. In that case, secondary prevention efforts would apply to those who had already 
manifested the disease but were at present asymptomatic.
39
 By way of example, a person 
with hyperglycemia who is unaware of it until screening occurs would be the target for 
secondary prevention efforts. Tertiary prevention efforts could include active clinical 
treatment which is undertaken to reduce the severity of the primary disease or to reduce 
its complications.
40
 As Robert Gordon‘s piece criticizes, the various levels of prevention 
were not meant to be used in a hierarchical manner with primary being seen as a superior 
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preventive effort to the others but instead were intended to be applied based on the 
particular context of the disease and its degree of manifestation and burden. He states: 
Although it was not the intention of the Commission to suggest that primary is 
preferable, and secondary is second rate, this impression may develop, 
particularly among lay persons who may have responsibility for important 
decisions that bear on  preventive programs. Careful quantitative analysis of 
benefits, costs, risks, and effectiveness frequently reveals that a preventive 
intervention is best applied only to a  high-risk group, the evidence of high risk 
being a finding that can be related to the biologic origin of disease. Though 
‗secondary,‘ this may well be the optimal preventive strategy.41 
 
Presumably, Gordon‘s analysis that the inappropriate ordinal priority ranking of these 
interventions based on the potentially misleading terms primary and secondary would 
also extend to tertiary interventions. 
 Application of this classification to asthma prevention in minority populations 
illustrates the integration of the three levels.
42
 Primary prevention of asthma might 
include targeting a major risk factor in its development such as low-birth weight. By 
focusing on pre-natal care and increasing birth weight, children would likely be able to 
fully avoid ever developing asthma. A secondary prevention activity would be early 
identification through screening programs. After proper screening the child with 
undiagnosed asthma and his family could make changes in their environment to avoid the 
progression of symptoms and the full blown manifestation of the disease. For those 
whose asthma had already manifested and were experiencing active symptoms tertiary 
prevention would focus on mitigating disease complications through ensuring access to 
and correct use of medications, or earlier intervention when symptoms surface.
43
  
 As the example of asthma illustrates, the classification system of prevention 
stages acknowledges the importance of clinical interventions to reduce the severity of the 
symptoms associated with already present disease. Yet the concern which Gordon raised 
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regarding the potential for the levels of preventive efforts to be misunderstood as 
indicating priority or preferability is, this chapter argues, evident in analyses of obesity. 
Consider the application of the classification framework to preventive efforts aimed at 
obesity and its co-morbidities. Primary efforts at complete avoidance of obesity focus on 
such things as changing the built environment. Secondary preventive efforts include 
measurement of BMI, along with screening for obesity and its co-morbidities. Weight 
loss surgery when used to diminish the burden of disease in those already diagnosed can 
be seen as both a secondary and tertiary level intervention, designed to prevent further 
obesity and to prevent obesity associated co-morbidities. As in the case of asthma, each 
level of prevention should be deemed equally valuable. Each is intended to meet a 
particular goal as a tool of public health efforts at various points along the disease 
manifestation continuum.
44
 That stage of temporal intervention is confused with social 
priority or ethical hierarchy among the levels of intervention evidences a continuing 
confusion about their meaning and goals. For reasons discussed in the previous chapter 
and explained below, the social construction of obesity and the tendency to moralize 
about it, may exacerbate both this confusion and the negative impact of regarding some 
types of prevention as ethically preferable. 
A.iii Contemporary Moralizing Attached to Public Health Campaigns 
 Since the early days of public health, its evolution and successes have been both 
gratifying and troubling. The success of public health initiatives has meant that as a 
population, residents of the United States and other wealthy nations are safer and less 
likely to fall victim to relatively avoidable, by modern standards, health threats such as 
smallpox and diphtheria. Immediate dangers to life and quality of life in developed 
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countries have been substantially diminished.
45
 The counterpoint to that success, 
however, has been a kind of identity crisis within public health.
46
 Immediate health 
threats which are under control require only ongoing surveillance and modification of the 
interventions already in place. Annual flu vaccination campaigns require ongoing 
surveillance, modification to account for variations in the strains of influenza expected to 
manifest, and annual education campaigns, but the course of action and intervention need 
has been fairly well-established over the years. 
 Modern public health efforts are substantially different from the early public 
health successes.
47
 The recent focus of public health has been described as increasing the 
standard of living among citizens and providing expert advice on a range of issues 
including nutrition, physical health, longevity, and the imposition of rules thought to 
benefit the masses. Today public health is grounded in epidemiology but interventions 
are shaped by economic, social, and political concerns.
48
 The modern scope of public 
health has been criticized for being so broad as to engender substantial confusion over its 
proper place in the lives of citizens, the amount of control with which it should exert its 
authority, and the type of tactics it should use to produce its desired results.
49
 While many 
of these questions are not dissimilar to early ruminations in the exercise of public health, 
the issues to which they apply are. The majority of modern public health issues are 
muddier with less well-defined immediate and communicable risks than those which 
have already been addressed.
50
 Public health issues, as well as the interventions to 
address them, interact with economic, social, and political concerns. 
 Much has been written on the new moralizing vocation of modern public health.
51
 
Expert advice dispensed by those who are knowledgeable has sometimes been thought to 
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be sufficient for rational moral agents to act in their own health interests. Unfortunately, 
the expert public health advice may not be able to be wholly or even partially applicable 
because of the personal situations of the individuals the advice is intended to motivate. 
Thus, as described by Bernard Turnock , when the expert advice of public health, fails to 
effect the type of changes anticipated, the entire field of public health, or individual 
voices within it, may chastise those who ignored the advice. Targets of such chastising 
may include patients who contract HIV or Hepatitis C in spite of sincere and thorough 
expert public health initiatives, or the obese who fail to realize significant weight loss in 
the face of health promotion and weight loss activities.
52
 Public health‘s zeal and good 
intentions may serve as spurious justification for its moralizing tone. 
  Public health initiatives directed at conditions having a substantial behavioral 
component have now adopted a stance which can be described as the idealistic, 
moralizing, and stigmatizing.
53
 Public health efforts are idealistic because they reflect and 
valorize the way in which individuals and systems should behave and should act in order 
to obtain the best possible health outcomes. The modern focus of public health is the 
avoidance of disease in future generations of as yet identified individuals. As in the past, 
this focus on future generations ignores the risks to and manifestation of disease in 
current individuals. In the past, such a future focus could be justified because of the lack 
of curative interventions. Today an exclusive or excessive future focus denies the reality 
of effective individual-level interventions do currently exist. In light of effective 
individual-level technologies choosing one level or prevention to the exclusion of the 
other is unethical.  
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A.iv Obesity, Weight Loss Surgery, and Public Health 
 The utilization of surgical weight loss interventions has been criticized because it 
provides individual benefit but fails to address the greater public health concern of 
increasingly large numbers of people diagnosed as being obese.
54
 In one of the rare 
bioethical treatments of obesity and WLS, an article by ethicist Rosemarie Tong, 
provides an analysis of the relative risks and benefits of both the ―high risk (clinical) and 
population (public health) approach to obesity and overweight.‖55 In her comparative 
analysis Tong offers the following insight: 
Instead of wasting time and resources on normal weight individuals, the clinician 
focuses on an already overweight individual, particularly those who threaten to 
enter the obese category. Why waste money educating slim-enough people about 
the dangers of a condition they do not manifest? Instead, hammer the message 
about ―fat‖ home to those patients whose clothes are already painfully tight.56 
 
Tong analyzes the relative merits of public health and clinical strategies by likening 
bariatric surgery to a ―quick fix‖ which she further suggests Americans love. Finally she 
summarizes her analysis by concluding that ―the benefits [of a public health campaign] 
outweigh the risks of a public health campaign against obesity.‖57  
 Tong‘s article ultimately acknowledges a need for both clinical interventions and 
public health strategies to address obesity. Yet is persistently confuses the purpose and 
focus of each type of initiative, and fails to acknowledge the complexity of obesity for the 
individual so diagnosed. Moreover, it appears that she does not fully comprehend the 
usefulness of bariatric surgery for those immediately afflicted who are seeking resolution 
to serious problems within a narrow window of time. The comparative time frame of 
effectiveness of these strategies is the obese person‘s own statistically diminished life 
span, not one or even several generations in the future. This longer time frame of multiple 
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generations has been required to realize public health‘s successes in tobacco cessation, 
while this level of success has yet to be achieved by public health strategies intended to 
diminish overconsumption of alcohol.
58
 Tong‘s article suggests that ethicists are not 
comfortable working in the realm of public health but are more comfortable in the realm 
of clinical medicine. While it is indeed true that clinical medical issues have occupied 
much more of bioethicists‘ attention and the bioethical literature, when bioethicists do 
turn their attention to topics that cross into both the clinical and public health spheres, 
they must be careful to clearly distinguish the goals and the focus of each of these 
enterprises. This is particularly true if ethicists choose one strategy over the other to 
address a particular issue.  
 Unlike Tong, who acknowledges what appears to be competition between clinical 
and public health strategies addressing obesity, another article intended as comprehensive 
ethical analysis of bariatric surgery fails to acknowledge this competition as an ethical 
concern. An article by Bjorn Hoffmann lays out what he sees as the ethical issues 
surrounding bariatric or WLS. He terms his method of ethical analysis to be an 
―axiological approach.‖59 The intended goal of his approach is to pose several morally 
relevant questions which are designed to reveal the ethical values applied to a particular 
intervention, in this case WLS.
60
 His analysis fails however to take up or even 
acknowledge the concern of conflating the population-level goals of public health 
initiatives with the individual-level goals of clinical medicine interventions for its 
treatment. In a follow-up commentary to Hoffmann‘s original piece two authors did take 
up this particular concern.
61
 It appears however, that they too are confused by the proper 
ethical framework which ought to be applied to public health initiatives on obesity and a 
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different ethical framework which applies to clinical interventions. The commentary 
critical of Hoffmann‘s ethical analysis states: 
Bariatric Surgery is a technology-intensive, personalized response to a global 
public health problem. It is far too expensive and far too risky to be an effective 
solution for a problem of that kind.
62
 
 
In stating that bariatric surgery is a response to a global health problem the commentators 
misunderstand the appropriate focus of such interventions; they conflate the goals of 
clinical medicine with the goals of public health. Later in the same commentary they 
suggest that it is inappropriate to focus on WLS as an intervention since other venues, 
primarily public health initiatives have not yet been given sufficient resources or a 
genuine opportunity to ameliorate obesity. They write: 
Similarly, if full-scale public health initiatives were mounted, the comparative 
cost effectiveness of various treatments including bariatric surgery might change 
dramatically. So, rather than pointing out the need for additional research on 
bariatric surgery, the call should be for additional study of all possible parts of a 
public health response and a new comparative analysis.
63
 
 
In characterizing their position, they refer to it as ―big picture approach‖ intended to offer 
better conceptualization of the problem and pointing to more promising solutions.
64
The 
big picture approach appears to be one focused on the health of the public, not the health 
of the individual currently diagnosed with obesity and its related co-morbidity. It is 
equally true that theirs is a zero-sum approach; they seem to assume that public health 
and clinical pathways cannot be simultaneously pursued or that pursuit of one must be 
purchased by ignoring the other.  
 Finally, the commentators summarize their position on WLS in the following 
way: 
Bariatric surgery is short-term in that it is highly individualized (rather than 
population based) and focused on post facto treatment (rather than prevention). As 
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such, it should not be the sole, or even the primary response to a genuine public 
health crisis. It is critical that the social sources of the obesity epidemic be taken 
seriously in order to prevent a skewed analysis of bariatric surgery that vastly 
overestimates its potential as a solution.
65
 
 
The authors are correct in asserting that WLS is not the answer to the growing public 
health problem of obesity. However, their analysis fails to recognize that WLS should not 
be utilized to solve the public health problem of obesity. The commentators commit the 
category-mistake discussed earlier in this chapter. Furthermore, the authors fail to 
recognize that by re-directing resources toward mounting comprehensive public health 
initiatives to ameliorate obesity, individuals in the present will likely continue to grow 
increasingly more debilitated and lose both quality and years of life.  
 A Danish study seems to support the prejudice that obesity amelioration through 
public health initiatives should be given higher priority than clinical approaches. The 
study showed that people are willing to fund public health approaches more often than 
clinical treatment, including WLS.
66
 The survey study‘s aim was to investigate the 
Danish public‘s support for publicly funded obesity treatment versus prevention. (It is 
important to note that the study was conducted in a country, unlike the United States, 
with publicly funded health care which would likely pay for weight loss interventions 
such as surgery.) The study also examined whether levels of support, or lack thereof, 
could be explained by negative attitudes toward obese people and/or the belief that those 
who are obese are personally responsible for their condition. Participants (n = 1,141) 
completed a web-based questionnaire designed to assess attitudes toward public funding 
for obesity-related health care, and to investigate the impact, of the following attitudes: 
dislike of obese people, and the perceived controllability of obesity. The study found that 
public funding of some obesity treatments, such as weight-loss surgery, attracted very 
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limited public support. A majority of the Danish public did support what the authors‘ 
term as ―softer‖ treatment interventions such as supervised diet and exercise and public 
health initiatives focusing on primary prevention. Attitudes about the acceptability of 
various interventions for obesity were found to be best predicted by the belief that 
individuals are personally responsible for their obesity. Participants believing that obesity 
is an issue of personal responsibility were more likely to favor public health strategies 
than participants whose belief about the origins of obesity were less strongly tied to 
personal responsibility. Furthermore, when the option of WLS was re-framed as a life-
saving intervention ―a sizable proportion who initially disapproved of public funding for 
WLS changed their minds.‖67 The following article reveals attitudes on the support of 
public health efforts towards ameliorating childhood obesity. 
 An article on childhood obesity calls for more resources to support public health 
efforts to address obesity and expresses skepticism about developing additional treatment 
interventions presumably including weight loss surgical treatment. The authors write: 
This public health crisis demands increased funding for research into new dietary, 
physical activity, behavioral, environmental and pharmacological approaches for 
prevention and treatment of obesity, and improved reimbursement for effective 
family-based and school-based programmes. However, because this epidemic was 
not caused by inherent biological defects, increased funding for research and 
health care, focusing on new treatments will probably not solve the problem of 
paediatric obesity…68 
 
While it has been shown that obesity is an increasing public health concern,
69
 to discount 
the benefit of obesity surgery for the individual because it does not effect a cure for 
obesity as a public health issue fundamentally misunderstands the social role of clinical 
medicine, a role which should co-exist with public health efforts to address obesity. In 
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contrast, one commentator recognizes the potential role of WLS in the treatment and 
prevention of co-morbidities, here obesity-related diabetes (diabesity):  
Prevention of this diabesity epidemic through effective public health lifestyle and 
environmental initiatives to change the population‘s dietary and movement 
behaviors would be of highest priority. For those already suffering from diabesity, 
effective treatment is important. A therapy that provides remission of both 
diabetes and obesity should attract enormous interest and activity.
70
 
 
This commentary goes on to express the belief that WLS should have an important role in 
the early intervention of co-morbid disease associated with obesity. The article 
acknowledges the importance of both strategies and expresses what appears to be the 
unique insight that, at least at the present time, public health strategies are not able do the 
work of clinical medicine to resolve individual-level obesity. Instead, individual-level 
treatments such as WLS must be employed to help resolve immediate problems of those 
currently afflicted.  
 It is thus clear that the three-level classification of public health prevention 
strategies discussed in the previous section permits more than one narrow conception of 
prevention.
 71
 Although popular conceptions of prevention may be limited to ensuring 
that the disease never manifests in an individual—i.e., the avoidance of disease rather 
than the curtailment of disease once manifest—if the full scope of prevention strategies is 
properly applied, surgery would appropriately be considered secondary or tertiary 
prevention techniques and would therefore be seen as acceptable even perhaps a victory 
in the domain of public health. (Indeed, in the case of breast cancer prevention, 
prophylactic mastectomy is the most effective preventive intervention for those carrying 
BRCA1/2 mutations.) Public health initiatives defined as primary do continue to be 
confused as having ethically salient ordinal ranking ahead of other types of efforts.
 72
 The 
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following describes several public health strategies which have been employed to reduce 
obesity. 
  To ―combat the nation‘s obesity epidemic‖73 public health strategies include 
increased taxation of ―junk foods‖, eat-less-and-exercise-more campaigns, state specific 
bans on trans-fats, high-fructose corn syrup awareness advertising campaigns, removal of 
snack and soda vending machines from elementary and high schools, requiring that 
nutritional information be posted on restaurant menus, re-inventing guides to proper food 
portions (e.g. phasing out the food pyramid guide in favor of the eat-well plate) among 
others. Research done on public health strategies for obesity has found that such 
interventions, many of which have been initiated only recently, either have not had 
sufficient time, opportunity, or resources to show significant results or that it is difficult 
to discern what if any improvements are attributable to these efforts.
74
 It has also been 
noted that some public health initiatives are difficult to evaluate due to the limited 
number of studies that meet rigorous research standards and the fact that they tend to 
report non-comparable outcomes.
75
 A meta-analysis by Katz et al. examined the success 
of initiatives undertaken in schools and in workplace settings reviewed all published 
results of such interventions between 1966 and 2001, Initially 44 studies were included in 
the school sample and 35 in the work place sample; however, after being evaluated for 
quality, only 10 school and 20 worksite studies were included in the meta-analysis. All 
interventions were related to altering diet or increasing physical activity; the outcome 
measures were primarily weight-related measures such as BMI, weight or other 
anthropometric measures (e.g., waist to hip ratio), with subjects followed for at least 6 
months.
76
 Some studies showed modest weight loss in six months, approximately 4 
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pounds on average for participants; however, the task force conducting meta-analysis 
determined that ―insufficient evidence existed to determine the effectiveness of 
combination nutrition and physical activity interventions to prevent or reduce overweight 
and obesity in school settings because of the limited number of qualifying studies 
reporting non-comparable outcomes.‖77 This meta-analysis demonstrates that accurate 
evaluation of the efficacy of school and work-based public health initiatives for weight 
loss is hampered by lack of rigor, but suggests that the amount of weight loss realized 
through such initiatives is likely modest.
78
 For those who are obese, an average of 4 
pounds of weight loss in six months‘ time would likely be insufficient to improve their 
overall health and well-being and rid them of both the physical and social co-morbidities 
associated with extra weight.  
  Another concern potentially hampering public health efforts to reduce obesity 
may be the lack of relatability in health promotion messages. A meta-analysis by 
Malterud and Tonstad sought to analyze challenges faced by health promotion strategies 
to address obesity within a Scandinavian context.
79
 The review of primary studies on 
health promotion efforts in Norway and Finland found that these health promotion efforts 
faced several challenges related to the unequal distribution of vulnerability to weight gain 
within the population. Individual factors such as race, age, socioeconomic factors, and the 
presence of abuse or neglect, among others, made developing effective general 
population-based public health efforts an unrealistic expectation. The very nature of such 
a broad-based population-wide intervention discounted variables and failed to address the 
highly nuanced and individualized factors believed to influence the development and 
maintenance of obesity. The authors outlined implications of their analysis for practice. 
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They recommended that health promotion needs to be highly individualized and tailored 
to the obese person. Preventing weight gain requires attention to the person‘s socio-
demographic, cultural, and genetic characteristics. Health promotion initiatives, as a part 
of the public health arsenal of tools, are unable to provide this individualized attention.
80
 
Even more, when such interventions fail, this failure can wrongly be used to turn weight 
control into a question of morality and self-control. The study suggests that when general 
health promotion messages are delivered (even those which lack reliability) and then 
prove ineffective in assisting the individual to lose weight and gain health, the 
assumption is that the message recipient (the obese person) has failed to appropriately 
take up and use the helpful professional expertise provided.
81
 The situation then becomes 
one of blaming the victim. The study concludes that ―cultural aspects on identity and 
morality may create victim blaming and disempowerment obstructing health promotion 
strategies for weight control.‖82 The obese person, originally thought to lack morality and 
self-control, has now ―proven‖ his moral inferiority by once again failing to lose weight 
in accordance with the non-specific health promotion messages promulgated. 
 Commentators Puhl and Heuer concur, arguing that he possibility of obesity 
stigma, whether intended or unintended, should be an important consideration in the 
development of more useful and helpful public health messages. ―For the public health 
community to address the widespread health and social disparities faced by obese 
people,‖ they state, ―we must move past the victim-blaming approach and instead 
advocate a comprehensive obesity prevention strategy that includes efforts to reduce 
weigh-based stigma and discriminations.‖83 Recognizing the additional burden that public 
health initiatives can impose by seeming to blame obese people for both their condition 
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and their failure to utilize expert information may be a first step toward avoiding 
campaigns that are actually counter-productive to achieving the goals of public health. 
  Public health and clinical medicine are best used as complementary efforts. With 
regard to obesity, public health efforts should be focused on the prevention of obesity, the 
prevention of further weight gain, or the curtailment of disease in those who are already 
obese. Clinical medicine addresses the needs of the individual who has become obese and 
faces secondary and tertiary co-morbidities associated with excess weight. Neither 
approach should be expected to accomplish the goals of the other, though both must 
embrace preventive interventions to achieve their respective goals. Commentators who 
advocate public health approaches to the exclusion of clinical medical interventions to 
address obesity mix their differing foci and goals, and further, risk employing the 
normative framework appropriate to population-level interventions to criticize individual-
focused interventions like WLS. This category mistake may result in applying a 
moralized framework within the clinical medical context where promoting patient 
autonomy and well-being are the appropriate normative goals of the professional 
obligation of individual care. 
  In summary, the goals of public health and clinical medicine are not the same. 
Public health focuses at the population-level and permits for various degrees of disease 
prevention from never developing disease to effectively curtailing its co-morbidities in 
those who have already developed the disease. Clinical medicine is focused on the 
individual and on resolving the particular, often highly nuanced, medical issues of the 
identified patient and avoiding the onset of (additional) co-morbidities.
84
 Each enterprise 
makes a distinct contribution to the development and implementation of systems intended 
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to address the many problems, origins, and solutions attributable to obesity. Public health 
efforts, as well as clinical medical technologies, should both be employed.
85
 However, 
holding WLS accountable for not alleviating the public health problem of obesity and 
discrediting its clinical utility because it does not have direct social utility, is to conflate 
the goals of public health and clinical medicine. This category mistake has unfortunate 
ethical implications when bioethicists, policymakers, or the public are led to discount the 
value of WLS. Embracing public health initiatives to the exclusion of providing a 
medically warranted continuum of care to obese individuals would unjustly sacrifice 
currently obese individuals for the good of future populations.  
  Applying the public health yardstick to measure what is essentially a clinical 
medicine issue undermines assessment of the potential utility of WLS. Weight-loss 
surgery has its greatest potential utility at the level of an individual‘s health, and it may 
be the individual-level intervention with the greatest clinical utility, i.e., it may have the 
highest probability of promoting patient well-being. It has been shown to be more 
effective than other individual-level interventions, and it has also been shown to be a cost 
effective clinical intervention in the long-run.  
 Although it is beyond the scope of this dissertation‘s argument to engage in an 
exhaustive cost effectiveness analysis, both the clinical utility and the potential cost 
effectiveness of WLS will be addressed in the next sections of this chapter. This project‘s 
second chapter presented some evidence of the general efficacy of WLS as an 
intervention for obesity. The following section will provide detailed evidence of the 
ability of WLS to reduce or fully alleviate various co-morbidities—both physical and 
social—and to thereby constitute an effective individual-level preventive and 
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therapeutic/curative treatment. Establishing the clinical utility of WLS supports the 
argument that it should be fully embraced by clinicians and the public as part of the 
establishing an effective continuum of care for obesity. 
B. The Clinical Utility of Weight Loss Surgery and Its Personal Utility 
 This section will first review the general data on the effectiveness of WLS to 
effect durable weight loss. It will then provide detailed empirical evidence which shows 
that WLS does indeed constitute a useful technology to employ in ameliorating the major 
physical and psycho-social co-morbidities of those who are obese. It will argue that WLS 
is therefore an effective clinical intervention for obesity. In short, this section will show 
that WLS has clinical utility at the individual patient level. Clinical utility is defined and 
used here as ―the usefulness of an intervention for, or in, clinical practice.‖86 Moreover, 
this section will briefly discuss the financial costs of providing WLS to ameliorate its co-
morbidities in comparison to the financial costs associated with treating the co-
morbidities of obesity over the course of a lifetime. Finally, this section will use 
individual narratives of those who have undergone WLS to demonstrate that WLS has 
personal utility in meeting patients‘ unique, highly personal goals. 
B.i Clinical Utility of Weight Loss Surgery 
 Where appropriate, this subsection will discuss the outcomes of specific 
interventions such as gastric banding or Roux-en Y gastric bypass; however, in general, 
the resolution of co-morbidities has been most effective and durable for those who are 
obese and have undergone Roux-en-Y gastric bypass surgery.
87
 The ability of WLS to 
resolve individuals‘ obesity-related patho-physiology will be discussed and will include 
the following areas: hypertension, diabetes, sleep apnea, cancer, mortality, depression, 
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and other various quality of life indicators. To begin, however, this sub-section reviews 
the clinical utility of WLS for weight loss itself.  
 As previously discussed in Chapter two various forms of WLS have been in use 
for over sixty years.
88
 While some earlier permutations of the surgery are no longer 
utilized and have been supplanted by more successful less invasive options, WLS is 
generally regarded as ―the most effective treatment‖ for those who have extreme 
obesity.
89
 A systematic meta-analysis of short and medium term weight-loss durability 
was conducted by reviewing data from 43 outcome studies on subjects who had 
undergone various types of WLS. ―The most important single observation to be drawn 
from this meta-analysis is that pooled data of all operations demonstrates that bariatric 
surgery can achieve a major reduction in weight which is sustained for at least ten 
years.‖90 The authors conclude that current bariatric operations achieve a major and 
durable weight loss in the medium term.  
 Bariatric surgery results in significant and durable weight loss. Specifically, 
surgical patients have been shown to lose as much as 60 percent of excess weight in the 
first six months following surgery and 77 percent of excess weight at the twelve month 
mark following the intervention.
91
 Overall, the likelihood of major complications is about 
2.5 percent across all types of surgery.
92
 Mortality attributable to the bariatric surgery is 
approximately 0.1 percent.
93
 Furthermore, clinical evidence has shown that the risks of 
morbid obesity outweigh the risks of bariatric interventions for obesity.
94
 Bariatric 
surgery has also been shown to extend the life span of the gastric bypass patient by as 
much as 89 percent. The risks of premature death due to obesity have been shown to be 
reduced by 30-40 percent for those undergoing WLS.
95
 Bariatric surgery is also useful in 
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preventing, improving or resolving more than forty obesity related diseases and 
conditions.
96
 Several of the major and most dangerous co-morbidities, both physical and 
psychosocial, associated with obesity are improved by WLS. The research in each of 
these areas is discussed below. 
B.i.a Hypertension 
  Sugerman et al. evaluated the pre and postoperative relationships between 
hypertension and type 2 diabetes in severely obese patients and the effects of gastric 
bypass induced weight loss. Data regarding patients‘ pre and postoperative diabetes, 
hypertension, and other co-morbidities including sleep apnea and joint disease, were 
collected on 1,025 patients who had surgery by one general surgeon at a University-
affiliated hospital over a nineteen year period of time.
97
 Pre-operatively, 51 percent of the 
sample had hypertension either alone or in combination with diabetes. Postoperatively, 
after one year with a follow up rate of 91 percent, hypertension had resolved in 69 
percent of those who had undergone the procedure. At follow up of between five and 
seven years the resolution of hypertension remained at 66 percent. African American 
patients, who have a higher risk of hypertension in general, were less likely to have 
significant resolution of their hypertension following the WLS. Additionally the study 
showed that for those whose hypertension resolved it was associated with a greater 
excess weight loss relative to their initial weight.
98
 
  The Swedish Obese Subjects Study, a long term longitudinal published in the New 
England Journal of Medicine, evaluated the effects of WLS across many clinical 
indicators at the two and ten year post-surgical intervals. Unique in its design, this study 
matched 2,010 patients who underwent gastric surgery with 2,037 who were 
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conventionally treated to evaluate numerous co-morbidities associated with obesity. 
Initially there was significant improvement in hypertension found in surgically treated 
patients as compared to matched controls. However, the improvements noted at two years 
were no longer present at the eight year interval post-surgery. It was noted that those who 
underwent gastric bypass surgery, as opposed to other surgical techniques, had a 
significantly greater weight loss and also were better able to maintain a decrease in blood 
pressure for a more sustained period of time following surgical weight loss intervention.
99
 
Research on the resolution of diabetes is provided in the next subsection. 
B.i.b Diabetes 
 A meta-analysis conducted of all articles published between January 1, 1990 and 
April 30, 2006, included 621 studies, on the effects of weight loss surgical interventions 
indicated that overall 78.1 percent of diabetic patients showed complete resolution of 
diabetes while diabetes was improved in 86.6 percent of patients.
100
 Diabetes resolution 
was greatest in patients who had undergone biliopancreatic diversion or duodenal switch. 
The second most efficacious intervention for resolving diabetes was gastric bypass 
surgery. Banding interventions followed gastric bypass in resolving diabetes.
101
 The 
meta-analysis concluded that: 
 the clinical and laboratory manifestations of type 2 diabetes are resolved or 
 improved in the greater majority of patients following bariatric surgery; these 
 responses are more pronounced in procedures associated with a greater percentage 
 excess of body weight loss and [diabetes resolution] is maintained for two years 
 or more.
102
 
   
  A 2009 study in the journal Surgery for Obesity and Related Diseases showed 
that early remission of type 2 diabetes occurred in 89 percent of patients following Roux-
en-Y gastric bypass.
103
 The study included 177 patients, and the follow up period ranged 
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from 5-16 years post operatively. Of the 177 patients, 157 had a complete remission of 
type 2 diabetes postoperatively. Twenty patients did not benefit from a remission in their 
type 2 diabetes even though they had experienced significant loss of excess weight. The 
study further showed that the durability of remission from type 2 diabetes diminished 
over time. At more than 5 years post-surgical intervention 43.1 percent of patients 
continued to show a remission in their diabetes. While remission of type 2 diabetes was 
found to be more durable in men it was also found that weight regain was statistically 
significant but a weak predictor of diabetes reoccurrence. The study posits that durable 
remission of type 2 diabetes remission is most closely correlated with an early disease 
stage at gastric bypass,
104
 which suggests that earlier surgical intervention may be 
optimal as the window of opportunity time to resolve this co-morbidity may diminish 
with delayed intervention.
105
 
  Two studies published in March 2012—one conducted at Catholic University in 
Rome, the other at the Cleveland Clinic—further establish a positive relationship between 
surgical weight loss interventions and the resolution of diabetes.
106
 The Catholic 
University study compared two types of surgery with usual medical treatment. After two 
years, the surgical groups had complete remission rates of 75 percent and 95 percent; 
there were no remissions in patients who received medical treatment.
107
 The second 
Cleveland Clinic study compared two types of surgery with an intensive medical 
regimen. The remission rates one year after surgery were lower than in the Italian 
study—42 percent and 37 percent—at least in part because the American study used a 
stricter definition of remission. The intensive medical treatment led to remission in 12 
percent of patients. The study suggests that the mechanism for resolution of type 2 
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diabetes may have to do with changes in the gut which are not fully understood at the 
present time.
108
 Limitations of the studies include that each was done at a single 
institution and only report results over two years; however, the results may warrant 
earlier surgical treatment for weight loss in those with type 2 diabetes.
109
 
 In order to maximize the window of opportunity for resolving type 2 diabetes it 
may be necessary that obese patients embark as early as possible on a continuum of 
clinical care that takes them, from the offices of primary care physicians to specialists in 
WLS. To accomplish this.the stigma currently associated with obesity and obesity 
interventions would need to be addressed, since we have seen that bias and stigma can 
prevent physicians from engaging in conversation about surgical interventions for 
obesity. Empirical research indicating the restorative effects of surgical weight loss 
interventions, with resultant remission of co-morbidities, should motivate efforts to 
address physicians‘ personal negative feelings about those who are obese. Improvements 
in sleep apnea are revealed in the following subsection. 
B.i.c Sleep apnea  
 A study of the effectiveness of bariatric surgery as a treatment for obstructive 
sleep apnea (OSA) in patients with clinically significant obesity demonstrated that OSA 
is prevalent pre-operatively in 60 percent of patients who were to undergo bariatric 
surgery.
110
 In this study 100 patients were evaluated for symptoms of OSA by 
polysomnography before gastric bypass surgery. Pre-operativee and postoperative scores 
of Epworth Sleepiness Scale (ESS), Respiratory Disturbance Index (RDI), and other 
parameters of sleep quality were compared to determine if bariatric surgery altered OSA 
as weight loss progressed. Pre-operative evaluation revealed that 13 patients had no OSA, 
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29 had mild OSA, while the remaining 58 patients were being treated pre-operativeely for 
moderate-severe OSA.
111
 Following bariatric surgery, at a median of 6 months follow-up, 
BMI and ESS scores improved to date, 11 patients had completed postoperative 
polysomnography (3-21 months) after losing weight. There was significant improvement 
in ESS, minimum O2 saturation, and sleep efficiency when comparing pre-operative and 
postoperative scores. The study concludes that gastric bypass is an effective treatment for 
OSA in patients with clinically significant obesity.
112
 
 Another study evaluating the impact of surgically induced weight loss on 
Obstructive Sleep Apnea/Hypopnea Syndrome (OSAHS) examined electrocardiographic 
changes, pulmonary arterial pressure, and daytime sleepiness in morbidly obese patients 
in 16 women and 13 men who underwent bariatric surgery within a 3-year period.
113
 
Weight loss induced by surgery eliminated OSAHS in 46 percent of obese patients with 
an important improvement in oxygen saturation. Neck, thorax, waist and hip 
circumferences decreased significantly after surgical intervention but only neck 
circumference correlated significantly with the apnea/hypopnea index. 
Electrocardiographic abnormalities were present in 9 patients (31 percent) pre-
operatively (sinus arrhythmia, ventricular arrhythmias, and sinus arrest). The number of 
electrocardiographic abnormalities decreased after surgery but new abnormalities 
appeared in some patients. Systolic pulmonary arterial pressure significantly decreased in 
the group of patients in whom OSAHS disappeared after surgery. The study concluded 
that bariatric surgery effectively reduces respiratory disturbances during sleep and 
improves pulmonary hypertension. Electro cardiographic abnormalities change after 
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surgery and that some daytime sleepiness appeared not to be related to respiratory 
disturbances during sleep.
114
 
 Obstructive sleep apnea and hypopnea syndrome are associated with high 
mortality and serious morbidity, and it appears that weight loss induced through surgical 
intervention will correct both, thus improving both the physical co-morbidity and 
providing a useful resolution to diminished quality of life associated with daytime 
sleepiness.
115
 From the perspective of the individual with sleep apnea or hypopnea 
syndrome associated with excess weight, there appears to be evidence that surgical 
weight loss intervention is individually useful in providing relief from this life limiting 
co-morbidity. Post-surgical reductions in cancers are discussed below. 
B.i.d Cancer/Malignancy 
 One study reviewed the incidence of cancer and mortality data through 2007 
from the Utah Cancer Registry (UCR) which compared 6,596 Utah patients who had 
undergone gastric bypass between the years 1984–2002 with 9,442 severely obese 
persons who had applied for Utah Driver‘s Licenses during the same time.116 Controls 
were group matched to represent the gender, age, and BMI distribution of the surgical 
patients. The study outcomes included data on the incidence, case-fatality, and mortality 
for cancer by site and stage at diagnosis of all gastric bypass patients, compared to 
severely obese controls that had not undergone surgical weight loss interventions. 
Follow-up was conducted over a 24-year period with the mean follow up time being 
approximately 12.5 years.
117
  
 Study findings included that the total cancer incidence was significantly lower in 
the surgical group as compared to matched controls. A lower incidence of cancer in the 
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WLS patients versus the control group was primarily attributed to decreased incidence of 
cancer diagnosed at regional or distant stages. The terms regional or distant refer how far 
the cancer had spread from its site of origin—regional refers to affected areas closer in 
proximity, such as immediately adjacent lymph nodes, while distant refers to cancer 
which has spread farther from the original site. Cancer mortality was found to be 46 
percent lower in the surgery group compared to matched controls. Although the apparent 
protective effect of surgery on risk of developing cancer was limited to cancers likely 
known to be obesity related, the inverse association for mortality was seen for all cancers. 
Significant reduction in total cancer mortality in gastric bypass patients compared with 
severely obese controls was associated with decreased incidence, primarily among 
subjects with advanced cancers. The study findings suggest that gastric bypass provides 
useful reduction in an individual‘s cancer risk, presumably related to weight loss. The 
study reported a significant 60 percent reduction in cancer mortality when comparing 
post-gastric bypass patients to severely obese controls. Additional follow-up at five years 
found that a 46 percent reduction in cancer mortality persisted.
118
  
 These findings suggest that gastric bypass surgery may result in lower cancer 
incidence and mortality. The study authors emphasize that bariatric surgery is not an 
accepted therapy for cancer, and in fact, history of an internal malignancy within a 5-year 
period is often considered a contraindication for obesity surgery. The cancer-related 
benefits of gastric bypass surgery were shown to be strongest in the women studied. The 
study noted that since severe obesity is more prevalent in women than men and 80 
percent of patients who undergo gastric bypass surgery are women, the results of our 
study have important medical and population implications. Although the benefit of 
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reduced incidence was limited to cancers likely related to obesity, reduction of cancer 
mortality was seen for both obesity-related and non-obesity-related cancers. The research 
findings support recommendations for reducing weight to lower cancer risk and suggest 
that since surgical weight loss interventions have been shown to provide the most 
sustainable weight loss for individuals, surgically induced weight loss may provide a 
valuable tool for individuals seeking to reduce the likelihood of developing obesity 
related cancers and malignancies.
119
 
 The previously discussed Swedish Obese Subjects Study also provides 
longitudinal data on the incidence of cancer in those who have undergone WLS and 
matched controls. Information regarding the incidence of cancer was gleaned from the 
available data set. The number of first-time cancers after subjects were included in the 
study was found to be lower in the surgery group (n=117) than in the control group 
(n=169). In female subjects, the number of first-time cancers was lower in the surgery 
group (n=79) than in the control group (n=130), however the study showed no similar 
effect in male subjects with 38 male subjects in the WLS group who developed first time 
cancer compared 39 in the male control group. Study authors posit that bariatric surgery 
is associated with reduced cancer incidence in obese women, however, they note that the 
same positive results were not indicated for the men included in the study.
120
 
Improvements inoverall mortality rates are shown below. 
B.i.e Mortality  
A study designed to test the hypothesis that bariatric surgery can reduce long-term 
mortality and the morbidly of obese patients used an observational 2-cohort method 
consisting of a treatment cohort (n=1,035) which included patients who had undergone 
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bariatric surgery at the McGill University Health Centre between 1986 and 2002 and a 
control group (n =5,746) matched for age and gender. Subjects were identified from the 
Quebec provincial health insurance database. Those with medical conditions (other than 
morbid obesity) at cohort-inception were excluded. The cohorts were followed for 5 
years.
 121
 The study found that bariatric surgery resulted in significant reduction 
(approximately 67.1 percent) in mean percent excess weight loss. The study further 
showed that bariatric surgery patients had reductions in risk for developing 
cardiovascular, cancer, endocrine, infectious, psychiatric, and mental disorders compared 
with matched controls. The only exceptions were hematologic and digestive diseases. 
There was no difference found in hematologic disease mortality and morbidity, and there 
were increased rates of digestive diseases found among the bariatric surgery cohort. 
Overall, the mortality rate in the bariatric surgery cohort was 0.68 percent compared with 
6.17 percent in controls, which translates to a reduction in the relative risk of death by 89 
percent. This study shows that weight-loss surgery is useful in significantly decreasing 
the overall mortality of those who undergo surgical weight loss interventions. Moreover, 
surgically induced weight loss reduces the development of new health related conditions 
in morbidly obese patients.
122
 
 A New England Journal of Medicine article analyzed the extensive data set from 
the Swedish Obese Subjects Study to report on the overall mortality found during 10.9 
year follow up. At the time of data analysis regarding overall mortality, the follow up rate 
was reportedly 99.9 percent with all but three of the subject‘s vital statistics being known 
to the investigators.
123
 With regard to overall mortality there were 129 deaths among 
those in the control group (n=2,037) and 101 deaths among those in the surgery group 
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(n=2,010) during the study time frame. The most common cause of death was found to be 
heart attack with 25 subjects in the control group and 13 subjects in the surgery group 
succumbing to the heart attack. The second most commonly noted reason for mortality 
was cancer with 47 control group and 29 surgery group members dying of cancer during 
the study follow up.
124
 Overall the study concluded ―that bariatric surgery in obese 
subjects was associated with a reduction in overall mortality, as compared with 
conventional treatment in contemporaneously matched, obese controls.
125
 In the section 
below information is provided on the resolution of other co-morbidities related to obesity. 
B.i.f Other co-morbidities 
 It is not possible to review all of the available data regarding the usefulness of 
surgical interventions for obese individuals in resolving physical co-morbidities 
associated with excess weight. It is necessary to limit this review to the key studies of the 
many commonly experienced co-morbidities. These provide the critical empirical data 
which should inform physician judgment and counsel of their obese patients. There are 
several other areas of physical co-morbidity which, while not covered here in detail, have 
also shown to improve physical symptoms found among obese individuals. Research has 
shown that surgically induced weight loss also improves lower back pain and decreases 
the pain associated with degenerative joint diseases (which decrease mobility), improves 
female hormone dysfunction which can cause infertility, reduces idiopathic inter-cranial 
hypertension (pseudo tumorcerebri), hernia risk, and nonalcoholic liver disease.
126
 These 
findings may have more salience for some obese individuals than others based on their 
individual goals and activities.  
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 This discussion of the clinical utility of WLS in addressing various co-morbidities 
will now turn to depression and suicide. Depression has been strongly associated with 
obesity in the literature and is common, debilitating, and complex. Like obesity, 
depression has a biological basis but patients‘ experience of the condition is exacerbated 
by the stigma that attaches to it as a mental illness. For those who have both obesity and 
depression, the intersectionality of the associated stigma can be particularly 
debilitating.
127
 
B.i.g Depression 
 Research conducted as a part of a doctoral dissertation in counselor education 
and supervision at Duquesne University evaluated the pre and post-surgical experience of 
depression, anxiety, and general quality of life measurements at two, four, and six months 
post-surgery in patients who had undergone bariatric surgical interventions at West Penn 
Hospital in Pittsburgh,PA.
128
 Subjects had undergone bariatric surgery between 1999 and 
2005. During that time 720 individuals, 540 men and 146 women received gastric bypass 
surgery for weight loss. The disproportionately male study participants were thus atypical 
with regard to gender. Archival data was retrieved from pre-procedure baseline and post 
procedure administration of the Beck Depression Inventory, Beck Anxiety Inventory and 
the RAND SF-36 Health Survey. The study showed a significant and linear improvement 
in the experience of depression found among pre-surgical candidates to post-surgical 
candidates. The improvements showed steady decreases in the experience of depression 
immediately following gastric bypass surgery and at the three postoperative 
evaluations.
129
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 In a 2011 study designed to examine whether there are improvements in 
depressive symptoms following bariatric surgery and in what specific depression domains 
improvements may manifest, Hayden et al. used the Beck Depression Inventory (BDI). 
The study included obese patients who had undergone laparoscopic adjustable gastric 
banding (LAGB) surgery and had completed the BDI at baseline and 1 year following 
surgery. There were two groups of patients included in the study, a general background 
group and a group identified as experiencing elevated depressive symptoms based on the 
BDI.
130
 Study results showed that BDI scores fell for both groups, indicating a reduction 
in the experience of depression post-surgery. With regard to specific changes in the 
experience of depression in particular depression domains, patient scores on the negative 
self-attitude subscale were significantly greater prior to surgery than the two other 
subscales and showed the greatest improvement 1 year following LAGB. The study 
further showed that pre-existing antidepressant therapy had little or no association on the 
BDI scores or on its change following weight loss. This study showed that while high 
rates of depression are generally reported in relation to obesity there is a significant 
decrease in depressive symptoms experienced following weight loss due to surgical 
intervention.
131
 Rather than pointing to an overlap in physical symptoms between obesity 
and depression, this study seems to show that the negative attitudes towards self is the 
reason that BDI scores are elevated pre-intervention. These results may indicate that the 
social construction of the stigmatizing condition of obesity may lead to a negative self-
attitude and depression prior to WLS and that improvement in social acceptability as part 
of weight loss subsequently leads to improvements in perceived social acceptability and 
hence decreases in the experience of depression. However not all of the data show that 
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depression is adequately resolved in all patients following bariatric surgical interventions. 
While this may be true for many there is a mounting body of research which indicates 
that for a concerning number of patients there is an increased risk of both suicide 
attempts and completions following surgical weight loss interventions. Suicide attempts 
and completions are generally regarded as the outcome of untreated depression and are 
discussed below.  
B.i.h Suicide 
  This subsection reveals data on post-surgical suicides. Tindle et al. examined 
post-bariatric surgery suicides, including as variables elapsed time since the operation, 
sex, age, and suicide death rates, and compared this data with US suicide rates. They 
studied medical data, obtained from the Pennsylvania Health Care Cost and Containment 
Council, on Pennsylvania residents who had received bariatric surgery between January 
1, 1995 and December 31, 2004. The study matched mortality data from suicides between 
September 1, 1996 and December 28, 2006 with the medical records of those who had 
undergone WLS between January 1, 1995 and December 31, 2004. Statistics were 
obtained from the Division of Vital Records, Pennsylvania State Department of Health. 
The data showed that there were 31 suicides in 16,683 operations. In this group the 
overall rate was 6.6 per 10,000 people. Among men the rate was 13.7 per 10,000 people 
and for women the rate was 5.2 per 10,000.
132
 About 30 percent of suicides happened 
within the first 2 years after surgical intervention for weight loss, with almost 70 percent 
occurring within the first 3 years. For every age category except the youngest, suicide 
rates were also found to be higher among men than women. Age- and sex-matched 
suicide rates in the general US population (ages 35-64 years) who had not undergone 
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weight loss surgical intervention were reported as 2.4 per10,000 (men) and 0.7 per10,000 
(women).Compared with age and sex-matched suicide rates in the US, there was a 
substantial increase in the number of suicides among all patients who had bariatric 
surgery in Pennsylvania during a 10-year period. It was concluded by the investigators 
that these data show a need to develop a more comprehensive surveillance and follow-up 
methods of patients undergoing surgical weight loss interventions in order to evaluate 
factors which may lead to post-bariatric surgery suicide.
133
 
 The usefulness of weight loss surgical interventions to individuals across many 
commonly identified and experienced categories of co-morbidity has been validated in 
numerous studies covering many domains. Due to the sheer number of variations in 
surgical weight loss interventions it is somewhat difficult to make specific comparisons 
with regard to the impact of particular surgical weight loss interventions as related to 
specific outcomes as much of the research combines patients who have undergone any 
one of a number of accepted surgical weight loss interventions. The following subsection 
addresses the financial cost associated with WLS. 
B.i.i Financial costs 
 This section will now briefly turn to the financial costs of providing WLS to 
ameliorate its co-morbidities in comparison to the financial costs associated with treating 
the co-morbidities of obesity over the course of a lifetime. Powers et al. examined both 
the financial impact of obesity on society and the financial consequence of treating 
patients who are obese with WLS across several published studies. They reviewed 
various studies and quantified the economic savings and benefits to quality-of-life and 
length-of-life associated with decreased mortality and health costs across these studies.
134
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While the specific studies examined found differing levels of cost savings, and savings 
were unequally distributed among third-party payers, the patient, and the employers this 
study concluded: 
In summary, for morbidly obese people who have costly comorbid conditions, 
operative therapy offers a large potential benefit in quality of adjusted life-years 
and savings to the total medical expenses incurred by patients and their 
employers.
135
 
 
A study conducted by the Veterans Administration Health System explored the economic 
burden of caring for veterans with clinical obesity and co-morbidities.
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 It 
retrospectively examined the records of 25 male patients who had undergone WLS 
between 1999 and 2001, and reviewed all obesity-related health care costs including 
hospitalizations, outpatient doctor visits, medication usage, and the cost of home health 
devices both one year prior to WLS and one year post-surgery. All patients had 
undergone Roux-en-Y gastric bypass surgery (RYGBP). The study concluded that 
operative treatment of clinically severe obesity reduced obesity-related costs and the 
utilization of healthcare resources at the time of follow-up, which was approximately 
eighteen months following surgery. The study further found that ―the cost of undertaking 
RYGBP at the VA is offset by reduction of health care costs within the first year of 
surgery.‖137 Furthermore, based solely on cost saving from decreased utilization of health 
care relative to the cost of surgery, it concluded that the data support ―allocation of 
resources to support existing bariatric surgery programs throughout the VA system.‖138 
 An employer-based study of WLS costs evaluated the private third party payer 
return on investment for bariatric surgery.
 139
 The study identified morbidly obese 
patients age 18 years or older through an employer claims database of more than 5 
million employees between the years 1999-2005. Each patient (N=3,651) who had 
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undergone WLS during this time was matched with a control subject who was also 
morbidly obese but had not undergone WLS. The patient and control matching included 
demographic, co-morbidity, and the types of health care expenditures which were 
incurred. The two groups were compared for total healthcare costs in the six months prior 
to surgery through the end of their enrollment in the employer sponsored health plan. The 
average bariatric surgery cost was between $17,000-$26,000 dollars. In comparing the 
two groups, the study authors state ―we estimated all costs to have been recouped within 
2 years for laparoscopic surgery patients and within 4 years for open surgery patients.‖140 
The study did not specifically evaluate quality-of-life or length-of-life benefits 
attributable to the surgery. In what the study termed ―take-away points‖ the authors note, 
that ―even ignoring potential quality of life and length of life benefits, as well as 
disability and work loss, third-party payers can rely on bariatric surgery paying for itself 
through decreased co-morbidities within 2-4 years.‖141 
 While an exhaustive review of the financial costs associated both with obesity and 
its treatments are not possible here the above data do offer some insight that overall, the 
costs associated providing WLS are lower than the costs of treating the co-morbid 
diseases associated. This cost savings was reported across several different studies. The 
above economic data appear to support WLS as a potentially cost effective intervention 
for obesity. WLS does not appear to further burden the health care system by being 
disproportionately expensive in relation to the cost of treating the co-morbidities of those 
who do not receive WLS. On the contrary, there appears to be a cost savings as well as an 
improvement in quality-of-life and length-of-life for these patients along with a reduction 
in the overall financial burden of obesity for third party payers.  
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B.ii Personal Utility of Weight Loss Surgery 
 Empirical research detailed above as well as a plethora of other studies not 
specifically discussed in this dissertation, establish the clinical utility of WLS as an 
individual-level intervention for sustained weight loss and reduction of obesity-associated 
co-morbidity. That is, however, only one part of the evidence to be evaluated. Even with 
widespread general agreement that WLS decreases physical and psychological co-
morbidities consistent with several of the generally accepted and identified goals of 
medicine, these endpoints do not provide a complete picture. The usefulness of WLS may 
also be evaluated in terms of its personal utility for those who choose this weight loss 
option. Conceptions of the personal utility of WLS can be as unique and intricate as the 
reasons for the development and maintenance of an individual‘s obesity in the first place. 
Evidence of the personal utility of WLS is found throughout the narratives included in 
this section. 
As established in chapter three, there are few venues for those who have 
undergone WLS to share their experience without concern about rejection and 
stigmatization. One safe forum in which to share such narratives is a blog on WLS. The 
following narrative expounds the usefulness of WLS for a particular patient, named 
Rauncie who underwent Roux-en-Y gastric bypass surgery in 2010. Her story, recounted 
in her words, reveals an often overlooked dimension of the usefulness of WLS. She 
begins her story by informing readers that her development of obesity was complex and 
partly the result of attempting to protect herself from additional victimization, having had 
the unfortunate experience of being raped. She writes: 
I had some struggles as a young woman and was a victim of rape and had severe 
abandonment issues. Food had been my best friend. I lived my life in a daze only 
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feeling from the neck up. I allowed people to abuse me and I felt life happened to 
me rather than feeling I had any control over anything. I lost weight only to gain 
weight back over and over and finally eating myself up to 287 pounds. At 5'4" 
with a small frame that is a lot of weight to carry.
142
 
 
She goes on to describe the way in which she internalized the various victimizations 
which she had experienced so that she began to accept societal stigmatization as being 
deserved.  
I was numb emotionally but I hated myself. I went from bad relationship to bad 
relationship partly because I felt that was all I deserved. I talked to myself in the 
mirror in a way that would have gotten me slapped by someone else. I was cruel 
to myself and destructive in many ways.  
 
However, she also recounts that she began to see herself in a different light, in essence to 
acknowledge that a different story, one with an alternative ending, was indeed possible. 
She continues: 
As I grew older I began to have an inner shift. I realized that I needed to love 
myself right where I was. I was never going to be able to take care of me if I did 
not. I began to do deep work and my words in the mirror began to change. I began 
to say "I care about you". At first there were many tears but years of hatred and 
self-loathing began to fall away and I decided I was no longer going to live with 
the label of victim.
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But the realization of this alternate life story that this would require assistance. 
 
I began to do research on weight loss surgery. It was something I had considered 
before but always thought it was the easy way out. I went to an information 
session for the first time about 3 years ago. I walked away thinking it was not for 
me that I would just do it on my own. I continued to work on my inner self and 
then the year of my 49th birthday I decided that year 50 would be my year. One 
night after spending time with a very dear friend she pulled me aside in tears and 
told me that she was afraid she was going to lose me. She shared how heartbroken 
she was to see me using a cane. In the past I would have been upset and offended 
that someone would have said something about my weight. This time I was not 
offended I knew that what she was saying was true. In addition I had a friend who 
offered to pay for me to attend Weight Watchers meetings at work with her. 
I thought to myself ...I have people who really love me, they loved me enough to 
speak up in love. It gave me that extra push to move forward and I went back to 
an information session and made up my mind after weighing the options that I 
was going to have RNY bypass surgery. I had diabetes, high blood pressure and 
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sleep apnea. I was walking with a cane. I was tired all the time and had no 
energy.
144
 
 
Like many patients who eventually undergo WLS Rauncie had to overcome the societal 
stigma which she had internalized which told her she was unworthy because of 
intersection of various marginalizations as a rape victim, a woman, and an obese person. 
Furthermore she related additional feelings of failure based on the fact that she could not 
overcome obesity without WLS, despite several attempts. These deeply entrenched 
socially-constructed messages had to be de-constructed before she was able to access 
efficacious treatment. Regarding the pre-surgical process Rauncie recalls: 
The process began for me in July of 2010 with an initial appointment. I then had 
to go for a psychological evaluation and nutritional appointments. I was finally 
approved for surgery and given the date of Dec 3, 2010. I remember that the week 
before surgery I was so scared that I had thoughts of backing out. I was afraid I 
would die on the table. In reality...I did have a rebirth. I left behind the victim in 
that operating room. For me this was a rite of passage from one part of my life to 
another. This tool has changed my life.
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Her narrative recounts numerous post-surgical improvements in physical health and 
quality of life. 
Today it is 13 months since I had my surgery. I weighed in this morning at 142 
pounds. I have lost half my weight since my surgery. But more than that I am 
healthy. I am no longer on medication for diabetes or High Blood Pressure and I 
gave my cane away. I have so much energy that I have done more in the past year 
than I have done in probably 10 years. I am teaching classes, going to the gym, 
dancing, singing...and living my life with open arms and open eyes. My inner 
work has excelled and I have found that the true key to all this is that it is a tool. I 
must work at it every single day. I never thought in a million years that structure 
and accountability would be the thing that freed me to live a happy life. I always 
thought the opposite...
146
 
 
For Rauncie, WLS assisted her in re-gaining her health and re-established many quality 
of life factors which had been so diminished by obesity. For her it was a procedure which 
offered and made good on opportunities to reclaim both health and the vitality of living.  
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She continues: 
…My life has changed in such positive ways that I would do this over again in a 
heartbeat but I would not have waited so long. My advice to anyone considering 
the surgery is this: If you want to be successful see this for what it is a tool for 
lifestyle change. If you have the surgery and then try to figure out what you can 
get away with doing afterwards you are going to end up right back where you 
started from. Everyone loses in the beginning; it is the way the surgery works. But 
if you are eating the same or cheating early in the game eventually the weight will 
come back. I spend each day of my life awake, alive, vigilant and responsible for 
my actions. I do not pray, hope or wish that the scale would stay where it is or go 
lower...I work at it. We are responsible for the final outcome of the surgery. We 
are given a valuable tool that can change our lives if we use it correctly. If you 
think this is the easy way then follow my journey for just a day and you will see 
that I and others like me must work at it every single day. I write all my food 
down, I do research, I take responsibility for what I put in my mouth every single 
time I open it...
147
 
 
She appears to be realistic that WLS is a tool which offers significant help for a condition 
she could not overcome on her own but for which she will ultimately be responsible for 
maintaining in the future.  
 Rauncie speaks openly about the trade-offs of having surgery and some of the 
side-effects which are possible. She remarks that on balance, in looking at the risks, 
benefits, and side-effects relative to what she has gained she believes she made a good 
decision. The very individualized criteria of personal utility were satisfied for Rauncie by 
WLS. She writes: 
... People ask me about loose skin, missing foods, any regrets... I do have loose 
skin but I do not care about that. I would rather have loose skin than diabetes, 
High blood pressure and a cane as my constant companion. I do not miss the food 
that made me sluggish and fat. I have no regrets. 
 
At 145 pounds I fit in a size 8 jeans, I can wear heals [sic], I can play on the floor 
with my grandchildren and I have a lap they can sit on. My name is Rauncie. My 
50th birthday present to myself was a new life. I wanted to grow old watching my 
grandchildren grow up and living a life of purpose. I will live the rest of my life 
grateful for this second chance to live my life fully engaged and loving myself. 
Starting weight 287 Current weight 142 Surgery: RNY gastric bypass Dec 3, 
2010‖148 
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Rauncie‘s narrative shows that WLS was able to provide both clinical utility and 
personal utility. Clinical utility was realized because the surgery used as a tool provided 
sufficient weight loss to ameliorate her physical and quality of life co-morbidities. As 
shown above the research indicates that her weight loss and thus likely the resolution of 
her co-morbidities will remain durable for at least ten years. Moreover, WLS was useful 
in assisting Rauncie to meet her own highly personal goals for weight loss which 
included over-coming several forms of victimization and marginalizations which so 
burdened her and which resulted in the manifestation of her obesity in the first place. For 
Rauncie WLS was a tool for helping her to claim an alternative narrative other than that 
of the victim of damaging life experiences. Rauncie needed assistance to claim an 
alternative story. She needed the assistance of those in medicine.  
 The following narrative further illustrates the personal utility of WLS for another 
patient: 
 At the age of twenty-one, I had Roux-en-Y gastric bypass (weight loss surgery). 
Even though I was young, I had already reached 285 pounds, and I was saddled 
with the co-morbidities of obesity. My adolescent body was bearing what should 
have been the diseases of a much older adult. I was on medications for high 
cholesterol, asthma, and depression and had been diagnosed with fatty liver 
disease, high blood pressure, and pre-diabetes. I was a very sick young woman, 
and I was in dire need of treatment. For me, the answer was weight loss surgery. 
Because I was a college student, bariatric surgery was only a viable option for me 
because I was still on my parent‘s excellent health insurance.149 
 
The author speaks not only about losing excess weight and its associated physical co-
morbidities, but also about having been able to abandon other signs of her obesity. It 
appears that these ―badges‖ as she refers to them include the stigma associated with being 
obese: 
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Now, two years out from surgery, my story is very different. I no longer openly 
carry the badges of obesity, and my comorbidities have been alleviated. I am a 
healthy weight individual.
150
 
 
This narrative reveals that for this young woman WSL proved to be personally useful as 
she recalls the difference between her impaired life prior to WLS and her co-morbidity 
free life following the intervention. Some of the personal meaning of no longer being 
obese may lie within her comment about no longer openly carrying the badges of obesity; 
its social and thus personal meanings no longer apply to her.  
 The following section discusses the importance of the physician-patient 
relationship. Specifically this section will address the way that this important relationship 
can serve to assist or impede those who are obese from gaining access to WLS. The 
physician-patient relationship, with its potential for inherent power dynamic, may be 
further affected by the stigmatization of obesity and a differential application of common 
bioethical principles which govern clinical medicine.  
B. iii Clinical Medicine and the Doctor-Patient Relationship 
  In contrast to public health, the goals of clinical medical intervention are to 
restore individual patient health, to prevent or ameliorate morbidity when possible, or 
failing in those aims, to provide effective palliation.
151
 To achieve these goals, clinical 
medicine is also highly dependent on a mutually trusting physician-patient relationship. 
Some have argued that the overall effectiveness of clinical medicine is mediated by the 
quality of the physician-patient relationship, of which trust and trustworthiness are 
integral components.
152
 In the ideal case, within the context of this trusting fiduciary 
relationship various treatment options can safely be explored, agreed upon, and 
undertaken. Although, as Dorothy Roberts describes, this ideal doctor-patient relationship 
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does not occur for various disempowered members of society.
153
 Roberts writes about the 
experience of women of color as patients within the institution of medicine. Using 
intersectionality as her approach, she expounds on the political dimension of the doctor-
patient relationship. Roberts writes, ―Black women experience various forms of 
oppressions simultaneously, as a complex interaction of race, gender, and class that is 
more than the sum of its parts.‖154 As has been argued elsewhere in this dissertation, 
obesity must be included as a form of marginalization along with those identified by 
Roberts. Whether male or female, black or white, those who are obese have diminished 
power and authority relative to the dominant group in much the same way as the women 
of color about whom Roberts writes. With regard to the experience of women of color 
who seek medical treatment Roberts says that various marginalizations intersect to alter 
their experience physician-patient relationship moving it further away from the ideal: 
 Race, class, and gender structure doctors‘ knowledge of their patients and their 
interpretation of the ethical principles they apply to their interactions with 
patients. My point is not only that physicians bring to their encounters with 
patients the same prejudices as exist in the rest of society. The relationship 
between doctor and patient is determined by political arrangements and not solely 
by the individual characteristics of the two actors.
155
  
 
The outcome of the oppressions, whose sum is indeed greater than its parts, of which 
Roberts writes, is that the ethical principles generally utilized in the physician-patient 
relationship and intended to be foundational in the practice of medicine are applied 
differently. ―The experience of women of color confirms that these principles are 
themselves determined according to power. In other words, the very meaning of truth, 
consent, and confidentiality depends on social arrangements.‖156 Assuming the accuracy 
of Robert‘s analysis, the physician-patient relationship may be more susceptible to the 
usual power differentials in the presence of intersecting marginalizations. 
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 Informed decision-making, and specifically informed consent, is predicated on the 
existence of an effective provider-patient relationship.
157
 Failure to provide material 
information regarding obesity and its treatment options may substantially undermine trust 
within the physician-patient relationship, and certainly undercuts patient autonomy and 
the possibility of informed decision making. Failures of trust and failure to provide 
material information thus undermines the efforts of clinical medicine to treat patients‘ 
obesity. Lack of trust, inadequate information and communication, or all of these can also 
limit the clinical and individual usefulness of WLS. These topics will be taken up in 
greater detail in subsequent chapters.The final section of this chapter will provide a 
superior framework from which to view the utility of WLS in light of discussions above 
regarding its social, clinical, and personal utility. 
C. Re-Framing Obesity and the Utility of Weight Loss Surgery 
  Although WLS does not adequately solve the public health problem of obesity 
and as an individual-level intervention should not be held to that standard, WLS does 
effectively promote the traditionally espoused goals of clinical medicine. These goals 
include the promotion of individual patient‘s health and/or prevention of disease, 
maintaining or improving patient quality of life, cure of disease, prevention of premature 
death, improving or maintaining patient functional status, educating patients regarding 
their conditions and likely prognosis, prevention of harm to the patient in the course of 
care, and when all else fails, assisting the patient in a peaceful death.
158
 Providing 
information about the full range of treatment options—and, as this dissertation argues, 
treating obesity like other medical conditions—promotes justice, informed decision-
making, and trust within the patient-doctor relationship.  
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  To criticize surgical interventions for weight loss based on their limited social 
utility in addressing the public health issue of obesity is to confuse the aims of these 
different health-related enterprises. From the perspectives of the individual medical 
practitioner and her patient the question of the utility of employing WLS to treat obesity 
should be understood as an issue of clinical medicine and not of public health practice. In 
this way the ethical confusion over the limited social utility of WLS as an appropriate 
clinical medicine intervention should be dissolved. Therefore, it is possible to reframe a 
fundamental criticism of WLS as one of mistaking clinical medicine goals for public 
health goals. Viewed within the framework of clinical medicine, WLS may be seen to 
have great clinical and personal utility. The following section reveals that WLS reduces 
the transmission of obesity in families and across generations. 
C.i Diminished Intergenerational and Familial Transmission of Obesity 
  It is important to note that research has shown that the effects of WLS may indeed 
have a broader utility than had previously been attributed to it. In short, WLS can have 
benefit beyond the individual surgical candidate.
159
 The broader usefulness of the surgery 
includes evidence that it may serve to curtail the generational transmission of obesity 
which is often found in families. Research has shown that mothers who have undergone 
WLS, and subsequently lost a significant amount of weight, prevented the transmission of 
obesity to their children, who were followed up to eighteen years post maternal surgery. 
Kral et al. compared the prevalence of obesity in 172 children between the ages of 2 to 18 
years and born to 113 obese mothers who had realized substantial weight loss after bilio-
pancreatic bypass surgery with 45 same-age siblings who were born before maternal 
surgery. Both groups were compared with current population standards for weight. The 
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researchers used data from patient records, as well as follow up telephone calls to collect 
data on childhood and adolescent weights.
160
 Data analysis revealed that following 
maternal surgery, the prevalence of obesity in the offspring showed a 52 percent decrease 
and severe obesity a 45.1 percent decrease, with no increase in the prevalence of being 
under-weight. Additionally, data showed that for both male and female children who 
were aged 6 to 18 years of age and born after maternal surgery, the prevalence of 
overweight was reduced to population levels. Researchers concluded that the prevalence 
of overweight and obesity in children of mothers with large voluntary post-surgical 
weight loss was similar to that in the general population, with no increase in underweight. 
The researchers suggest that study results demonstrate the importance of potentially 
modifiable epigenetic factors in the cause of obesity.
161
 The following section discusses 
some of the broader effects of WLS. 
C.ii Broader Positive Effects 
 Much has been written on the social contagion aspects of weight gain.
162
 The 
question of whether the opposite might be true, that for those who lose weight there may 
be some associated benefit for family members, was the focus of study conducted by 
Woodard et al.
163
 The study, among the first of its kind, sought to answer whether the 
experience of WLS and the weight loss effected by it for one member of the family might 
have a broader usefulness for other adult family members living with the patient. The 
researchers sought to better understand whether healthy behavior transmission may be 
enhanced by one member of the family undergoing a Roux-en-Y gastric bypass surgery. 
Prospective, longitudinal, and multidimensional health assessments were administered to 
the patient and family members before and 1 year after index Roux-en-Y gastric bypass 
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surgery. The study, conducted at an academic bariatric center for excellence between 
January 1, 2007 and December 31, 2009, included eighty-five participants (35 patients, 
35 adult family members, and 15 children <18 years old). The patient subjects underwent 
Roux-en-Y gastric bypass surgery and associated dietary and lifestyle counseling. The 
primary outcomes included weight and expected body mass index. Secondary outcomes 
included waist circumference, quality of life (36-Item Short Form or Pediatric Quality of 
Life Inventory), healthy behaviors, eating behaviors, and activity levels. Family 
participants were grouped by relationship to the patient for data analysis.
164
 The data 
indicated that before the operation, 60 percent of adult family members and 73 percent of 
children of patients undergoing Roux-en-Y gastric bypass surgery were themselves 
obese. At 12 months after the operation, significant weight loss was observed in obese 
adult family members (from 234 to 226 pounds; P = .01). The data revealed a trend for 
obese children to have a lower body mass index than expected for their growth curve 
(31.2 expected versus 29.6 observed; P = .07). Additionally, it was found that family 
members had increased their daily activity levels (adults, from 8 to 17 metabolic 
equivalent task-hours, P = .005; and children, from 13 to 22, P = .04). Adult family 
members also had improved eating habits with less uncontrollable eating (from 35 to 28; 
P = .01), emotional eating (from 36 to 28; P = .04), and alcohol consumption (from 11 
drinks per month to 1 drink per month; P = .009).
165
 The researchers concluded that 
gastric bypass surgery may ―render an additional benefit of weight loss and improved 
healthy behavior for bariatric patients' family members.‖166 While this study sample was 
small and the data gathered were from only one bariatric center for excellence, 
nonetheless broader effects of WLS were observed in the sample, which indicates that 
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WLS can have beneficial outcomes for other family members with modest improvements 
in healthy behaviors and weight loss. 
 In addition, a meta-analysis examining the psychosocial outcomes of bariatric 
surgery especially considering the presence of or reduction in psychiatric co-morbidity, 
psychopathology, psychosocial functioning, econometric data, and general quality of life 
indicator suggests that WLS has clear benefits. A review of literature reporting all 
controlled and non-controlled published trials between 1980 and 2002 that examined the 
relationship between pre and post bariatric surgery psychosocial functioning reveals that 
patient perceptions of stigma (including self- stigmatization), their employability, risk for 
depression, experience of depression and anxiety, social functioning, eating pathology, 
self-esteem, income, use of sick time, disability benefits, and other quality of life 
indicators improve at statistically significant levels following weight loss produced with 
the assistance of surgical intervention.
167
 The relevant literature was identified by a 
search of computerized databases and included all articles published in English and 
German during the two decade period. The study included only research which met the 
requirements of the evidenced-based guidelines of the Agency for Health Care Policy and 
Research and the Scottish Intercollegiate Guidelines Network. In all, there were 171 
publications which met criteria and were included for review. There were 63 articles, 
including two systematic reviews, identified. A total of 40 studies were focused on 
psychosocial outcomes after obesity surgery. This meta-analysis of available research 
concluded that mental health and psychosocial status, including social relations and 
employment, opportunities improve for the majority of people after bariatric surgery. 
This led to an improved quality of life among bariatric surgical patients. The presence of 
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psychiatric co-morbidity, predominantly affective disorders, and psychopathologic 
symptoms decreased post-surgically. One exception noted to the improvements found 
among bariatric patients was with those who had a severe pre-existing (pre-surgical) 
psychiatric co-morbidity. In this group no significant improvements in psychosocial 
functioning were found. The researchers concluded that concerns that obesity surgery 
will reinforce psychiatric symptoms and lead to a reduction in patient quality of life seem 
to be unfounded. In fact the opposite appears to be the case. In general, improvements in 
psychosocial functioning were reported across the studies reviewed and these 
improvements led to increases in reported overall quality of life.
168
 
 Each of these quality of life indicators can be shown to have an impact on familial 
relationships and parental choices regarding how to care for children. In other words, 
weight loss surgical interventions may indeed have some measure of positive influence 
on third parties and thus potentially on populations, the focus of the public health 
enterprise. Moreover, quite obviously obesity is manifested in individuals just like 
influenza or HIV. If each of these disabling conditions could be effectively treated in the 
individual, their public health threat—their burden at the population level—would be 
significantly decreased. In each case, primary or secondary prevention may be more cost-
effective, but effective individual treatment may also reduce the population-level societal 
burden of obesity. 
D. Conclusion 
 This chapter has argued that it is inappropriate to dismiss WLS as a valid 
individual-level clinical technology based on the erroneous application of public health 
goals to what is, fundamentally, also an issue of clinical medicine. To conflate the goals 
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of public health initiatives with the goals of clinical medicine was shown to be 
unacceptable in light of the availability of WLS which carries with it both acceptable 
levels of known risk, and an empirically substantiated ability to meet several of the goals 
of medicine and reduce co-morbid disease. Moreover, this conflation further diminishes 
the relevance of a trusting and caring physician patient relationship in addressing 
obesity—also identified under the goals of medicine. The conflation between public 
health goals and the goals of clinical medicine thus applies an unattainable and 
inappropriate set of outcome standards to WLS. In light of a clearer understanding of the 
standards by which weight loss surgical interventions should be evaluated, substantial 
empirical evidence of its clinical usefulness, and bolstered by patient narrative extolling 
its personal utility, more should be done to assist patients in understanding WLS as a 
valid choice along a continuum of care. This, as yet to be adopted, obesity continuum of 
care could and should be offered to obese patients attempting to resolve their co-morbid 
diseases associated with excess weight.  
 Chapter five will argue that given the myriad of social, environmental, and 
biological factors associated with the development and maintenance of obesity and in 
light of the empirical and narrative evidence of its clinical and personal utility as a 
treatment which provides resolution or improvement of various life limiting co-
morbidities, medicine is obligated to recognize and overcome its own biases and stigma 
in order to present a complete picture of the available continuum of care to obese 
patients, including the recognition that surgical intervention for obesity is an ethically 
valid option. Issues of justice, fairness, autonomy in treating this condition and promoting 
patient welfare requires that the present medical system and those working within it 
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overcome outdated personal bias in favor of empirical evidence, on which such science 
should rightly rest, of the usefulness of WLS as an individual-level intervention. 
Moreover, continued failure to do so violates the goals of medicine and the obligation of 
patient non-abandonment to which physicians, on behalf of the medical system, are called 
to abide and promote. 
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Chapter Five: Justice, Fairness, and Autonomy in Treating Disease and Promoting 
Patient Welfare 
 This chapter discusses how interactions between physicians and obese patients 
may fail to fulfill the demands of respect for autonomy, patient welfare promotion, and 
justice. These problematic interactions may occur in the context of appointments whose 
primary purpose is to address the patient‘s obesity, but they can also occur in the contexts 
whose focus is on another health concern of the patient. The chapter will argue that 
physicians‘ failure to address patient obesity is a form of patient abandonment, and 
further that the healthcare system abandons obese patients. Physician failure to address 
patient obesity, and to do so with respect and compassion, effectively re-victimizes obese 
patients. This is particularly ethically problematic because the healthcare system should 
protect and promote the welfare of the vulnerable, not participate in their victimization. 
 The chapter will further argue that in these respects obesity is treated in a manner 
different from other health conditions. It will argue that this differential treatment of 
patients with obesity constitutes an injustice. Physicians address patient obesity less 
frequently, less adequately, and less respectfully than they treat other life-threatening and 
co-morbidity producing conditions such as hypertension. This is, the chapter will argue, 
unfair. Further, physician reluctance to refer obese patients for weight loss surgery 
(WLS) constitutes a specific injustice, as well as being contrary to patient welfare. In 
contrast to discussion and referrals for surgical intervention in other conditions, WLS is 
frequently not presented as a treatment option.  
Even in the context of cirrhosis secondary to alcoholism—similar to obesity 
because the health condition arises from ingestion that harms the body—designations of 
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blame have been largely replaced by more compassionate treatment. The focus is on 
resolution of the disease-causing behavior and curtailment of the disease. For instance, 
liver transplantation for the former alcoholic is not seen as being particularly ethically 
problematic even though there may be a residual charge of failed personal responsibility.
1
 
In this instance the physician‘s obligation to continue to care for the patient with end-
stage liver disease through this difficult and life-threatening ailment supersedes her 
personal feelings regarding the cause of the disease. Moreover, the bioethical literature 
supports the physician‘s obligation of continued care and the healthcare system‘s 
provision of treatment. Most analyses support the former alcoholic‘s equal status in 
competing for scarce organs for transplantation. A similar shift away from ascriptions of 
moral failing and toward provision of a continuum of appropriate, compassionate care 
has occurred with regard to those who have HIV in the United States.
2
 The once highly 
contentious backward-looking ascriptions of responsibility and moral depravity have 
subsided in favor of a clinically based continuum of care which seeks to find solutions to 
symptoms and disease processes as they arise. To the extent that physician and healthcare 
ascription of responsibility in these instances is backward-looking, the point is not to 
moralize, but to understand causation in order to prevent further harm and to provide 
efficacious treatment. A new liver for an active alcoholic will only temporarily resolve 
his health issue; discovering whether an HIV-infected person is having unprotected sex, 
and seeking to persuade him not to, maximizes protection of future partners from HIV 
infection and the patient from opportunistic infections. The overall goal of identifying 
cause is forward-looking, and all viable treatment options are rightly considered. The 
physician does not abandon such patients in their time of greatest need. Instead the 
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physician examines all viable treatment options and often encourages the patient to 
consider previously unconsidered options. Doing so may enhance the physician-patient 
relationship, promotes patient self-determination, and fulfills the physician‘s fiduciary 
responsibilities vis-à-vis her patient. This chapter argues that a similar shift from a 
moralizing stance must occur in obesity treatment. Physicians should examine their obese 
patients‘ behaviors not to ascribe backward-looking moralized responsibility, but to 
identify opportunities for future-oriented intervention. Physicians should not ignore their 
patients‘ obesity, but address it and discuss the full range of viable treatment options. 
Doing so would promote patient welfare and autonomy. It would also treat obesity in a 
manner similar to other similarly serious health conditions. Justice demands no less.  
 Section one of this chapter will take up systemic barriers, violations of respect for 
patient autonomy, informed consent, and veracity as they relate to obese patients‘ 
accessing WLS. This section provides insight into the ways that foundational principles 
and practices have been disregarded with deleterious outcomes for patient welfare and 
self-determination. The second section of this chapter will discuss how ascriptions of 
moralized responsibility or blame to obese patients have permitted physicians and the 
healthcare system to transgress the demands of fair treatment with regard to obese 
patients‘ access to WLS. Comparison to the treatment of other conditions will be made to 
establish that obesity and obese patients are not treated fairly. Section three will offer an 
alternative approach to improve current practices which will better promote and support 
commonly accepted ethical principles and the goals of medicine. This alternative, 
consistent with feminist thought and focused on holistically caring for those marginalized 
by their obesity, takes into account the need to infuse care into healthcare interactions 
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and systems in the treatment of obesity. An ethic of care which incorporates an 
understanding both of the vulnerability and overlapping marginalizations of those who 
are obese, along with recognition of the medical relevance of highly personal factors, will 
facilitate a more comprehensive continuum of care and more just and beneficial treatment 
of obesity. The outcome of implementing this approach will be improved clinical care 
which offers true care of those who are obese and affords them the opportunity to make 
more fully informed decisions based on their vision of their own welfare and values. The 
first section begins by discussing autonomous decision making, informed consent, and 
physician veracity in light of the goals of medicine with regard to obesity and access to 
WLS. 
A. Barriers to Accessing Weight Loss Surgery, Autonomy, Informed Consent, and 
Veracity 
 This section briefly reviews the goals of medicine and the commonly accepted 
ethical practices which have come to support them. This section will address the ways in 
which current practices observed in the physician-patient relationship involving obese 
patients violate the goals of medicine and the obligations of physicians. Specific breaches 
of physician obligation with regard to patient welfare, autonomy, informed consent, and 
veracity are elucidated, in part with reference to research on the attitudes and practices of 
physicians with regard to the referral of obese patients for WLS. Research findings 
highlight the disparity between physicians‘ belief in the efficacy of WLS and physician 
referral practices for WLS. Various reasons for the disparity between strong evidence of 
effectiveness and low referral rates will be addressed. Subsection one explores systemic 
and other impediments to accessing WLS. Subsection two discusses physician 
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obligations to their patients including respect for autonomy, informed consent doctrine, 
and the concept of veracity.  
A.i Goals of Medicine and Systemic Barriers to Accessing Weight Loss Surgery 
As briefly discussed in the previous chapter, the goals of medicine include: 
promotion of health and prevention of disease; maintenance or improvement of quality of 
life through relief of symptoms, pain and suffering; cure of disease; prevention of 
untimely death; improvement of functional status or maintenance of functional status; 
education and counseling of patients regarding their condition and prognosis; avoidance 
of harm to the patient in the course of care; and when no other options exist assisting in a 
peaceful death.
3
 In both clinical medicine and much of bioethical literature, there is an 
assumption that the goals of medicine are well understood and thus do not require further 
inquiry.
4
 One implication of this assumption is that in the practice of clinical medicine 
carrying out the goals of medicine are routinely and uncontroversially pursued no matter 
the diagnosis. Bioethicist Daniel Callahan states that the goals of medicine are  
treated as a topic to which, it is thought, everyone already knows the answer and 
 thus is not worth spending time on: or as an interesting but highly abstract, 
 academic topic of little importance to clinicians and busy health care workers.
5
 
 
However, it seems that a common understanding or acceptance of the goals of medicine 
as they relate to the treatment of those who are obese should not be so readily assumed. 
The use of WLS in the treatment of obesity and its manifold co-morbidities has 
plateaued in the United States.
6
 Comparative data on the utilization of bariatric surgery 
between 1993 and 2007 reveal that while obesity continues to generally be on the rise the 
use of bariatric surgery for sustained weight loss has ―remained stable since 2003‖.7 
While there are many possible system-level contributors to this plateau, one may be the 
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requirement of bariatric center of excellence designation to be eligible for Medicare 
reimbursement. In November 2003, the American Society for Bariatric Surgery 
established the Surgical Review Corporation (SRC) as an independent nonprofit entity 
for quality control of bariatric surgery and as a resource for data collection and analysis 
in an effort to discern best practices. SRC developed standards that were accepted and 
implemented by the bariatric surgical community. A system was developed for hospitals 
and clinics to receive designation as a center for excellence. The process takes substantial 
time and resources.
8
 Obtaining center for excellence designation is generally easier for 
larger hospitals with substantial resources than it is for community facilities with modest 
resources. Hence, this requirement has effectively moved access to bariatric surgery 
farther from rural patients and has funneled services to larger, urban, university affiliated 
programs thought to produce better results. Another possible reason for the plateau in 
utilization is the near simultaneous reductions in the number of third-party insurances 
providing coverage for surgical weight loss procedures and reductions in reimbursements 
for re-hospitalizations following surgery.
9
 As a result of these factors it is more difficult 
for people to access WLS as treatment for their obesity and its co-morbidities.  
In addition to system-level concerns about access, which certainly can impair self-
determination and autonomy, individual-level contributors impair access to WLS. In 
questioning the overall low usage of various types of metabolic/bariatric surgery world-
wide Henry Buchwald and Danette Oien, physicians at the University of Minnesota in the 
Department of Surgery, state in their address to the 14
th
 World Congress of the 
International Federation for the Surgery of Obesity and Metabolic Disorders: 
It is also difficult to believe that only 1 percent of eligible individuals would elect 
surgery if it were available to them. The answer, therefore, must be denial of 
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patient access to bariatric surgery by private or governmental payers for 
healthcare, lack of knowledge of the bariatric surgery option in some 
communities, misunderstanding about the management of obesity as a disease, 
and the continuing underlying prejudice against the  obese.
10
  
 
Buchwald and Oien acknowledge both systemic and individual-level barriers to accessing 
WLS. They specifically posit issues of prejudice against obese people among the barriers. 
Influence of prejudice against obese people to which they refer can be identified within 
the physician-patient relationship, specifically in violations of respect for autonomy, the 
requirements of informed consent, and the obligation of veracity. It is upon these 
physician-patient based relationship barriers to WLS that the following subsection will 
focus.  
A.ii Respect for Autonomy, Informed Consent, and Veracity 
Respect for autonomy is of immense importance in medical ethics and in ethics 
more generally. Bioethicists Tom Beauchamp and James Childress observe that ―respect 
for the autonomous choices of persons runs as deep in common morality as any 
principle...‖11 According to Beauchamp and Childress, to respect the autonomy of agents 
is: 
…to acknowledge their right to hold views, to make choices, and to take actions 
based on their personal values and beliefs. Such respect involves respectful 
action, not merely a respectful attitude. It requires more than non-interference in 
others‘ personal affairs. It includes, in some contexts, building up or maintaining 
others‘ capacities for autonomous choice while helping to allay fears and other 
conditions that destroy or disrupt autonomous action. Respect, in this account, 
involves acknowledging the value and decision-making rights of persons and 
enabling them to act autonomously, whereas disrespect for autonomy involves 
attitudes and actions that ignore, insult, demean, or are inattentive to other‘s rights 
of autonomous action.
12
  
 
The goals of respecting autonomy in the doctor-patient relationship have at their root 
both considerations of human dignity and patient welfare. Beauchamp and Childress 
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continue: 
Personal autonomy encompasses at a minimum self-rule that is free from both 
controlling interference by others and from certain limitations such as inadequate 
understanding that prevents meaningful choice. The autonomous individual acts 
freely in accordance with a self-chosen plan, analogous to the way an independent 
government manages its territories and establishes its policies. A person of 
diminished autonomy, by contrast, is in some respect controlled by others or 
incapable of deliberating or acting on the basis of his or her desires or plans.
13
 
 
With regard to obese patients, physicians can fail to respect autonomy and fail to promote 
autonomy in several ways. Firstly, physicians often fail to address or even acknowledge a 
patient‘s obesity. Secondly, physicians can fail to discuss WLS as a possible treatment 
option at all and finally, they can choose to discuss surgical options for weight loss in 
only very advanced stages of the disease process where few or no other technologies are 
available.  
 In the first case, when obesity is not acknowledged by the physician at all, 
patients are denied the opportunity to avail themselves of assistance and education about 
associated a potentially serious medical problems. In a study conducted on the initiation 
of weight loss discussions with patients in primary care it was found that although 65 
percent of the random sample of patients was overweight or obese, discussions were 
initiated by the physician about excess weight in only 17 percent of these interactions.
14
 
In this case patients may not be made aware of the potentially serious nature of their 
problem and thus will not be able to take evasive measures to avoid co-morbidities in the 
future. Additionally, in cases where earlier intervention might be feasible, this 
opportunity is lost if the discussion of weight never occurs. In essence, patient autonomy, 
which in this instance includes the ability to act sooner rather than later, is not promoted 
when physicians fail to address legitimate concerns about patient weight. 
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 In the second instance, when the option of WLS is never discussed with the 
patient as a matter of course in clinical care, the patient may not see it as a viable option 
or conversely may not be motivated to take alternative actions, if possible, to avoid 
surgery down the road. In the absence of physician discussion of WLS, the patient may 
assume that if bariatric surgery were a viable option to achieve sustained weight loss, the 
physician would discuss it. Alternatively, when the option of WLS is not introduced until 
the patient is in advanced stages of obesity perhaps with multiple co-morbidities prevents 
the patient from utilizing WLS to avoid those co-morbidities or their further advance. 
Each of these situations fails to evidence respect for patients‘ right of self-determination 
and to maximize opportunities for autonomous decision making and self-care.  
Avidor et al. surveyed over 478 physicians from six subspecialties to learn their 
attitudes and practices regarding the treatment of their morbidly obese patients.
 15
 
Bariatric surgery was perceived as the most effective treatment option available to the 
patient with 49 percent of respondents indicating that they believe the intervention to be 
effective. One component of the study focused on the referral rates for bariatric surgery. 
Across this diverse group of cardiologists, gynecologists, endocrinologists, internists, 
family practitioners, and bariatricians in comparing physician recommendations for 
bariatric surgery and other interventions for weight loss such as diet and exercise or 
pharmaceuticals, it was found that overall, ―notwithstanding physicians‘ strong 
perception of the successful outcomes associated with bariatric surgery, all six groups 
surveyed recommended it infrequently, suggesting surgery to only 15.4 percent of their 
morbidly obese patients.‖16 While the patients met the criteria for bariatric surgical 
interventions based on the BMI guidelines set forth by the National Institutes of Health, 
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the physicians cited various reasons for not making appropriate referrals: they preferred 
to manage the patient by themselves, they did not believe in referring patients for 
bariatric surgery, and they felt that most patients meeting criteria for surgery would not 
benefit in the long term. Additional reasons cited were that referrals require too much leg 
work, the physician was unfamiliar with local bariatric surgeons, or they thought their 
patients would not meet criteria for the surgery.
17
 The study authors concluded that 
―therapy for the morbidly obese, therefore, does not mirror accepted 
guidelines….Morbidly obese patients deserve to benefit from improved care, the 
hallmark of which could be referral for bariatric surgery.‖18  
This study above reveals a complex relationship between physicians‘ personal 
beliefs and evidence based medicine (EMB) indicating that WLS does indeed produce 
long-term sustained improvements in co-morbidities while improving longevity and 
quality of life and personal beliefs. Personal beliefs, likely based at least in part on the 
social construction of obesity and stigmatization of obese people as lazy, unmotivated 
and unworthy, coupled with the medical acceptability of particular technologies for the 
resolution of obesity (e.g., individual diet and exercise, commercial weight loss 
programs, pharmacology) appear to dissuade physicians from discussion of efficacious 
surgical treatment. As a result, patients must work harder to overcome practitioner bias to 
access an intervention that the physicians themselves believe to be effective. 
Furthermore, utilization of WLS will require the support of the physician throughout the 
evaluation process and through post-intervention follow up. 
Respect for autonomy obligates healthcare providers both to act ways that 
enhance their patients‘ autonomy or afford them opportunities to exercise and advance 
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their autonomy, and not to act in ways that impede or impair patients‘ autonomous 
decision making. Failing to discuss potentially efficacious WLS violates both obligations. 
Insofar as obesity itself impairs patients‘ abilities to pursue their life plans, failure to 
discuss a means of addressing their obesity fails to afford them autonomy-enhancing 
opportunities. Failing to present material information regarding their health condition and 
its treatment prevents patients from making autonomous healthcare decisions and, as the 
following argues, violates requirements of informed consent, a doctrine and practice that 
seeks to enable such autonomous decision making.  
As a legal doctrine, informed consent in medicine has a long history evolving 
from tort law regarding battery. As an ethical, legal, and regulatory doctrine governing 
research, informed consent has developed from hard lessons learned about the need to 
respect persons and protect their welfare.
19
 In the twentieth century, the doctor-patient 
relationship evolved from a paternalistic one in which decisions were made for patients to 
one usually characterized by shared decision making
20
 and governed by the requirements 
not merely of consent,
21
 but of informed consent.
22
 
Several conceptions of informed consent have been elucidated including viewing 
informed consent as a ―specific rule-governed practice, as autonomous authorization, and 
as shared decision making‖.23 Informed consent as a rule-governed practice focuses on 
the way it functions institutionally—both within healthcare settings and within the law 
(for clinical care) and regulatory structures (for research).
24 
The rule or norm-governed 
practice prescribes how informed consent should be obtained and its components, and 
establishes the legality of obtaining an individual‘s authorization or refusal as 
subsequently documented in physician notes or on a consent document. The model of 
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autonomous authorization refers to informed consent as an action whereby the patient (or 
research subject) authorizes the physician (or investigator) to act on the patient‘s behalf 
and whereby the patient/subject retains responsibility for having so authorized.
25
 Social 
scientist and bioethicist Ruth Faden and her co-author philosopher bioethicist Tom 
Beauchamp carefully explain the ways in which these two senses of informed consent do 
and do not overlap. Philosopher bioethicist Dan Brock explains the model of shared 
decision making, the presumed facts-values ―division of labor‖ within the relationship, 
and how the model interacts with the demands of informed consent.
26
 Brock provides 
reasons to question the notion that physicians provide the medical facts within the doctor-
patient relationship, while patients provide their values, and then through some dialogical 
process a shared decision is reached. Instead, he argues, patients also bring factual 
information to the interaction, patients form values and preferences in light of the medical 
information physicians disclose, and the medical information itself is not value-free as 
the ―division of labor‖ would imply. What all conceptions of informed consent share, 
however, is that at its core informed consent is a process which is intended to promote 
patient autonomy and support pursuit of the patient‘s conception of her own welfare. 
As a clinical and legal practice, the process of informed consent is generally 
considered to involve five elements: competence (of the patient), disclosure (of material 
information by the physician), understanding (of that information by the patient), 
voluntariness (of the patient‘s decision), and the decision (i.e., the patient‘s consent or 
refusal).
27
 Disclosure cannot be of all information that is true of the clinical situation, nor 
can patients be expected to understand all such information. Instead, what is required is 
that physician‘s disclosure the information that is material to the patient‘s decision, and 
 252 
 
in turn, the patient must have substantial understanding of it. The commonly accepted 
―information elements‖ considered material to such decision making are the patient‘s 
disease process, prognosis, benefits and burdens of the recommended treatment option, 
the benefits and burdens of reasonable alternative treatments, and the likely outcome of 
choosing to forgo any treatment.
28
 These elements must be disclosed for informed 
consent in the norm-governed, legally effective sense to have occurred. A prerequisite for 
such informed consent is that the patient must be competent to make the particular 
decision being asked of her. Further, informed consent is to be obtained from a patient 
with free will, i.e., one who is not unduly influenced by pressure from others, fear, 
internal compulsions, or some other factor that overwhelms her free will.
29 
 
Returning now to the patient-physician interactions in the treatment of those who 
are obese, it becomes clear that physicians‘ failure to discuss WLS as a treatment option 
may violate the disclosure requirements of informed consent and fail to fulfill the ideal of 
shared decision making. For patients currently meeting the eligibility criteria for the 
surgery, failure to discuss it is a clear violation of the requirement to provide information 
regarding treatment options. Even for those who do not currently meet such criteria, the 
failure to discuss it as a potential future option may be considered a violation. At the very 
least, not discussing WLS fails to educate and empower obese patients and does not 
enhance opportunities for autonomous action. For those patients for whom WLS would 
be either a potentially efficacious treatment, or potentially the most efficacious option, 
failure to provide such information fails to promote their welfare. 
It appears that there could be a residual charge of apparent paternalism in the 
approach taken by physicians with regard to their obese patients. Paternalism is defined 
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as a policy or practice of treating or governing people in a fatherly manner, especially by 
providing for their needs without giving them rights or responsibilities.
30
 Paternalism is 
generally seen to have two interwoven parts: overriding patient rights or liberties and 
doing so to preserve patient welfare. A paternalistic approach would limit the options 
available to the patient to those which the authority believes to be in the patient‘s best 
interest. In medical contexts, any potentially justifiable paternalism would require that the 
physician seeking the patient‘s good would have adequate knowledge of the highly 
personal factors which patients find relevant to their welfare, or it assumes that the 
clinical outcome is the only consideration and therefore the path to be chosen is clear 
based on these limited and subjective considerations. Yet insofar as physicians fail to 
afford their patients access to WLS in cases where WLS would be an efficacious 
treatment option, their withholding of information cannot be truly paternalistic, as it does 
not adequately provide for patient needs or seek their welfare. Clearly physicians who 
routinely withhold information about WLS where it may be efficacious do not accurately 
give priority to the clinical outcome of weight loss, as the evidence surrounding it 
establishes its potential efficacy. Moreover, as previous chapters have established, there 
is also reason to think that many physicians ignore or discount the personal factors 
relevant to their patients‘ experience of obesity. 
An additional aspect of paternalism pertinent for considering physician interaction 
with obese patients is provided by considering philosopher Joel Feinberg‘s distinction 
between hard and soft paternalism. 
Hard paternalism will accept … that it is necessary to protect competent adults, 
against their will, from the harmful consequences even of their fully voluntary 
choices and undertakings. Soft paternalism holds that the state [or others have] … 
the right to prevent self-regarding harmful conduct…when but only when that 
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conduct is substantially nonvoluntary, or when temporary intervention is 
necessary to establish whether it is voluntary or not.‖31  
 
The distinction rests on whether the party interfering with another‘s freedom of action or 
self-regarding conduct believes that person to be competent and autonomous (hard 
paternalism) or believes him to be somehow less than fully autonomous (soft 
paternalism). Perhaps physicians who withhold information about WLS from their obese 
patients believe that these patients are less than fully autonomous. They may take their 
patients‘ obesity as evidence of their inadequate will (willpower) or less than full moral 
agency. Where these physicians might generally avoid hard paternalism with patients 
they deem competent, they may find soft paternalism acceptable with regard to obese 
patients to whom they apply stereotypes of being less intelligent or out of control. This 
line of reasoning is purely speculative. Moreover, these physicians would still have to be 
able to reasonably assume that these patients‘ pursuit of WLS would be self-regarding 
harmful conduct, and this assumption cannot be supported by current data. 
 If a physician believes that the patient lacks some relevant information about the 
procedure, its risks, benefits, or necessary post-surgical changes in life-style, or is in 
some way being unduly pressured and hence is unable to make an autonomous decision 
soft paternalism may well be justified in the short run. However, these elements which 
may initially be seen to necessitate such soft paternalism can be overcome. If a physician 
believes that a patient is not capable of understanding and making a decision about WLS, 
or of undertaking post-surgical life-style changes, then the appropriate response is not to 
withhold the option, but to pursue alternate means of patient education or to seek a 
supportive party or even surrogate decision maker. If a physician believes that a patient is 
being pressured into seeking WLS, it is incumbent on her to learn who or what may be 
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applying pressure on the patient and determine whether these pressures can be addressed. 
Rather than pursuing soft paternalism, creating the conditions of information exchange, 
understanding, and voluntariness necessary for truly informed consent would enable the 
patient to access the treatment option with maximal potential for clinical and personal 
utility. Failing to discuss the full range of treatment options available to obese patients is 
morally unjustified because it violates both the physician‘s obligations to respect patient 
autonomy and promote patient welfare and the tenets of a valid informed consent process. 
 Another possible reason for withholding information about WLS could be that the 
physician is skeptical about the efficaciousness of various treatment options and believes 
that withholding information about it is for the patient‘s own good. Nevertheless, it is 
incumbent upon the physician to be able to provide appropriate evidence based 
information regarding various treatment options.
32
 The obligation is grounded in the 
ethico-legal doctrine of informed consent and in the ethical requirement of respecting and 
supporting the patient‘s autonomy. If the physician is unable to fulfill this obligation, she 
should provide the proper referral for her patient so that the patient can obtain accurate 
information that meets the standard of care.  
 If, instead of being motivated my misguided but ―good intentions,‖ the failure to 
provide information about WLS is based upon the physician‘s own bias against those 
who are obese, perhaps a moralizing attitude that people responsible for their weight gain 
should not be afforded a ―quick fix‖ of surgery, then the physician cannot be deemed 
paternalistic, but simply acts unethically in terms of concerns for justice and patient 
autonomy and welfare. In either case—explained by either misinformed paternalism or 
outright bias—the outcome is similar: information is withheld from patients which is vital 
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to making informed decisions about any of their medical conditions and treatment 
options. Additional moral obligations such as that of truth-telling are also infringed upon 
by current practices. 
The obligation of truth-telling flows from respect for autonomy and the 
requirements of informed consent. This obligation of veracity is violated when physicians 
fail to discuss the full range of available treatment options with their obese patients. 
Beauchamp and Childress discuss this as a moral rule which among others is vital to the 
professional-patient relationship and to promoting trust within it.
33
 Veracity refers to 
providing the ―comprehensive, accurate, and objective transmission of information, as 
well as the way the professional fosters the patient‘s or subject‘s understanding. In this 
regard, veracity is closely related to respect for autonomy.‖34 Furthermore, veracity is 
closely tied to obligations of fidelity, promise keeping and contract.  
[When] … we communicate with others, we implicitly promise that we will speak 
truthfully and  that we will not deceive listeners. By entering into a relationship in 
health or research, the patient or subject enters into a contract that includes the 
right to truthful information regarding diagnosis, prognosis, procedures, and the 
like… .relationships between health professionals and patients and subjects 
require trust, and adherence to rules of veracity is essential to trust.
35
 
 
Failure to discuss the full spectrum of options for weight reduction in accordance with the 
standards of informed consent is therefore a breach of trust and veracity. Moreover, while 
the full scope of treatment options for weight loss should rightly be discussed, it is 
particularly ethically troubling that the most efficacious technology to date for sustained 
weight loss would be excluded in discussions with obese patients who may well benefit 
from the procedures.  
 The discussion of surgical intervention for weight loss serves several purposes 
which enhance the goals of medicine and more fully meet the physician moral obligations 
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to their patients. Specifically, discussions about the option of WLS may better prepare the 
patient for the evaluation process and assist in understanding that WLS is but one of the 
long term tools needed for sustained weight loss and reduction in life-threatening co-
morbidities. Further, a candid compassionate discussion of WLS can help to reduce the 
internalization of cultural stigma which can impair patients from accessing WLS. In 
essence, honest discussion of WLS as a viable option enhances patient autonomy; it treats 
the patient as an agent with decisional authority. It may increase some patients‘ self-
esteem. It respects the patient as a moral equal in a process of shared decision making. 
Failure to discuss this option seriously diminishes the opportunity for patients to make 
informed decisions based on their conceptions of well-being and is an untruthful 
representation of the options available. The following section argues that failure to 
discuss the full range of medically appropriate treatment options with obese patients is 
also unjust.  
B. Blame and the Principle of Justice in the Context of Obesity Treatment 
  This section takes up justice concerns with regard to obesity treatment. It is 
argued that obese patients are treated unjustly when the full range of treatment options is 
not disclosed to them or when their obese condition is ignored by their physician. There 
is injustice in treating obese patients as putatively less capable of participating in shared 
decision making, less entitled to the protections afforded by disclosure within informed 
consent, or less worthy of a potentially life-saving and quality of life enhancing 
intervention, in comparison to patients with conditions other than obesity. This chapter 
argues that violations of the principle of justice continue unabated in the sphere of obesity 
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treatment when treatment of obesity is compared to treatment of other medical conditions 
with complex lifestyle, genetic, or environmental origins.  
 The first subsection argues that attributions of moral blame and personal 
responsibility for obesity have been relied upon to justify this disparate treatment. The 
second subsection analyzes the injustice of such attributions and then advocates changes 
in the healthcare system and doctor-patient relationship that will make the treatment of 
obese patients more just by them equal treatment and less restricted access to evaluation 
for efficacious treatment.  
B.i Blame and Access to Treatment 
  Blameworthiness and personal responsibility for one‘s medical condition have 
historically influenced the way in which the individual with the disease, the disease itself, 
and the application of potential interventions has been seen.
36
 History has shown that 
perceptions of blame are often inaccurate as they tell only part of the complex story. 
Moreover, with thoughtful focused efforts these misperceptions of culpability can be 
changed or dispelled leading to more just treatment of patients and a reduction in the re-
victimization of the individual with the medical condition.
37
 This section will first discuss 
the concept of blame for various diseases and for obesity. Then, the way in which 
perceptions of blame influence access to potential treatments will be discussed. 
  The writings of Susan Sontag articulate the experience of illness and the 
metaphors which surround various types of illness and which are applied to those who are 
ill. Often the metaphors involve the perceived guilt of the patient either for causing the 
illness or for failing to avoid illness. In Sontag‘s first book she writes of her own 
experience of having been diagnosed with cancer. She recounts that some forms of cancer 
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such as lung cancer are seen as being more blameworthy (having been caused by the 
patient‘s cigar smoking). The perception of patient culpability permits both the medical 
profession and society at large to pass judgment on the moral character of the person.
38
 
Obesity is subject to similar charges of blameworthiness and occasions similar 
metaphors.  
  In her second book Sontag takes up the once highly charged issue of personal 
responsibility and derelict moral character for acquiring HIV
39
 Sontag argues that as with 
cancer, the metaphors of HIV have influenced societal response to those so diagnosed 
and their clinical care. Sontag suggests that diseases whose cause is uncertain and whose 
treatment is limited tend to evoke fear and revulsion.
40
 In the beginning of the HIV/AIDS 
epidemic, society at large and the culture of medicine was focused on issues of blame, 
personal responsibility, and sin.
41
 Since the first reports of American men dying of 
Pneumocystis Carninii Pnemonia in the early 1980‘s stigma and shame were attached to 
the diagnosis. The first deaths due to HIV/AIDS were among those already marginalized 
and considered to be deviant based on sexual orientation or personal behavior. ‗If only 
they weren‘t homosexual‘, ‗if only they weren‘t IV drug users‘, were common ascriptions 
of culpability. These various ascriptions were used against sufferers as a means of 
avoiding caring for these marginalized patients.
42
 From the perspective of dominant, 
majority culture, all four phases of care that Tronto identifies were withheld from those 
with HIV/AIDS. They were not cared about; no one took responsibility for them; 
caregiving was not afforded them by mainstream communities, and they did not receive 
care. The uncertainty of the cause of AIDS, its modes of transmission, and the then 
undetermined likelihood that caring for those with AIDS would lead to deadly infection 
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seemed to legitimate the failure of the healthcare system to respond compassionately or 
quickly. Some saw the diagnosis as appropriate punishment for the immoral behaviors of 
homosexuality, bisexuality, promiscuity, prostitution, or drug use. The early HIV/AIDS 
epidemic was fraught with ascriptions of blame which were as unhelpful in one-on-one 
clinical interactions as they were stigmatizing and divisive at a social level. These 
ascriptions are said to have delayed appropriate investigation into the disease, its 
potential treatments, and their application under President Reagan‘s administration. The 
slow governmental response to this epidemic is said to have facilitated additional 
potentially avoidable deaths early on.
43
 At the time a widely distributed quote, which was 
unable to be properly attributed but was said to come from an anonymous surgeon, stated, 
―We used to hate faggots on an emotional basis. Now we have a good reason.‖44 It was 
the attribution of moral depravity to those infected which was seen to warrant both a slow 
response to the epidemic and a paucity of compassion within the medical community and 
from the society at large. As discussed in previous chapters, a similar though perhaps less 
overt lack of compassion exists for those who are obese. This failure of compassion is 
based upon the construction of obese people as Other, as being inferior both morally and 
intellectually, and as being outside or marginalized from dominant mainstream culture. 
Moreover, the presumption that obesity is primarily a self-inflicted condition has fostered 
ongoing ascriptions of blame.  
  An analogous situation occurred around alcoholism. However, based on medical 
evidence and the promotion of the disease model of addictions, the construction of those 
who are alcoholic softened.
45
 The attributions of personal blame and responsibility which 
once overwhelmed the medical treatment of alcoholism have abated, or at least overt 
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attributions of blame are less acceptable.
46
 Now the healthcare system treats the disease 
of addiction to alcohol, not an irresponsible, non-compliant, ―did it to themselves,‖ 
resource draining, morally flawed character. The changes which have been realized in 
attributions of blame for those who are alcoholic have been lead in part by changes 
initiated by the medicine. These changes included a shift in the construction of 
alcoholism and drug abuse from being caused by moral failure to instead being a disease 
state which is progressive in nature. Though the disease of alcoholism is not fully 
understood, ascriptions of blame have receded. The shift away from unhelpful ascriptions 
of blame paved the way for increased access to appropriate treatment interventions for 
this disease and decreased stigma of those who are alcoholic.  
 The ideological shift with regard to both alcoholism and HIV/AIDS reinforces 
that present ascriptions of blame against those who are obese can be altered. By similarly 
diminishing ascriptions of culpability for this highly complex multifactorial condition it 
may be possible to improve both the experience of compassion and access to effective 
treatment for those who are obese. 
   Patients are vulnerable on many levels, including financial and personal levels. 
As Sontag succinctly puts it, ―Etymologically, patient means sufferer.‖47 Moreover many 
patients experience altered concepts of their own identity which can be deeply 
disturbing.
48
 Much has been written about the various aspects of patient vulnerability.
49
 
Even if patients bear some degree of responsibility for their condition, once they become 
a patient—a sufferer—ascriptions of blame are no longer useful. The patient suffers, and 
the role of medicine is to reduce suffering whenever possible by utilizing the full scope of 
available technologies to do so.
50
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  In chapter three the influences of theology on the construction of both obesity and 
those who are obese was discussed. Examination of evolving theological constructs 
around suffering provides insight into the unhelpful nature and plausible consequences of 
assigning blame to those who suffer. In a recent work by Father James Keenan SJ, 
Professor of Theological Ethics at Boston College, he focused on the evolution of the 
concept of suffering in moral theology in the twentieth century.
51
Tracing the 
understanding of suffering across this time span he focuses on the work of four scholars: 
Bernhard Häring,
52
 Gustavo Gutierrez,
53
 Edward Schillebeeckx,
54
 and Margaret Farley.
55
 
In discussing the work of Gustavo Gutierrez, Keenan acknowledges his significant 
contribution in identifying a deep concern for the oppressive suffering of the poor.
56
 
Gutierrez‘ work summoned people to stand in solidarity with those who are marginalized 
by power and economic forces beyond their control.
57
 Much like feminist theorists who 
employ the concept of intersectionality, Gutierrez urged action to reduce the suffering of 
those who are marginalized by ―interlocking patterns of oppression and domination, 
established by structures of economic and social power.‖58 Since the publication of 
Gutierrez‘ seminal work, the ―preferential option for the poor‖ has come to encompass all 
those who are marginalized or pushed to the periphery of society, including those who 
are ill.
59
 Those who are obese have been shown to be marginalized in several key life 
areas including health and economic advancement. Moreover a disproportionate number 
of those who are obese are also marginalized due to race or class or geographic location. 
As such, Gutierrez would likely urge that the obese are sufferers to whom a particular 
obligation of solidarity, advocacy, and compassion are owed.
60
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   Schillebeeckx‘ work on suffering is notable for his analysis of the common 
response to suffering shared by religions. Schillebeeckx suggests that the proper response 
to suffering of any kind is to find a way to eliminate it.
61
 Keenan takes exception 
however to Schillebeeckx‘ distinction between merited suffering and unmerited suffering, 
stating: 
I think holding onto this distinction is deeply problematic. To the extent that we 
leave the distinction intact, to that extent we still believe that we can determine 
who should be the beneficiaries of our compassion and who should not. But, how 
can we know that someone‘s suffering is really ―unmerited?‖ How do we arrive at 
such divine judgment? Does the AIDS victim really have to be a child or a 
hemophiliac? Does the cancer victim really have to have been taking every 
precaution against carcinogens? Does [the] tortured political activist really have to 
have been politically prudent? Does the date rape victim really have to be 
insisting on ―No‖ the entire time?...if we insist on the distinction, it seems to me 
that a deep residue of moralism is apparent whenever listeners are  encouraged to 
sift out the ―merited‖ from the ―unmerited suffers.62  
 
One might similarly ask if it is appropriate to demand that a person who is obese have 
avoided every dessert, exercised at least three times a week, and tried all possible 
solutions for weight loss from diet and exercise to Weight Watchers to pharmacology in 
order to gain compassion for her suffering. Furthermore, one might ask if we also need to 
inquire whether those who are obese also have sufficiently attempted to overcome other 
overlapping marginalizations such as race or gender or genetics which also influence the 
development of obesity. Keenan summarizes the consequences of continued failure to 
relinquish the concepts of merited and unmerited suffering, stating: 
  Let us not deny that evidently some suffering is tragically unmerited but I am sure 
that in most instances our difficulty is not in acknowledging that, but in our 
propensity to judge another‘s suffering as merited. Is not the ultimate purpose of 
the distinction to winnow out those people whom we believe are not worthy of 
our compassion?...So are we not finally left with the distinction as little more than 
a device that allows us to withdraw compassion and confirm our self–serving 
righteousness? The distinction allows us, I think, the opportunity to parse out our 
sympathy in very condescending and stingy ways.
63
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For those in medicine who retain the distinction that obesity is merited suffering, the 
result may be a lack of compassion and a parsing out of which interventions are 
appropriate or inappropriate based on the blameworthiness of the individual. This may 
serve to prevent the physician from exploring the full scope of efficacious treatments, 
including WLS, with the sufferer. Being able to re-conceptualize suffering to reject the 
distinction between merited and unmerited suffering would be a strong step forward in 
reducing unhelpful attributions of blame found in the treatment of those who are obese.  
 It may be possible to positively influence efforts to reduce this unhelpful 
distinction between merited and unmerited suffering among physicians. In one study, 
Roberts et al. paired a small group of third-year medical students with obese patients 
undergoing evaluation for bariatric surgery.
64
 Students established a longitudinal 
relationship with the patient and family members lasting approximately a year, received 
faculty mentorship from the physician caring for the patient, and kept a journal in which 
they reflected on their various experiences. Students‘ reflections were analyzed for 
common themes and changes in perceptions or attitudes. Goals of the study included: 
determining whether such extended interactions with obese patients would alter the 
perceptions, attitudes, and potentially the future practices of the medical students. Two 
specific goals of the study were to determine whether students would develop a better 
understanding of the impact of obesity on individuals from a personal, social, medical 
and financial perspective and to determine the impact, if any, of this extended 
relationship on medical students‘ beliefs about obesity as a disease and those who are 
obese.
65
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Questionnaires at baseline and at the study‘s conclusion queried student attitudes, 
stereotypes, ability to accurately estimate body size and BMI as well as the ability to 
ascertain deficits in other physicians‘ knowledge and attitudes about obesity. With regard 
to accurately estimating body size and BMI it was hypothesized that if students 
underestimated patient weight these inaccurate estimations may serve as a barrier which 
would preclude any discussion of weight or weight loss options. Student responses to 
knowledge and attitude assessment queries were found to differ from those previously 
reported for practicing physicians on many survey statements, including student 
participants more strongly agreeing with the relationship between obesity and serious 
medical conditions, the need to educate patients about obesity risks, and willingness to 
recommend bariatric surgery evaluation. These differences were maintained after clinical 
clerkships had been completed. Reflection themes included a growing ability to recognize 
obesity stereotypes, improved estimation of body mass index, and an awareness of other 
physicians‘ negative attitudes about obesity and those who are obese.66  
The investigators concluded that those students who get to know patients who are 
obese, thus relying on personal experience instead of social construction of those who are 
obese, may have different, more compassionate, and more accurate attitudes toward 
obesity than those reflected in prior data regarding attitudes of physicians in practice. 
This development, implementation, and assessment of a novel pilot program to teach 
third-year medical students about obesity and bariatric surgery suggests a potential 
impact on student attitudes and understanding of obesity and obesity surgery. It is 
important to emphasize that the study also concluded that this small group of medical 
 266 
 
students would be more likely to recommend evaluation for bariatric surgery to their 
patients in the future.
67
  
Ascriptions of blame and personal moralized responsibility have once again been 
shown to be as unhelpful for solving the problem of obesity as they have been for other 
medical conditions. In fact, these backward-looking ascriptions of responsibility shift the 
focus away from solutions. As has occurred with HIV, alcoholism, and other complex 
diseases, it is possible to reduce the ascription of blame for obesity and to erase the 
distinction between merited or unmerited suffering. In order to accomplish these goals, a 
concerted effort to change the way obesity and suffering are conceptualized, as well as 
concrete efforts to alter physician understanding of those who are obese, will be 
necessary. The following section discusses the ways in which concern for justice may 
help to motivate such efforts. The section opens with an analysis of the unfair treatment 
of those who are obese.  
B.ii Justice  
 All conceptions of the demands of justice share the underlying principle of formal 
justice: relevantly similar people or situations must be treated similarly.
68
 Formal justice 
in medicine requires treating patients similarly on the basis of their similar need for care. 
This section argues that the withholding of access to WLS constitutes a failure to fulfill 
the demands of formal justice and that this failure may be attributed to general social 
attitudes and physicians‘ beliefs that obese people fail to merit interventions in the same 
way as patients afflicted with other medical conditions. Employing merit as the basis for 
access to healthcare interventions has been determined to be ethically unacceptable since 
there was social and bioethical rejection of the criteria employed by the Seattle God 
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Committee in allocating dialysis.
69
 Second, insofar as merit can be meaningfully 
considered, obese people merit treatment for their condition as much as people with 
hypertension, multiple sclerosis, diabetes, cancer, and alcoholism do. All of these 
conditions are complex, multifactorial conditions to which the individual patient's 
behavior may contribute to symptom manifestation; however, in no case is it considered 
appropriate to say that the person merits her disease and therefore does not merit 
treatment. 
For many other invasive medical procedures, including high cost and technology-
laden transplantation, bioethical analysis appears to have effectively dealt with the issues 
of social justice and patient deservingness by employing the principle of respect for 
autonomy as well as stringent clinical protocols for medical appropriateness.
70
 For 
instance, candidates for liver transplantation whose liver disease can be attributed to 
alcoholism are subject to appropriate clinical measures to determine their clinical 
suitability but are no longer treated as less deserving of transplantation because of the 
behavioral components of their disease process.
71
 Discussion and exploration of the 
option of liver transplantation is not withheld from those suffering with liver disease 
because they have in the past been causally responsible for the damage to their liver.  
The first step in a developing a more just system for the treatment of obesity is to 
ensure that obesity is addressed, and that it is routinely raised with patients as a health 
concern and topic appropriate for clinical discussion (not a moral problem). In keeping 
with the goals of medicine, the patient should be educated on the risks of excess weight 
and potential for life-threatening co-morbidities. Educational dialogue such as this meets 
the goal of medicine which encourages ―education and counseling of patients regarding 
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their condition and prognosis.‖72 The physician‘s willingness to initiate such discussions 
may help to create an environment of appropriate trust and mutual respect. The clinical 
encounter should be one that is marked by respect, emotional safety, and a lack of stigma, 
embarrassment, blame, and ridicule.
73
 As established before, failure to broach this 
important health topic constitutes a breach the goals of medicine. What makes this a 
matter of justice, is that the entire continuum of individually appropriate treatments 
should be presented to obese patients as would be done for patients with cancer, leukemia 
or any other disease. As with all medical conditions, all treatment options should be 
considered with the patient from least invasive and lowest risk to more invasive, higher 
risk interventions; in the case of obesity this continuum would include diet and exercise, 
pharmacological interventions and when appropriate, the option of surgical weight loss 
should be discussed.  
  Chronic kidney disease is one condition for which a continuum of care focused on 
appropriate clinical indicators and best practices has been instituted. Like obesity, chronic 
kidney disease is a progressive and debilitating health problem. It is caused by and 
influenced by a myriad of factors including lifestyle choices and genetics.
74
 For this 
medical condition, steps have been taken to standardize diagnosis, staging, and the 
appropriate interventions to be considered at each stage. A consensus statement by the 
Kidney Disease Outcomes Quality Initiative outlines a progressive clinical management 
system which attempts to standardize clinical understanding of this disease as well as 
appropriate clinical interventions across the spectrum and in keeping with best practices 
at each stage. While the recommendations are focused on avoiding invasive, expensive 
interventions needed at later stages of disease progression, there are specific guidelines 
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for initiating both discussion of and the use of renal replacement therapy through various 
forms of dialysis. Moreover, consideration of patients for kidney transplantation, an 
invasive surgical technology, is also addressed as part of this comprehensive clinical 
continuum of care.
75
 This document institutionalized a continuum of care for those who 
are identified as having chronic kidney disease.
76
 No such continuum of care has been 
adopted for the treatment of those who are obese.
77
  
The current lack of a continuum of care for obesity is in direct violation of the 
formal principle of justice and appropriate standards of medical care. This problem has 
deep roots and is systemic.
78
 John Dixon, Head of Obesity Research at Monash 
University in Australia, discusses the disparity between indications for bariatric surgery 
and actual referral rates for evaluation for surgical weight loss interventions which he 
cites as being ―less than 1 percent of those eligible.‖79 He goes on to say, ―…even 
discussion of surgical referral is optional. It is time we articulated and defined a group of 
patients where referral for a surgical opinion is no longer merely an option but a 
physician‘s responsibility as best care for the patient.‖80  
…currently, we have no indications or guidelines that physicians could use for the 
obligatory referral for bariatric surgical assessment as a best practice. In turn, 
health care providers, insurers and payers can use their discretion in providing 
bariatric surgical services.
81
  
 
Citing the 1991 National Institutes of Health criteria for patient selection for 
gastrointestinal surgery for severe obesity he notes these expert recommendations: 
1. Patients seeking therapy for severe obesity for the first time should be 
considered for treatment in a non-surgical program with integrated components of 
dietary regimen, appropriate exercise and behavioral modification and support. 
2. Gastric restrictive or bypass procedures could be considered for well-informed 
and motivated patients with acceptable operative risks. 
3. Patients who are candidates for surgical procedures should be selected carefully 
after evaluation by a multi-disciplinary team. 
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4. The operation be performed by a surgeon substantially experienced with the 
appropriate procedures and working in a clinical setting with adequate support for 
all aspects of management and assessment, and  
5. Lifelong medical surveillance after surgical therapy is a necessity to monitor 
for complications and lifestyle adjustments.
82
  
 
In spite of these broad recommendations made over two decades ago, as yet there 
remains no standard for physicians to use regarding when, or even whether, to refer or 
initiate a discussion of bariatric surgery with patients who meet the BMI criteria. 
Physicians are left to rely on their own, socially influenced, potentially biased judgment 
and personal experience. 
Dixon suggests areas of refinement in the broad recommendations of the NIH. His 
refinements would take the broad NIH recommendations to a level which standardizes 
and institutionalizes a clinically appropriate continuum of care for patients who are 
obese. He outlines two clinical criteria based on BMI and/or co-morbidities, which 
include more clearly defined situations under which the physician would either be 
―obligated to discuss surgery as an option‖ or ―when surgical referral is appropriate and 
indicated as best care for the patient.‖83 His proposed refinement of the NIH 
recommendations would serve to align discussion of a continuum of obesity treatment 
with the approach employed for other medical conditions. Dixon makes clear the 
connection between concern for justice and the development and implementation of 
standards of, and guidelines for, obesity care.  
If those familiar with the current evidence regarding the net benefits of surgically 
induced weight loss cannot define and articulate a specific group of patients that a 
caring physician must refer for a surgical opinion, then we allow, by our silence, 
the current arbitrary and discretionary approach that is applied by health care 
providers, payers, insurers, and referring physicians.  
 
He concludes his recommendations with a call for the advocacy necessary to institute 
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such change. 
It is time for leaders with a clear understanding of outcomes of bariatric surgery to 
stand up and advocate for a standard of best care for those suffering from the 
more serious forms of this serious chronic relapsing condition. Guidance and 
education will be needed for both patients about their opportunities, and their 
primary care physicians about their responsibilities.
84
  
 
With regard to other conditions, and in medicine generally, it has been recognized that 
development of evidence-based clinical practice guidelines can help to ensure the 
equitable treatment of patients.
85
 Therefore, respect for patient autonomy and concern for 
patient welfare, along with considerations of justice support ensuring access to a 
continuum of obesity treatment.  
Individual practitioners should not be enabled to appoint themselves as 
gatekeepers, restricting access to important treatment information which should instead 
be provided to inform patients and empower them to make truly informed decisions about 
treatment. To withhold information or access to treatment alternatives is a violation of 
respect for patient autonomy, patient rights, and the requirements of informed consent 
doctrine. Further, as this section argued, the present system of obesity treatment is not 
just because it fails to treat patients with similar serious chronic conditions similarly.  
 The final section of this chapter returns to physicians‘ obligations and the goals of 
medicine to argue for the non-abandonment of obese patients and then applies a feminist 
ethic of care to the treatment of obesity to provide an ethical framework for improving 
the medical care of obese patients. In the first subsection, the obligation of non-
abandonment and the ethical goals it serves are discussed in relation to the harms obese 
patients in particular may experience if physicians refuse to provide them appropriate 
care. The second subsection presents an ethic of care and then applies it to the problem of 
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address obesity and the health problems of obese patients. It is argued that an ethic of 
care provides an ethical frame work for improving the treatment of obese patients and 
providing them the continuum of care that characterizes treatment of other life-
threatening chronic and acute conditions.  
C. The Physician Obligation of Non-Abandonment, and the Application of an Ethic of 
Care to Obesity 
 The previous section argued that justice demands similar treatment of those 
similarly situated and highlighted the ways in which justice is lacking in the clinical 
treatment of those who are obese. It was argued that patient welfare can be improved by 
adopting an appropriate continuum of care for those who are obese and that justice 
requires doing so to the extent that a continuum and guidelines for implementing exist for 
other conditions.
86
 The proposed continuum should not be solely reliant on physician 
discretion and lack of bias, but should be institutionalized as a matter of professional 
practice guidelines to ensure that all available technologies are explored, including 
discussion of surgical weight loss options. This final section of the chapter provides 
additional grounds for implementation of a continuum of care and locates these grounds 
in the physician‘s obligation of non-abandonment. In the first subsection, the obligation 
of non-abandonment and the ethical goals it serves are discussed in relation to the harms 
obese patients in particular may experience if physicians refuse to provide them 
appropriate care. The second subsection presents an ethic of care and then applies it to the 
problem of addressing obesity and the health problems of obese patients. It is argued that 
an ethic of care provides an ethical foundation for improving the treatment of obese 
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patients and providing them the continuum of care that characterizes treatment of other 
life-threatening chronic and acute conditions.  
C.i Non-Abandonment 
This chapter has addressed several obligations incumbent upon physicians in 
exercising their professional duties. These have included the obligation to evidence 
respect for persons, to respect autonomy, to be truthful, and to obtain informed consent. 
The professional obligation of non-abandonment also strongly supports provision of 
information about WLS to obese patients. In writing about the ethical obligations central 
to the social role of physicians, physicians Timothy Quill and Christine Cassel assert that 
―non-abandonment places the physician‘s open ended, long term caring commitment to 
joint problem solving at the core of medical ethics and clinical medicine‖.87 Especially in 
the context of chronic conditions like obesity, non-abandonment becomes an important 
obligation. While in the past, the acute nature of illness for which there were few curative 
interventions often caused quick death, today chronic conditions are an increasing focus 
of medical attention.
 88
 While Quill and Cassel do not specifically address obesity as a 
chronic illness it easy to see how obesity and its co-morbidities fit the description of the 
types of diseases to which they refer and how issues of abandonment and a call for non-
abandonment are warranted here.
89
 Quill and Cassel discuss the obligation of ―non-
abandonment as an obligation to respond to vulnerable persons whom we contact in our 
daily work.‖90 According to them, non-abandonment involves advocating for what is in 
the best interest of the patient, based on his unique clinical predicament, and in 
accordance with the patient‘s goals and own conception of welfare.  
 Similarly, in an article on patient-centered duties and limitations placed on the 
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right to refuse treatment for moral, religious or ethical reasons, Jill Morrison and Mikole 
Allekotte, attorneys with the National Women‘s Law Center, outline an argument 
regarding physician refusals of reproductive technologies that cites various harms and 
other unintended consequences of such refusals for patients.
91
 Though their argument is 
not centered on refusals to treat obesity or those who are obese much of the analysis 
applies and will be used here to explicate types of refusals and the potential patient harms 
they may cause to those who are obese. They begin by linking non-abandonment, trust, 
internal morality, and goals of medicine. 
By entering the medical profession, practitioners agree to a set of ethical 
principles which ensure that they will put the patient‘s interests before their own. 
Medical professionals have superior scientific knowledge and skill to that of the 
patient, which puts them in a position of trust and influence. Modern medical 
practice continues to move away from a model of paternalistic physician control 
over patients towards patient decision-making, which requires the professional to 
impart enough medical information for the patient to make an informed 
decision.
92
  
 
Quill and Cassel discuss the interplay of the obligation to non-abandonment with 
traditional bioethical principles. With regard to respect for autonomy, they write that 
―passively acceding to a patient‘s request that defies the physician‘s recommendations 
and clinical judgment without fully informing the patient and actively exploring 
alternatives can be a form of abandonment.‖93 In the case of a patient who prefers not to 
discuss her weight issues it certainly may be easier for the physician to choose not to 
bring up the subject at all since the patient ―doesn‘t want to hear it.‖ However, according 
to Quill and Cassel this would be a form of abandonment by failing to empower the 
patient to explore her options to seek her health-related welfare in light of her own values 
and priorities. Or the physician may fail to provide comprehensive information on weight 
loss alternatives because various weight loss technologies are not in keeping with the 
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physicians own values which dictate that weight loss should be earned and that surgical 
weight loss is too simple. That too would constitute a violation of respect for autonomy 
and is also a form of patient abandonment.
94
  
 Quill and Cassel align the obligation of non-abandonment with the principle of 
beneficence through the benefit afforded by the physician-patient relationship itself: 
adherence to the principle of beneficence, they write, ―ensures that a physician‘s actions 
benefit the patient…Whether a given act is beneficent may depend on the nature of the 
act itself or on its meaning to the participants in the context of their relationship.‖95 For 
patients who may have internalized the stigma of their obesity or experience obesity-
related abjection, the persistence of a physician in a relationship may afford special 
meaning and thus benefit.  
 Despite the potential importance for obese patients of non-abandonment, there is 
evidence that obese patients are abandoned and refused treatment because of their 
condition. The popular media reported, for example, that some physicians refuse to 
accept new patients who are obese.
96
 Specifically, in South Florida a group of 
obstetricians-gynecologists (OB-GYNS) have refused to accept obese patients. Some of 
these physicians cited that they are concerned with doing more harm than good in treating 
such patients, while still others have simply stated that their equipment (such as 
examination tables or gowns) are ill-equipped to handle larger patients. Still others are 
worried about malpractice suits following difficult births to mothers who are obese. The 
implications of such refusals to treat are far reaching. 
 First, when professionals refuse to treat obese people, there may be nowhere else 
in the patient‘s community to obtain similar care, or the cost of seeking treatment 
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elsewhere may have impose additional financial burdens on the individual or family. At a 
minimum, the obese person may experience a delay in obtaining necessary treatment. 
Moreover, a patient turned away by a practice may experience the emotional sequelae of 
rejection or abandonment, even if it is easy for him to access care elsewhere. For a 
member of a stigmatized or marginalized group, such emotional sequelae may be 
particularly damaging and reinforcing of already internalized stigma. When a physician 
refuses to treat an obese person for any ailment or condition, then no physician-patient 
conversation regarding obesity and treatment options can occur. The physician who has 
refused to provide treatment has effectively cut off an avenue to educate and potentially 
improve the condition of the patient. 
Second, within an existing physician-patient relationship, a physician may refuse 
to provide an obese patient information about the full range of treatment options for 
obesity, including WLS. The patient may not even be aware that he has been denied 
potentially medically desirable treatment options. Failure to discuss options, give 
complete information about the likely consequences of obesity, or blatant disregard of the 
topic because it is too difficult or too fraught with emotion could equally be considered 
varying forms and degrees of patient abandonment. 
A third type of refusal of care occurs when physicians fail to make appropriate 
referrals for evaluation to bariatric surgery when requested by the patient. The 1991 NIH 
recommendations laid out a rudimentary clinical pathway.
97
 Physicians who fail to make 
appropriate referrals for WLS—either for those patients who request such referral, or for 
whom referral is the next appropriate step in providing care—breach of their duty of care. 
This either effectively denies patients potentially efficacious treatment, or leaves the 
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patient to seek alternatives without support. Because ongoing support is needed 
throughout the evaluation process for WLS and for post-surgical follow-up, the 
unwillingness of a local, primary care physician may effectively render a patient 
ineligible as a WLS candidate. 
These three types of treatment refusal constitute different degrees of patient 
abandonment. They fail to serve the patient‘s interest and the goals of medicine. Such 
partial and total abandonments subject obese patients to serious physical, emotional and 
financial consequences.  
They diminish the opportunity for the patient to access efficacious treatment 
along the continuum of their obesity. For instance, if when a patient is 25 pounds 
overweight detailed and ongoing discussions occurred with various physicians the patient 
may be able to make significant changes through diet and exercise or pharmacological 
interventions, which would ultimately enable him to avoid bariatric surgery. If the patient 
were unable to do so, then earlier conversations about all potential options, including 
WLS, would facilitate better informed decision making as a process which unfolds over 
the course of time. A process of shared decision making about obesity treatment could 
unfold over time, and if WLS is eventually deemed appropriate, informed consent for it 
would not be a relatively perfunctory event-based act which merely meets the legal 
criteria of consent. Instead, evaluation of and consent to WLS could fulfill the spirit of 
the doctrine of true informed consent. 
Ironically, by refusing to treat obese people or provide them with appropriate and 
timely information and referrals, physicians may be contributing to the need for WLS 
when in fact their expressed or unrecognized goal was to avoid surgery.
98
 Failing to 
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provide information about each of the treatment options‘ benefits and burdens may mean 
that patients fail to take seriously the nature of obesity and its potential to damage bodily 
function and quality of life. If the discussion is not undertaken with the patient, it may not 
be possible for the patient to realize its seriousness early enough to avoid permanent 
damage. In this case, patients for whom earlier interventions might have been possible 
may have advanced beyond that window of opportunity and now have fewer viable 
options to save their life and improve their condition. Take for example this personal 
story, recounted by a social worker who had worked on a surgical bariatric floor.
99
 The 
social worker was waiting with a patient who was preparing for WLS later that day. The 
patient was tearful, obviously distraught, and very afraid according to the social worker. 
The patient shared with the social worker that no one had ever mentioned WLS to her 
before the last year, even though she had been overweight for decades and had suffered 
from a number of obesity-related diseases. The patient now she felt she had no option but 
to go through with WLS because the physicians were telling her now that it was either 
WLS or death from her co-morbidities. The patient felt that she really had no choice at 
this late stage of disease even though she was told that she may indeed die on the 
operating table as at this point she was a marginal surgical candidate. The choice she 
faced was risking death due to co-morbidities or death during surgery. The patient 
wondered aloud why her doctors had been willing to treat her diabetes, hypertension, and 
other diseases but had been unwilling to discuss WLS with her. She wondered if she 
could have been better prepared if she had known about WLS sooner when she was 
healthier. While the patient did choose the option of surgery, she shared that she did not 
feel she had a true choice. She was angry and disillusioned by those who had taken an 
 279 
 
oath to help her through sickness. This patient articulated that she felt as though her right 
to make a truly autonomous choice about her care had been denied her because pertinent 
information needed to make a fully informed decision had been withheld over a period of 
several years.  
Refusals of treatment, information, or referral can serve to reduce the 
effectiveness of surgical weight loss interventions when they are eventually accessed. If a 
patient is refused information or is refused appropriate referral for treatment she may 
delay in seeking time sensitive treatment which if obtained earlier may have been more 
likely to succeed.
100
 For instance, research has shown that in the case of effectuating 
sustainable remission of type II diabetes, earlier intervention via WLS is superior to 
surgical intervention for weight loss once the patient‘s body has sustained greater 
damage.
101
 In essence there is a point of diminishing returns for ameliorating co-morbid 
disease even with the use of the most efficacious treatment currently available. 
Treatment refusals can present financial harms to patients and reduce the 
efficiency in health care delivery patients.
102
 Additional costs associated with seeking 
another provider who offers more comprehensive care of the obese patient may mean that 
low income people are denied access altogether. Moreover, patients may have limitations 
placed upon them by their insurance providers that are exacerbated by treatment refusals. 
For instance, some insurance limits the number of physician or specialist visits per year 
for patients. Any access to healthcare above that limit will need to be paid for by the 
patient out of pocket or at a higher rate. In addition to insurance and access issues, 
refusals can impose additional costs for treatment.
103
 If the patient does eventually access 
WLS it may be later rather than sooner and therefore additional patient share costs 
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incurred due to hospital day stays or co-payments may be present which would not 
otherwise have applied. Since the incidence of complications is greater the longer surgery 
is delayed and the sicker patients are it seems reasonable to assume that the financial 
burden to patients will be greater by delaying efficacious treatment as well. 
The obligation of non-abandonment requires that obesity and its treatment 
options, including bariatric surgery, be addressed by medical professionals. Non-
abandonment is marked by a willingness to engage the patient in ongoing discussions 
about what options exist for treatment even when those treatments are not optimal, and 
even if professionals believe that personal responsibility is at play in the patient‘s 
condition. The obligation of non-abandonment therefore requires medical professionals to 
discuss surgical options for weight loss when it might be clinically warranted in the 
future and certainly if it is clinically warranted under present circumstances. The 
following section discusses incorporating an ethic of care in the treatment of those who 
are obese and argues that this relational model which is sensitive to individual nuance and 
recognition of patient vulnerabilities, affords an ethical foundation for improving the care 
of those with obesity.  
C.ii An Ethic of Care 
Deontological, consequentialist, or rights-based approaches in ethics share a 
commitment to viewing individual moral agents as the fundamentally important unit of 
ethical analysis, societies as composed of individuals, and have tended to varying degrees 
to view individuals as substantially independent, autonomous, and rational. The emphasis 
of these theories is on rules, duties, justice, positive and negative rights, impartiality, 
universality, or utility.
104
 Care ethics on the other hand, evolved from a different 
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conception or construction of the person in society. The understanding of the individual 
as conceived by the ethic of care is that of an interdependent, essentially relational 
person. The individual is not an island but is instead part of multiple overlapping larger 
groups which begin in the family and continue into the larger society. An ethic of care 
emphasizes the ethical importance of human relationships and emotion based virtues such 
as benevolence, mercy, care, friendship, reconciliation, and sensitivity.
105
 According to 
philosopher Joan Tronto, an ethic of care is best understood not only as an approach in 
moral philosophy, but also as a political theory with relevance for all aspects of 
society.
106
 To be implemented in a just, productive, and non-self-abnegating way, she 
argues, an ethic of care requires a political structure that supports care activities. 
In the literature of ethics, the word care is frequently defined as a practice, value, 
disposition, or a virtue. These descriptors are often explained as overlapping and 
interrelated.
107
 For philosopher Virginia Held care is a form of labor and an ideal that is 
intended to guide normative judgment and action. Held explains care as ―clusters‖ of 
practices and values.
108
 Another definition of care, advanced by Tronto and Berenice 
Fischer, defines care as ―a species of activity that includes everything we do to maintain, 
contain, and repair our ‗world‘ so that we can live in it as well as possible. That world 
includes our bodies, ourselves, and our environment.‖109 Care in this regard is a holistic 
notion meant to encompass a broad swath of activities and domains including the body. 
Care requires morally good persons for fulfillment. ―To be a morally good person 
requires, among other things, that a person strives to meet the demands of caring that 
present themselves in his or her life‖.110  
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 An ethic of care is often explicitly tied to medicine and bioethics.
111
 This seems a 
somewhat natural pairing since medicine is a profession based on entering into a 
relationship the foundation of which is caring for patients. In essence by entering into the 
practice of medicine physicians and other healthcare professional have chosen to put 
themselves in a position where opportunities for caring present themselves continuously. 
In fact, meeting the care demands of people is at the heart of these professions. Treatment 
of obesity, as with other medical conditions, occurs in large part due to the efforts of 
those in caring professions such as physicians and nurses. Physicians enter the field of 
medicine for many reasons. Presumably one primary motivator to enter into the field of 
medicine is because of a desire to care for people in various states of health or illness.
112
 
Hence there is an expectation that taking up the demands of care will be present among 
those who enter become physicians and will manifest in particular ways.  
 The work of Tronto on both the practice of an ethic of care and its elements will 
be the starting point for this analysis. This framework will then be applied to the clinical 
care and treatment of those who are obese. Comparisons between the current and 
proposed systems will highlight the superiority of an approach grounded in an ethic of 
care for clinical engagement with obesity and its treatments. 
 In discussing an ethic of care Tronto points out that ―an ethic of care … requires 
some specific moral qualities.‖113 These include: attentiveness, responsibility, 
competence, and responsiveness.
114
 Attentiveness refers to recognizing that areas of need 
exist in the first place. Tronto states that this is the starting point of an ethic of care 
because without well-honed skills at noticing an opportunity for care there can be no 
subsequent action of providing care or meeting the need.
115
 Following that logic, 
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inattentiveness or blatantly ignoring areas or situations in need of care is considered a 
violation of this standard and a form of failure to provide care. Lack of attentiveness 
would then seem even more of a moral failing within a profession whose purpose it is to 
recognize the needs of caring for a person. Tronto goes on to say that ―one needs, in a 
sense, to suspend one‘s own goals ambitions, plans for life, and concerns in order to 
recognize and be attentive to others.‖116 While this may be idealistic, traditional medical 
ethics requires physicians to suspend their own interests to act for the sake of their 
patients‘ interests. It would also seem appropriate to require suspension of physicians‘ 
socially constructed bias regarding obesity; even temporary suspension may be required 
in order to be attentive to the needs of the obese patient. The second quality required of 
an ethic of care is responsibility. Recognizing the potential for confusion between the 
concepts of responsibility and obligation (such as those found in the Hippocratic Oath) 
Tronto distinguishes between the two by positing that responsibility deals with cultural 
practices which support care rather than a set of formal rules or duties which arise from 
caring obligations.
117
 Thus responsibility of caring might entail how a parent is to 
respond to the needs of his children. On the other hand, an obligation would be manifest 
in the duty of informed consent by a physician. For physicians it would seem that there is 
both a responsibility and subsequent obligations which arise from this professional caring 
role. As discussed in chapter three, responsibility involves taking care of the problem that 
attentiveness identifies.  
The third quality required for care is competence. Tronto explains the importance 
of this element when she says, ―Intending to provide care, even accepting responsibility 
for it, but then failing to provide good care, means that in the end the need for care is not 
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met.‖118 Failure to act competently fails at caring. Physicians who fail to recognize the 
relative merits of different weight loss interventions, for example, may be said to fail at 
caring for want to competence, not for lack of good intentions. In fact, some physicians 
who withhold information about WLS or refuse to refer patients for evaluation may be 
acting with paternalistic intentions, but fail to be truly caring because they lack particular 
competencies—namely, understanding their patients‘ particular needs and the potential 
benefits of WLS, overestimating the risks of surgery, or misunderstanding the etiology of 
obesity so they think surgery cannot truly benefit their patients. The final quality which 
Tronto discusses as being necessary to an ethic of care is that of responsiveness. 
Responsiveness is understood by Tronto as the care receiver‘s reaction to or acceptance 
of various elements found in the ethic of care. Responsiveness and vulnerability are 
closely linked according to Tronto.
119
 It is in the care receivers‘ recognition of 
vulnerability (need) that independence is challenged and interdependence acknowledged 
so that the moral actors can move forward together. The integrity of care is the 
culmination of each element described above which ―must fit into a whole.‖120  
Tronto acknowledges the complexity of care as a practice stating that: 
 
… it involves more than simply good intentions. It requires a deep and thoughtful 
knowledge of the situation, and of all of the actors‘ situations, needs and 
competencies. To use the ethic of care requires knowledge of the context of the 
care process.
121
  
 
At present the treatment of obese people by medicine seems to be lacking elements 
expected to be found in an ethic of care.  
An ethic of care, if properly applied, is of value in understanding the needs of 
those who are obese and the requirements of improving their treatment. Moreover, an 
ethic of care as applied here stands to ―allow us to move to a more just and caring 
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humane society.‖122 for those who are obese and suffer from its disabling co-morbidity. 
This is true for several reasons. First, an ethic of care stresses the importance of attending 
to particularity or to the specific circumstances surrounding an issue.
123
 Thus an ethic of 
care reinforces the individual-level attention demanded by all clinical medical 
encounters, including those where obesity or its co-morbidities is the health concern. 
Second, an ethic of care focuses on intervening with an understanding that individuals are 
in relationship (both with others and within systems such as the medical system).
124
 
Finally an ethic of care understands care to refer to some sort of active engagement which 
requires both an outward reach (on the part of the physician and the patient) as well as the 
implicit action towards resolution of the problem.
125
 It seeks a forward-looking goal, not 
the backward-looking assignment of causal or moral responsibility. 
Multiple factors of an ethic of care make it a productive normative framework for 
medical care in general and for obesity specifically. An ethic of care urges that 
engagement with the patient that begins at the level of the individual and her particular 
circumstances, not at the level of a condition considered generally. In other words, the 
person is the focus and not the obesity. An ethic of care provides for a vigorous 
engagement of potential solutions based upon needs of the individual while 
simultaneously focusing on the broader social and moral context of the care of all people 
with obesity within the medical system. Thus, an ethic of care allows for greater 
contextualization of the individual‘s problem of obesity, which simultaneously 
diminishes blame attributions while bolstering the focus on solution.
126
  
It is necessary to analyze why this distinction between person-first versus 
condition-first is important and how it will serve to positively alter the experience of the 
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patient. In starting with the person there is acknowledgment of obesity as a multi-factorial 
and highly contextualized problem, one requiring examination of the factors associated 
with this particular person‘s obesity and not obesity in general. So while it may be true 
that the patient does not get enough exercise and eats out too often, attending to obesity 
as multi-factorial and highly contextualized problem would lead the caring physician to 
examine in greater detail the contributors to lack of exercise and eating out frequently. If 
the inquiry is taken a few steps further by the caring physician then it may be revealed 
that patient is now caring for a disabled sibling which severely limits the time available 
for exercise and food preparation. Or it may be revealed that the patient has been verbally 
abused by his parents and now by his spouse and that he manages his emotions by 
covering them with food. Having done so for years in an effort to protect himself from 
one type of harm other types of harm have occurred. His body has borne substantial 
damage from this protective mechanism. Each of these highly contextual factors may be 
vital in determining the most appropriate course of clinical action and developing an 
individualized care plan with the goals of the patient and the patient‘s best interest at the 
forefront of the encounter.  
Contrast this approach with a more typical encounter which places the obesity at 
the center and the individual who is obese on the periphery. In this model, not based on 
the patient as individual but on the patient as a manifestation of the obesity, the process, 
the outcome, and the level of care experienced by the patient is likely to be vastly 
different. In more traditional models of patient interaction the physician observing that 
the patient is obese based upon BMI may counsel her on the importance of weight 
reduction and may even go so far as to discuss likely potential outcomes of failing to do 
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so. However, this more traditional model is likely to be lacking in an exploration of the 
multi-factorial etiology of the disease for this particular individual. As the patient is obese 
he or she obviously does not exercise and obviously eats more on a regular basis than is 
necessary. What is missing here is the exhaustive exploration of particularity which is 
found in a model which more closely attends to caring. The outcome of such an 
interaction may well be a superficial analysis of the problem leading to a faulty 
application of what is intended to be helpful professional advice. The patient is left 
feeling misunderstood and dissatisfied with perhaps no greater insight into the problem or 
its solutions while the physician is left feeling that discussing weight or weight loss 
options is futile. These feelings have now been reinforced for both parties. 
An ethic of care with its focus on attentiveness, responsibility, competence, and 
responsiveness concentrates on the various aspects needed to for healthcare to provide a 
more compassionate and active response to the medical condition of obesity. An ethic of 
care motivates and justifies forward-looking responsibility-taking in order to achieve a 
positive outcome, and will frequently eschew ascription of blame or backward-looking 
moral responsibility. An ethic of care seeks to understand a web of causes of a problem 
that needs to be taken care of; it therefore is not particularly concerned with looking 
backward to identify the cause of the problem. It instead views the multiple causes of a 
problem as multiple potential points of intervention or multiple resources for redress. The 
incorporation of the unique particularity of each person, upon which an ethic of care is 
based permits a system which is first concerned with the sufferer and second concerned 
with the obesity. It acknowledges the intersection of marginalizations and offers more 
compassionate understanding of the struggles associated with an individual‘s obesity. As 
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was shown in the research conducted with medical residents, perhaps both the patient and 
the practitioner can benefit from interventions that encourage active engagement of 
practitioners with patients as individuals. Such engagement increases understanding, 
builds mutual trust and respect, and facilitates finding potential resources to help address 
patients‘ needs. Such engagement and more nuanced understanding of the patients‘ needs 
promotes identification of solutions which are in keeping with the patient‘s conception of 
well-being and in alignment with accepted clinical standards for treatment. An ethic of 
care provides the ethical foundation that justifies and informs such a project of 
engagement.  
D. Conclusion 
 This chapter argued that the present system for the treatment of obesity fails to 
meet the goals of medicine, violates commonly accepted ethical principles and 
obligations, and is unjust. The current unjust approach to treating obesity was shown to 
have serious material implications for the welfare of those who are obese including 
delayed access to WLS or the withholding of WLS as a viable option. The current 
approach was revealed as violating the principle of formal justice by failing to afford 
patients with obesity the same care and access to efficacious treatment that is routinely 
provided to similarly situated patients with chronic, complex, debilitating, and life-
threatening conditions. This disparate treatment was attributed, in part, to unhelpful 
ascriptions of culpability for the condition. It was posited that such ascriptions may also 
lead physicians, imbued with the dominant social construction of obesity, to act in ways 
that are not truly in their patients‘ interests even as they misguidedly believe that they are 
acting paternalistically.  
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The chapter further argued that physicians‘ failure to address patient obesity is a 
form of abandonment, and moreover that the healthcare system abandons obese patients. 
Physician failure to address patient obesity, and to do so with respect and compassion, 
was shown to effectively re-victimize obese patients and cause them additional harms. 
This was shown to be particularly ethically problematic because the healthcare system 
should protect and promote the welfare of the vulnerable, not participate in their 
victimization. 
Such attitudes and failures were shown to reduce the opportunity for patient self-
determination and access to effective treatment. In examining the ways in which the 
current system curtails or violates respect for autonomy and patient welfare while 
perpetuating injustice, a picture of how the current system should be amended was 
introduced and grounded in an ethic of care. The new system requires abandoning the 
concepts of merited and unmerited suffering, facilitating a more comprehensive system 
based on an ethic of care, and finally adopting the proposed continuum of treatment for 
those who are obese. These changes will improve upon an unjust system thus providing 
one which is more caring, responsive, and ethically sound.  
The final chapter of this dissertation reviews the argument of this dissertation and 
provides a synopsis of individual chapter topics. 
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Chapter Six: Dissertation Conclusion 
 The final chapter reviews the overall argument of this dissertation and provides a 
synopsis of each of the chapters. The dissertation conclusion is provided in two sections. 
Section A summarizes the main points of the dissertation‘s argument while section B 
provides a brief review of material contained in each of this dissertation‘s chapters. The 
following section begins with a review of the arguments.  
A. Dissertation Argument Reviewed 
 This dissertation provided an ethical justification of surgical weight loss 
interventions in the treatment of obesity. Situating obesity as not only as a public health 
concern but also fundamentally a clinical medicine problem confronting individual 
patients and physicians, the dissertation argued that the time frame of public health 
interventions is too long for individuals presently facing obesity and its deleterious 
physical and social co-morbidities. It reviewed the risks of morbidity and mortality 
associated with obesity and the rates of success in reducing these risks associated with 
various interventions. It further argued that it is inappropriate to hold WLS to the goals of 
public health. This dissertation argued that failure to address weight loss on an individual 
level, and specifically to consider the clinical appropriateness of weight loss surgery 
(WLS) along a clinical continuum, raises serious questions about patient abandonment, 
failure to respect autonomy, and failure promote patient welfare. Moreover, social 
skepticism or rejection of WLS as a treatment option was revealed to raise concerns 
about fairness as these failures indicate that obesity is not regarded in relevantly similar 
ways to other life-threatening and health-impairing conditions.  
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To ground this argument, the dissertation examined various reasons that obesity 
and its myriad interventions, including WLS, are inadequately addressed in the clinical 
setting. It argued that considerations with cultural and ethical valence play a critical role 
in obesity‘s different and unfair treatment within clinical medicine. Gendered and 
theologically informed attributions of blame, shame, and self-stigma were shown to 
influence the attitudes and actions of both patients and clinicians with regard to 
addressing obesity. Inappropriate and conceptually confused ascriptions of responsibility 
were shown to impede social acceptance of, and access to, WLS. The dissertation 
criticized and subsequently reconceptualized these ascriptions of responsibility from a 
perspective informed by feminist epistemology and ethics in order to provide a more 
humane and nuanced foundation upon which reform of current clinical practices 
surrounding treatment of obesity can be built. These reforms included improvements in 
doctor-patient discussions of obesity and the adoption of clinical practice guidelines 
providing for a continuum of care. Informed by these feminist insights and a systems 
theory approach drawn from social work, the dissertation suggested specific revisions of 
the customary candidate selection process for those seeking WLS. Finally, this 
dissertation concluded that WLS is a valid option for those seeking resolution to life-
threatening co-morbid obesity related disease and that barriers to its access should be 
removed in healthcare. In support of the overall argument of this work, individual 
chapters provided areas of support which are briefly reviewed below. 
B. Chapter Synopses 
Chapter one provided relevant background information on the problem of obesity. 
The chapter examined controversies surrounding the most widely used tool for the 
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diagnosis of obesity, the measurement of BMI, along with reviewing several proposed 
alternatives which might provide a more accurate clinical data. Obesity trends as seen 
throughout the past fifty years of government data collection were reviewed. These 
surveys showed that obesity has become both more prevalent and more serious in the 
United States. Other international indicators revealed that obesity is a global problem. 
Increased obesity has subsequently led to increased physical and social co-morbidities 
such as diabetes, hypertension, reduced longevity, increased mortality, and in general 
diminished quality of life. Contested theories on the etiology of obesity and thus various 
ascriptions of blame were discussed. This chapter introduced the notion that various 
conceptualizations of obesity, including the appropriateness of its diagnostic tool, the 
acceptance of obesity as a disease, the understanding of obesity as a modern-day 
epidemic, and the subsequent approval or rejection of various interventions as applied to 
this problem, may serve to violate commonly accepted ethical frameworks such as those 
found in medical decision making, considerations of justice, and patient welfare.  
Chapter two explored the numerous technologies from self-help initiatives to 
surgical interventions and their associated normative frameworks which have been 
employed to treat obesity. Each of these technologies was shown to have met with 
varying degrees of success. Among organized self-help initiatives and commercial 
programs, it was shown that Weight Watchers, Inc. provided participants with superior 
weight loss results which may assist in diminishing co-morbidities associated with excess 
weight. Overall, self-help initiatives and commercial weight loss companies were shown 
to have a normative framework of self-reliance with some additional guidance offered to 
assist in overcoming a problem with myriad contributory factors. These programs were 
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shown to diminish one or several of the identified factors which are beyond an 
individual‘s direct control but which have been associated with the development or 
maintenance of obesity. Largely disappointing or failed efforts at pharmacological 
interventions were reviewed. Pharmacological interventions for obesity were shown to 
have traditionally suffered from either poor overall results or from an imbalanced risk-
benefit ratio for patients prescribed these medications. The result of this imbalanced 
equation has been serious and irreversible patient outcomes which necessitated the 
removal of some weight loss drugs from the market. The use and development of 
pharmacological treatments were shown to have advanced the normative framework to 
include an understanding that obesity may require more robust interventions than diet and 
exercise alone can produce. In fact pharmacological treatments revealed that obesity may 
be amenable to medical technologies. Finally, chapter two reviewed the development of 
various surgical interventions for weight loss which have developed over the course of 
the past half-century. Data were provided from various research studies indicating that 
surgery for weight loss thus far provides the best long-term outcomes when combined 
with subsequent lifestyle changes, and that the risks of surgery have been greatly 
diminished to the point of being considered manageable and similar to those experienced 
by patients when the gallbladder is removed. In spite of the efficacy of WLS and its 
manageable risks, this chapter revealed that exceptionalism has been and continues to be 
erroneously applied to this intervention. It was posited that continued exceptionalism 
applied to WLS likely has the effect of the intervention being viewed as too radical and 
hence real discussion of this intervention at a clinical level between patients and 
physicians may be thwarted.  
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The third chapter of this dissertation revealed several prominent ways in which 
obesity is a socially constructed phenomenon which relies on a faulty and fundamentally 
inadequate epistemology to frame the problem, an understanding of who are obese, and 
the appropriateness of various solutions to ameliorate the problem for the individual who 
is burdened, either physically, socially or both by their obesity. This chapter argued, that 
the dominant understandings of obesity neglect or discount important perspectives which 
must be considered in order to provide a more complete view both of the problem and the 
solutions. This chapter shed light on several social norms which inhibit the evolution of a 
more nuanced and enlightened understanding of obesity, as well as a wider acceptance 
and promotion of WLS. By utilizing feminist epistemological frameworks, current flaws 
in the construction of the obese identity, injustices present in the treatment of obese 
people, and the impediments to a wider acceptance and promotion of WLS were 
identified. 
 Chapter four argued that it is inappropriate to dismiss WLS as a valid individual-
level clinical technology based on the erroneous application of public health goals to 
what is, fundamentally, also an issue of clinical medicine. To conflate the goals of public 
health initiatives with the goals of clinical medicine was shown to be unacceptable in 
light of the availability of WLS which carries with it both acceptable levels of known 
risk, and an empirically substantiated ability to meet several of the goals of medicine and 
reduce co-morbid disease. This conflation was shown to further diminish the relevance of 
a trusting and caring physician patient relationship in addressing obesity. In light of a 
clearer understanding of the standards by which WLS should be evaluated, along with 
substantial empirical evidence of the clinical usefulness of this intervention further 
 301 
 
supported by patient narratives which expounded on the personal utility of this 
individual-level intervention, it was argued that more should be done to assist clinicians 
and patients in understanding surgical weight loss technologies as a valid choice along a 
continuum of care. This chapter argued in support of adopting a proposed continuum of 
care which includes consideration of surgical interventions in response to appropriate 
clinical indicators which do not rely solely on physician discretion.  
 This dissertation‘s chapter five argued that the present system for the treatment of 
obesity fails to meet the goals of medicine, violates commonly accepted ethical principles 
and obligations, and is unjust. The current approach to treating obesity was shown to 
have serious material implications for the welfare of those who are obese including 
delayed access to WLS or the withholding of WLS as a viable option. The current 
approach was revealed to violate the principle of formal justice by failing to afford 
patients with obesity the same care and access to efficacious treatment that is routinely 
provided to similarly situated patients with other chronic, complex, debilitating, and life-
threatening conditions. This disparate treatment was revealed to be attributed, in part, to 
unhelpful ascriptions of blame. It was posited that these ascriptions may also lead 
physicians, imbued with the dominant social construction of obesity, to act in ways that 
are not truly in their patients‘ interests though they misguidedly believe that they are 
acting paternalistically in doing so. The chapter further argued that physicians‘ failure to 
address patient obesity is a form of abandonment, and moreover that the healthcare 
system abandons obese patients. Physician failure to address patient obesity, and to do so 
with respect and compassion, was shown to effectively re-victimize obese patients and 
cause them additional harms. This was shown to be particularly ethically problematic 
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because the healthcare system is obligated to protect and promote the welfare of the 
vulnerable, not participate or perpetuate patient victimization. These attitudes and failures 
were shown to reduce the opportunity for patient self-determination and access to 
effective treatment. This chapter revealed how the current system should be amended by 
establishing a foundation in an ethic of care. The proposed system was shown to require 
abandoning the concepts of merited and unmerited suffering, facilitating a more 
comprehensive system based in an ethic of care, and adopting the proposed continuum of 
treatment for those who are obese. It was argued that these changes would improve upon 
an unjust system by providing one which is more caring, responsive, and ethically sound.  
 This dissertation has provided a heretofore absent ethical analysis of obesity, the 
obese identity, and various technologies for its treatment. This dissertation has concluded 
that the use of WLS in the treatment of an individual‘s obesity is not only clinically 
appropriate but should be more fully supported in healthcare by reducing bias and 
employing just practices in keeping with accepted ethical standards for other multi-
factorial conditions. Moreover, this dissertation has sought to provide a voice for those 
marginalized by the erroneous and partial construction of the obese identity which has 
until now served to silence those who are so afflicted and impede access to efficacious 
WLS. Ultimately, this dissertation has argued for the ethical and compassionate care and 
treatment of those who are obese. 
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